Unlock the full potential of your medical coding capabilities with the CPT® Advanced Coding Pack from the American Medical Association (AMA). Designed for professional medical coders, auditors, and billers like you, this comprehensive suite of resources provides everything you need to navigate the complexities of the CPT code set with confidence and precision.
Advanced Coding Pack includes:
CPT Assistant - Newsletter with official education and guidance
CPT Knowledge Base - Commonly asked coding questions answered by the experts
CPT Vignettes - Comprehensive clinical examples.
Add to your Find-A-Code subscription for $300 / person
Learn More and Subscribe
FA03.2 Other secondary osteoarthritis of other specified joint International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Laterality - only one may be selected [select] XK9J Bilateral XK8G Left XK9K Right XK70 Unilateral, unspecified Specific anatomy - multiple selections are allowed [select] XA6UT2 Joints of the head – XA65F2 Atlantooccipital joint – XA7EM1 Atlantoaxial joint – XA2SM2 Temporomandibular joint XA2NG8 Joints of the thorax – XA83N6 Sternocostal joint – XA30Q4 Costochondral joint – XA0892 Costovertebral joint – XA7AR2 Costotransverse joint – XA0ZE4 Facet joint XA1TL5 Joints of the pelvis – XA5A04 Lumbosacral joint – XA70B6 Sacrococcygeal joint – XA3T32 Sacroiliac joint – XA05J7 Shoulder joint –– XA49P8 Glenohumeral joint –– XA69U6 Acromioclavicular joint –– XA0CH1 Sternoclavicular joint – XA69H4 Elbow joint –– XA3G42 Proximal radioulnar joint –– XA46J3 Humeroulnar joint –– XA53P1 Humeroradial joint – XA27P3 Ankle joint –– XA8MM7 Talocrural joint –– XA2K81 Distal tibiofibular joint –– XA7SZ8 Subtalar joint – XA22T0 Joint of the foot –– XA2YS1 Intertarsal joint ––– XA4JJ1 Calcaneocuboid joint ––– XA0WY5 Talocalcaneonavicular joint ––– XA6NT7 Cuneonavicular joint ––– XA1N77 Cuboideonavicular joint ––– XA9SD1 Intercuneiform joint ––– XA2FA3 Cuneocuboid joint –– XA2MY1 Tarsometatarsal joint –– XA6FF3 Intermetatarsal joint –– XA8XU1 Metatarsophalangeal joint ––– XA7NJ7 First metatarsophalangeal joint ––– XA58K5 Second metatarsophalangeal joint ––– XA2792 Third metatarsophalangeal joint ––– XA7QC6 Fourth metatarsophalangeal joint ––– XA5A23 Fifth metatarsophalangeal joint –– XA04T7 Interphalangeal joint of the foot ––– XA87P9 Interphalangeal joint of great toe ––– XA5573 Proximal interphalangeal joint of the foot –––– XA56K9 Proximal interphalangeal joint of second toe –––– XA2QY2 Proximal interphalangeal joint of third toe –––– XA2R87 Proximal interphalangeal joint of fourth toe –––– XA1LM0 Proximal interphalangeal joint of fifth toe ––– XA0RK3 Distal interphalangeal joint of the foot –––– XA8UM5 Distal interphalangeal joint of second toe –––– XA43F0 Distal interphalangeal joint of third toe –––– XA8NU9 Distal interphalangeal joint of fourth toe –––– XA39U1 Distal interphalangeal joint of fifth toe –– XA9Z55 Transverse tarsal joint Has manifestation - multiple selections are allowed [select] MG30.30 Chronic secondary musculoskeletal pain from persistent inflammation MG30.31 Chronic secondary musculoskeletal pain associated with structural changes Has causing condition - a selection is required - multiple selections are allowed [select] 2A00 Primary neoplasms of brain – 2A00.0 Gliomas of brain – 2A00.1 Embryonal tumours of brain – 2A00.2 Tumours of neuroepithelial tissue of brain – 2A00.3 Central neurocytoma of brain – 2A00.4 Astroblastoma of the brain – 2A00.5 Primary neoplasm of brain of unknown or unspecified type –– 2A00.00 Glioblastoma of brain –– 2A00.0Y Other specified gliomas of brain –– 2A00.0Z Gliomas of brain, unspecified –– 2A00.10 Medulloblastoma of brain –– 2A00.11 Central primitive neuroectodermal tumour –– 2A00.1Y Other specified embryonal tumours of brain –– 2A00.1Z Embryonal tumours of brain, unspecified –– 2A00.20 Tumours of the pineal gland or pineal region –– 2A00.21 Mixed neuronal-glial tumours –– 2A00.22 Choroid plexus tumours –– 2A00.2Y Other specified tumours of neuroepithelial tissue of brain –– 2A00.2Z Tumours of neuroepithelial tissue of brain, unspecified 2A01 Primary neoplasms of meninges – 2A01.0 Meningiomas – 2A01.1 Mesenchymal tumours of meninges – 2A01.2 Primary neoplasm of meninges of unknown or unspecified type –– 2A01.00 Primary malignant meningioma –– 2A01.0Y Other specified meningiomas –– 2A01.0Z Meningiomas, unspecified 2A02 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system – 2A02.0 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system – 2A02.1 Tumours of cranial or paraspinal nerves – 2A02.2 Primary neoplasm of spinal cord of unknown or unspecified type – 2A02.3 Benign neoplasm of cranial nerves – 2A02.4 Benign neoplasm of spinal cord –– 2A02.00 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system –– 2A02.0Y Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system –– 2A02.0Z Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified –– 2A02.10 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves –– 2A02.11 Paraspinal neuroblastoma –– 2A02.12 Malignant neoplasm of the optic nerve –– 2A02.1Y Other specified tumours of cranial or paraspinal nerves –– 2A02.1Z Tumours of cranial or paraspinal nerves, unspecified 2A0Z Other and unspecified neoplasms of brain or central nervous system – 2A20 Non mast cell myeloproliferative neoplasms –– 2A20.0 Chronic myelogenous leukaemia, BCR-ABL1-positive –– 2A20.1 Chronic neutrophilic leukaemia –– 2A20.2 Primary myelofibrosis –– 2A20.3 Chronic eosinophilic leukaemia, not elsewhere classified –– 2A20.4 Polycythaemia vera –– 2A20.5 Non mast cell myeloproliferative neoplasm, unclassifiable –– 2A20.Y Other specified non mast cell myeloproliferative neoplasms –– 2A20.Z Non mast cell myeloproliferative neoplasms, unspecified ––– 2A20.00 Chronic myelogenous leukaemia with blast crisis ––– 2A20.01 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive ––– 2A20.02 Chronic myelogenous leukaemia, t(9:22)(q34; q11) ––– 2A20.03 Naegeli-type monocytic leukaemia ––– 2A20.0Y Other specified chronic myelogenous leukaemia, BCR-ABL1-positive ––– 2A20.0Z Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified – 2A21 Mastocytosis –– 2A21.0 Systemic mastocytosis –– 2A21.1 Cutaneous mastocytosis –– 2A21.2 Mast cell sarcoma –– 2A21.3 Extracutaneous mastocytoma –– 2A21.Y Other specified mastocytosis –– 2A21.Z Mastocytosis, unspecified ––– 2A21.00 Mast cell leukaemia ––– 2A21.0Y Other specified systemic mastocytosis ––– 2A21.0Z Systemic mastocytosis, unspecified ––– 2A21.10 Urticaria pigmentosa ––– 2A21.1Y Other specified cutaneous mastocytosis ––– 2A21.1Z Cutaneous mastocytosis, unspecified – 2A22 Other and unspecified myeloproliferative neoplasms – 2A30 Refractory anaemia – 2A31 Refractory neutropaenia – 2A32 Refractory thrombocytopenia – 2A33 Refractory anaemia with ring sideroblasts – 2A34 Refractory cytopenia with multi-lineage dysplasia – 2A35 Refractory anaemia with excess of blasts – 2A36 Myelodysplastic syndrome with isolated del(5q) – 2A37 Myelodysplastic syndrome, unclassifiable – 2A38 Refractory cytopenia of childhood – 2A3Y Other specified myelodysplastic syndromes – 2A3Z Myelodysplastic syndromes, unspecified – 2A40 Chronic myelomonocytic leukaemia – 2A41 Atypical chronic myeloid leukaemia, BCR-ABL1-negative – 2A42 Juvenile myelomonocytic leukaemia –– 2A42.0 Juvenile myelomonocytic leukaemia in complete remission –– 2A42.Y Other specified juvenile myelomonocytic leukaemia –– 2A42.Z Juvenile myelomonocytic leukaemia, unspecified – 2A43 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis – 2A44 Myeloproliferative and myelodysplastic disease, unclassifiable – 2A4Y Other specified myelodysplastic and myeloproliferative neoplasms – 2A4Z Myelodysplastic and myeloproliferative neoplasms, unspecified – 2A50 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement – 2A51 Myeloid neoplasm associated with PDGFRB rearrangement – 2A52 Myeloid or lymphoid neoplasms with FGFR1 abnormalities – 2A5Z Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified 2A60 Acute myeloid leukaemias and related precursor neoplasms – 2A60.0 Acute myeloid leukaemia with recurrent genetic abnormalities – 2A60.1 Acute myeloid leukaemia with myelodysplasia-related changes – 2A60.2 Therapy-related myeloid neoplasms – 2A60.3 Acute myeloid leukaemia, not elsewhere classified by criteria of other types – 2A60.4 Myeloid proliferation associated with Down syndrome – 2A60.5 Blastic plasmacytoid dendritic cell neoplasm – 2A60.Y Other specified acute myeloid leukaemias and related precursor neoplasms – 2A60.Z Acute myeloid leukaemias and related precursor neoplasms, unspecified –– 2A60.20 Therapy related acute myeloid leukaemia or myelodysplastic syndrome –– 2A60.2Y Other specified therapy-related myeloid neoplasms –– 2A60.2Z Therapy-related myeloid neoplasms, unspecified –– 2A60.30 Acute myeloid leukaemia with minimal differentiation –– 2A60.31 Acute myeloid leukaemia without maturation –– 2A60.32 Acute myeloid leukaemia with maturation –– 2A60.33 Acute myelomonocytic leukaemia –– 2A60.34 Acute monoblastic or monocytic leukaemia –– 2A60.35 Acute erythroid leukaemia –– 2A60.36 Acute megakaryoblastic leukaemia –– 2A60.37 Acute basophilic leukaemia –– 2A60.38 Acute panmyelosis with myelofibrosis –– 2A60.39 Myeloid sarcoma –– 2A60.3Y Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types –– 2A60.3Z Acute myeloid leukaemia, unspecified –– 2A60.40 Transient abnormal myelopoiesis –– 2A60.41 Myeloid leukaemia associated with Down syndrome –– 2A60.4Y Other specified myeloid proliferation associated with Down syndrome –– 2A60.4Z Myeloid proliferation associated with Down syndrome, unspecified 2A61 Acute leukaemias of ambiguous lineage – 2A70 Precursor B-lymphoblastic neoplasms –– 2A70.0 B lymphoblastic leukaemia or lymphoma, not elsewhere classified –– 2A70.1 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 –– 2A70.Y Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities – 2A71 Precursor T-lymphoblastic neoplasms – 2A7Z Precursor lymphoid neoplasms, unspecified – 2A80 Follicular lymphoma –– 2A80.0 Follicular lymphoma grade 1 –– 2A80.1 Follicular lymphoma grade 2 –– 2A80.2 Follicular lymphoma grade 3 –– 2A80.3 Primary cutaneous follicle centre lymphoma –– 2A80.4 Paediatric type follicular lymphoma –– 2A80.5 Follicular lymphoma in situ –– 2A80.6 Follicular lymphoma of small intestine –– 2A80.Y Other specified follicular lymphoma –– 2A80.Z Follicular lymphoma, unspecified – 2A81 Diffuse large B-cell lymphomas –– 2A81.0 Primary mediastinal large B-cell lymphoma –– 2A81.1 Intravascular large B-cell lymphoma –– 2A81.2 Plasmablastic lymphoma –– 2A81.3 Lymphomatoid granulomatosis –– 2A81.4 T-cell/histiocyte rich large B-cell lymphoma –– 2A81.5 Primary diffuse large B-cell lymphoma of central nervous system –– 2A81.6 Epstein-Barr Virus-positive diffuse large B-cell lymphoma of the elderly –– 2A81.7 Diffuse large B-cell lymphoma associated with chronic inflammation –– 2A81.8 ALK-positive large B-cell lymphoma –– 2A81.9 Primary effusion lymphoma –– 2A81.A Primary cutaneous diffuse large B-cell lymphoma, leg type –– 2A81.Y Other specified diffuse large B-cell lymphomas –– 2A81.Z Diffuse large B-cell lymphoma, not otherwise specified – 2A82 Mature B-cell neoplasm with leukaemic behaviour –– 2A82.0 Chronic lymphocytic leukaemia or small lymphocytic lymphoma –– 2A82.1 B-cell prolymphocytic leukaemia –– 2A82.2 Hairy-cell leukaemia –– 2A82.3 Splenic B-cell lymphoma or leukaemia, unclassifiable –– 2A82.Y Other specified mature B-cell neoplasm with leukaemic behaviour –– 2A82.Z Mature B-cell neoplasm with leukaemic behaviour, unspecified ––– 2A82.00 Chronic lymphocytic leukaemia of B-cell type ––– 2A82.0Y Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma ––– 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified ––– 2A82.10 B-cell prolymphocytic leukaemia in complete remission ––– 2A82.1Y Other specified b-cell prolymphocytic leukaemia ––– 2A82.1Z B-cell prolymphocytic leukaemia, unspecified – 2A83 Plasma cell neoplasms –– 2A83.0 Monoclonal gammopathy of undetermined significance –– 2A83.1 Plasma cell myeloma –– 2A83.2 Solitary plasmacytoma –– 2A83.3 Extraosseous plasmacytoma –– 2A83.4 Plasma cell leukaemia –– 2A83.5 Monoclonal immunoglobulin deposition disease –– 2A83.Y Other specified multiple myeloma and plasma cell neoplasms –– 2A83.Z Plasma cell neoplasm, unspecified ––– 2A83.50 Heavy chain deposition disease ––– 2A83.51 Light and heavy chain deposition disease ––– 2A83.52 Light chain deposition disease – 2A84 Heavy chain diseases or malignant immunoproliferative diseases –– 2A84.0 Alpha heavy chain disease –– 2A84.1 Gamma heavy chain disease –– 2A84.2 Mu heavy chain disease –– 2A84.Y Other specified malignant immunoproliferative diseases –– 2A84.Z Heavy chain diseases, unspecified – 2A85 Other specified mature B-cell neoplasms or lymphoma –– 2A85.0 Nodal marginal zone lymphoma –– 2A85.1 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach –– 2A85.2 Extranodal marginal zone B-cell lymphoma, primary site skin –– 2A85.3 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin –– 2A85.4 Lymphoplasmacytic lymphoma –– 2A85.5 Mantle cell lymphoma –– 2A85.6 Burkitt lymphoma including Burkitt leukaemia –– 2A85.Y Further specified mature B-cell neoplasms or lymphoma – 2A86 B-cell lymphoma, mixed features –– 2A86.0 Malignant lymphoma of B cell type, not elsewhere classified –– 2A86.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma –– 2A86.2 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma –– 2A86.Y Other specified B-cell lymphoma, mixed features –– 2A86.Z B-cell lymphoma, mixed features, unspecified – 2A8Z Mature B-cell neoplasms, unspecified – 2A90 Mature T-cell lymphoma, specified types, nodal or systemic –– 2A90.0 T-cell prolymphocytic leukaemia –– 2A90.1 T-cell large granular lymphocytic leukaemia –– 2A90.2 Chronic lymphoproliferative disorders of NK-cells –– 2A90.3 Aggressive NK cell leukaemia –– 2A90.4 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood –– 2A90.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated –– 2A90.6 Extranodal NK/T-cell lymphoma, nasal type –– 2A90.7 Enteropathy associated T-cell lymphoma –– 2A90.8 Hepatosplenic T-cell lymphoma –– 2A90.9 Angioimmunoblastic T-cell lymphoma –– 2A90.A Anaplastic large cell lymphoma, ALK-positive –– 2A90.B Anaplastic large cell lymphoma, ALK-negative –– 2A90.C Peripheral T-cell lymphoma, not otherwise specified –– 2B00 Subcutaneous panniculitis-like T-cell lymphoma –– 2B01 Mycosis fungoides –– 2B02 Sézary syndrome –– 2B03 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders ––– 2B03.0 Primary cutaneous CD30-positive anaplastic large cell lymphoma ––– 2B03.1 Lymphomatoid papulosis –– 2B0Y Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders –– 2B0Z Primary cutaneous T-cell lymphoma of undetermined or unspecified type – 2B2Y Other specified mature T-cell or NK-cell neoplasms – 2B2Z Mature T-cell or NK-cell neoplasms, unspecified 2B30 Hodgkin lymphoma – 2B30.0 Nodular lymphocyte predominant Hodgkin lymphoma – 2B30.1 Classical Hodgkin lymphoma – 2B30.Z Hodgkin lymphoma, unspecified –– 2B30.10 Nodular sclerosis classical Hodgkin lymphoma –– 2B30.11 Lymphocyte-rich classical Hodgkin lymphoma –– 2B30.12 Mixed cellularity classical Hodgkin lymphoma –– 2B30.13 Lymphocyte depleted classical Hodgkin lymphoma –– 2B30.1Z Classical Hodgkin lymphoma, unspecified 2B31 Histiocytic or dendritic cell neoplasms – 2B31.0 Juvenile xanthogranuloma – 2B31.1 Histiocytic sarcoma – 2B31.2 Langerhans cell histiocytosis – 2B31.3 Langerhans cell sarcoma – 2B31.4 Interdigitating dendritic cell sarcoma – 2B31.5 Follicular dendritic cell sarcoma – 2B31.6 Indeterminate cell histiocytosis – 2B31.7 Fibroblastic reticular cell tumour – 2B31.Y Other specified histiocytic or dendritic cell neoplasms – 2B31.Z Histiocytic or dendritic cell neoplasms, unspecified –– 2B31.20 Langerhans cell histiocytosis involving the skin –– 2B31.2Y Other specified Langerhans cell histiocytosis –– 2B31.2Z Langerhans cell histiocytosis, unspecified 2B32 Immunodeficiency-associated lymphoproliferative disorders – 2B32.0 Post-transplant lymphoproliferative disorder, early lesion – 2B32.1 Reactive plasmacytic hyperplasia – 2B32.2 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like – 2B32.3 Polymorphic post-transplant lymphoproliferative disorder – 2B32.Y Other specified immunodeficiency-associated lymphoproliferative disorders – 2B32.Z Immunodeficiency-associated lymphoproliferative disorders, unspecified 2B33 Malignant haematopoietic neoplasms without further specification – 2B33.0 Acute leukaemia, not elsewhere classified – 2B33.1 Myeloid leukaemia – 2B33.2 Chronic myeloid leukaemia, not elsewhere classified – 2B33.3 Lymphoid leukaemia, not elsewhere classified – 2B33.4 Leukaemia, unspecified – 2B33.5 Malignant lymphoma, not elsewhere classified – 2B33.Y Other malignant haematopoietic neoplasms without further specification 2B3Z Neoplasms of haematopoietic or lymphoid tissues, unspecified –– 2B50 Chondrosarcoma, primary site ––– 2B50.0 Chondrosarcoma of bone or articular cartilage of limbs ––– 2B50.1 Chondrosarcoma of bone or articular cartilage of pelvis ––– 2B50.2 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle ––– 2B50.Y Chondrosarcoma of bone or articular cartilage of other specified sites ––– 2B50.Z Chondrosarcoma of bone or articular cartilage of unspecified sites –– 2B51 Osteosarcoma, primary site ––– 2B51.0 Osteosarcoma of bone or articular cartilage of jaw ––– 2B51.1 Osteosarcoma of bone or articular cartilage of limbs ––– 2B51.2 Osteosarcoma of bone or articular cartilage of pelvis ––– 2B51.Y Osteosarcoma of bone and articular cartilage of other specified sites ––– 2B51.Z Osteosarcoma of bone and articular cartilage of unspecified sites –– 2B52 Ewing sarcoma, primary site ––– 2B52.0 Ewing sarcoma of bone or articular cartilage of limbs ––– 2B52.1 Ewing sarcoma of bone or articular cartilage of pelvis ––– 2B52.2 Ewing sarcoma of bone or articular cartilage of ribs ––– 2B52.3 Ewing sarcoma of soft tissue ––– 2B52.Y Ewing sarcoma of bone and articular cartilage of other specified sites ––– 2B52.Z Ewing sarcoma of bone and articular cartilage of unspecified sites –– 2B53 Fibroblastic or myofibroblastic tumour, primary site ––– 2B53.0 Myxofibrosarcoma, primary site ––– 2B53.1 Fibroblastic or myofibroblastic tumour of skin ––– 2B53.Y Other specified fibroblastic or myofibroblastic tumour, primary site ––– 2B53.Z Fibroblastic or myofibroblastic tumour, primary site, unspecified –– 2B54 Unclassified pleomorphic sarcoma, primary site ––– 2B54.0 Unclassified pleomorphic sarcoma of skin ––– 2B54.1 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum ––– 2B54.Y Unclassified pleomorphic sarcoma, primary site, other specified site ––– 2B54.Z Unclassified pleomorphic sarcoma, primary site, unspecified site –– 2B55 Rhabdomyosarcoma, primary site ––– 2B55.0 Rhabdomyosarcoma of the oral cavity or pharynx ––– 2B55.1 Rhabdomyosarcoma of respiratory or intrathoracic organs ––– 2B55.2 Rhabdomyosarcoma of male genital organs ––– 2B55.Y Rhabdomyosarcoma, other specified primary site ––– 2B55.Z Rhabdomyosarcoma, unspecified primary site –– 2B56 Angiosarcoma, primary site ––– 2B56.0 Angiosarcoma of heart ––– 2B56.1 Angiosarcoma of skin ––– 2B56.2 Angiosarcoma of breast ––– 2B56.3 Angiosarcoma of liver ––– 2B56.Y Angiosarcoma, other specified primary site ––– 2B56.Z Angiosarcoma, unspecified primary site –– 2B57 Kaposi sarcoma, primary site ––– 2B57.0 Kaposi sarcoma of lung ––– 2B57.1 Kaposi sarcoma of skin ––– 2B57.2 Kaposi sarcoma of gastrointestinal sites ––– 2B57.Y Kaposi sarcoma of other specified primary sites ––– 2B57.Z Kaposi sarcoma of unspecified primary site –– 2B58 Leiomyosarcoma, primary site ––– 2B58.0 Leiomyosarcoma of retroperitoneum or peritoneum ––– 2B58.1 Leiomyosarcoma of uterus ––– 2B58.2 Leiomyosarcoma of stomach ––– 2B58.Y Leiomyosarcoma, other specified primary site ––– 2B58.Z Leiomyosarcoma, unspecified primary site –– 2B59 Liposarcoma, primary site ––– 2B59.0 Liposarcoma of soft tissue of limb ––– 2B59.1 Liposarcoma of retroperitoneum or peritoneum ––– 2B59.2 Liposarcoma of male genital organs ––– 2B59.Y Liposarcoma, other specified primary site ––– 2B59.Z Liposarcoma, unspecified primary site –– 2B5A Synovial sarcoma, primary site ––– 2B5A.0 Synovial sarcoma of soft tissues of limb ––– 2B5A.1 Synovial sarcoma of respiratory or intra-thoracic organs ––– 2B5A.Y Synovial sarcoma, other specified primary site ––– 2B5A.Z Synovial sarcoma, unspecified primary site –– 2B5B Gastrointestinal stromal tumour, primary site ––– 2B5B.0 Gastrointestinal stromal tumour of stomach ––– 2B5B.1 Gastrointestinal stromal tumour of small intestine ––– 2B5B.Y Gastrointestinal stromal tumour of other gastrointestinal sites ––– 2B5B.Z Gastrointestinal stromal tumour of unspecified gastrointestinal sites –– 2B5C Endometrial stromal sarcoma, primary site –– 2B5D Malignant mixed epithelial mesenchymal tumour, primary site ––– 2B5D.0 Malignant mixed epithelial mesenchymal tumour of ovary ––– 2B5D.1 Malignant mixed epithelial and mesenchymal tumour of corpus uteri ––– 2B5D.Y Malignant mixed epithelial mesenchymal tumour, other specified primary site ––– 2B5D.Z Malignant mixed epithelial mesenchymal tumour, unspecified primary site –– 2B5E Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site –– 2B5F Sarcoma, not elsewhere classified, primary site ––– 2B5F.0 Sarcoma, not elsewhere classified of uterus ––– 2B5F.1 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum ––– 2B5F.2 Sarcoma, not elsewhere classified of other specified sites ––– 2B5F.3 Sarcoma, not elsewhere classified, primary site unknown –––– 2B5F.10 Myosarcomas of omentum –––– 2B5F.1Y Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum –––– 2B5F.1Z Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified –– 2B5G Myosarcoma of uterus, part not specified –– 2B5H Well differentiated lipomatous tumour, primary site –– 2B5J Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites –– 2B5K Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites –– 2B5Y Other specified malignant mesenchymal neoplasms –– 2B5Z Malignant mesenchymal neoplasm of unspecified type –– 2B60 Malignant neoplasms of lip ––– 2B60.0 Basal cell carcinoma of lip ––– 2B60.1 Squamous cell carcinoma of lip ––– 2B60.Y Other specified malignant neoplasms of lip ––– 2B60.Z Malignant neoplasms of lip, unspecified –– 2B61 Malignant neoplasms of base of tongue ––– 2B61.0 Squamous cell carcinoma of the base of the tongue ––– 2B61.Y Other specified malignant neoplasms of base of tongue ––– 2B61.Z Malignant neoplasms of base of tongue, unspecified –– 2B62 Malignant neoplasms of other or unspecified parts of tongue ––– 2B62.0 Squamous cell carcinoma of other or unspecified parts of tongue ––– 2B62.1 Malignant neoplasms of lingual tonsil ––– 2B62.Y Other specified malignant neoplasms of other and unspecified parts of tongue ––– 2B62.Z Malignant neoplasms of other or unspecified parts of tongue, unspecified –––– 2B62.10 Squamous cell carcinoma of lingual tonsil –––– 2B62.1Z Malignant neoplasms of lingual tonsil, unspecified –– 2B63 Malignant neoplasms of gum ––– 2B63.0 Squamous cell carcinoma of gum ––– 2B63.Y Other specified malignant neoplasm of gum ––– 2B63.Z Malignant neoplasms of gum, unspecified –– 2B64 Malignant neoplasms of floor of mouth ––– 2B64.0 Squamous cell carcinoma of floor of mouth ––– 2B64.Y Other specified malignant neoplasm of floor of mouth ––– 2B64.Z Malignant neoplasms of floor of mouth, unspecified –– 2B65 Malignant neoplasms of palate ––– 2B65.0 Adenocarcinoma of palate ––– 2B65.1 Squamous cell carcinoma of palate ––– 2B65.Y Other specified malignant neoplasm of palate ––– 2B65.Z Malignant neoplasms of palate, unspecified –– 2B66 Malignant neoplasms of other or unspecified parts of mouth ––– 2B66.0 Squamous cell carcinoma of other or unspecified parts of mouth ––– 2B66.Y Other specified malignant neoplasms of other and unspecified parts of mouth ––– 2B66.Z Malignant neoplasms of other or unspecified parts of mouth, unspecified –– 2B67 Malignant neoplasms of parotid gland ––– 2B67.0 Adenocarcinoma of parotid gland ––– 2B67.1 Squamous cell carcinoma of parotid gland ––– 2B67.Y Other specified malignant neoplasms of parotid gland ––– 2B67.Z Malignant neoplasms of parotid gland, unspecified –– 2B68 Malignant neoplasms of submandibular or sublingual glands ––– 2B68.0 Adenocarcinoma of submandibular or sublingual glands ––– 2B68.1 Squamous cell carcinoma of submandibular or sublingual glands ––– 2B68.2 Other specified malignant neoplasms of submandibular or sublingual glands ––– 2B68.Z Malignant neoplasms of submandibular or sublingual glands, unspecified –– 2B69 Malignant neoplasms of tonsil ––– 2B69.0 Squamous cell carcinoma of tonsil ––– 2B69.1 Other specified malignant neoplasms of tonsil ––– 2B69.Z Malignant neoplasms of tonsil, unspecified –– 2B6A Malignant neoplasms of oropharynx ––– 2B6A.0 Squamous cell carcinoma of oropharynx ––– 2B6A.Y Other specified malignant neoplasms of oropharynx ––– 2B6A.Z Malignant neoplasms of oropharynx, unspecified –– 2B6B Malignant neoplasms of nasopharynx ––– 2B6B.0 Squamous cell carcinoma of nasopharynx ––– 2B6B.1 Malignant epithelial neoplasms of nasopharynx, unspecified type ––– 2B6B.2 Malignant neoplasms of pharyngeal tonsil ––– 2B6B.Y Other specified malignant neoplasms of nasopharynx ––– 2B6B.Z Malignant neoplasms of nasopharynx, unspecified –––– 2B6B.20 Squamous cell carcinoma of pharyngeal tonsil –––– 2B6B.21 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil –––– 2B6B.2Y Other specified malignant neoplasms of pharyngeal tonsil –––– 2B6B.2Z Malignant neoplasm of pharyngeal tonsil without mention of type –– 2B6C Malignant neoplasms of piriform sinus ––– 2B6C.0 Squamous cell carcinoma of piriform sinus ––– 2B6C.Y Other specified malignant neoplasms of piriform sinus ––– 2B6C.Z Malignant neoplasms of piriform sinus, unspecified –– 2B6D Malignant neoplasms of hypopharynx ––– 2B6D.0 Squamous cell carcinoma of hypopharynx and variants ––– 2B6D.Y Other specified malignant neoplasms of hypopharynx ––– 2B6D.Z Malignant neoplasms of hypopharynx, unspecified –– 2B6E Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.0 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Y Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Z Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified –– 2B6Y Other specified malignant neoplasms of lip, oral cavity or pharynx –– 2B70 Malignant neoplasms of oesophagus ––– 2B70.0 Adenocarcinoma of oesophagus ––– 2B70.1 Squamous cell carcinoma of oesophagus ––– 2B70.Y Other specified malignant neoplasms of oesophagus ––– 2B70.Z Malignant neoplasms of oesophagus, unspecified –––– 2B70.00 Barrett adenocarcinoma –––– 2B70.0Y Other specified adenocarcinoma of oesophagus –––– 2B70.0Z Adenocarcinoma of oesophagus, unspecified –– 2B71 Malignant neoplasms of oesophagogastric junction ––– 2B71.0 Adenocarcinoma of oesophagogastric junction ––– 2B71.Y Other specified malignant neoplasm of oesophagogastric junction ––– 2B71.Z Malignant neoplasms of oesophagogastric junction, unspecified –– 2B72 Malignant neoplasms of stomach ––– 2B72.0 Adenocarcinoma of stomach ––– 2B72.1 Malignant neuroendocrine neoplasm of stomach ––– 2B72.Y Other specified malignant neoplasms of stomach ––– 2B72.Z Malignant neoplasms of stomach, unspecified ––– 2B80 Malignant neoplasms of small intestine –––– 2B80.0 Malignant neoplasms of duodenum –––– 2B80.1 Malignant neoplasms of jejunum or ileum –––– 2B80.2 Malignant neoplasms of small intestine, site unspecified –––– 2B80.Y Other specified malignant neoplasms of small intestine –––– 2B80.Z Malignant neoplasms of small intestine, unspecified ––––– 2B80.00 Adenocarcinoma of duodenum ––––– 2B80.01 Neuroendocrine neoplasm of duodenum ––––– 2B80.0Y Other specified malignant neoplasms of the duodenum ––––– 2B80.0Z Malignant neoplasms of duodenum, unspecified ––––– 2B80.10 Adenocarcinoma of jejunum or ileum ––––– 2B80.11 Neuroendocrine neoplasms of jejunum or ileum ––––– 2B80.1Y Other specified malignant neoplasms of jejunum or ileum ––––– 2B80.1Z Malignant neoplasms of jejunum or ileum, unspecified ––––– 2B80.20 Adenocarcinoma of small intestine, site unspecified ––––– 2B80.21 Neuroendocrine neoplasms of small intestine, site unspecified ––––– 2B80.2Y Other specified malignant neoplasms of small intestine, site unspecified ––– 2B81 Malignant neoplasms of appendix –––– 2B81.0 Adenocarcinoma of appendix –––– 2B81.2 Neuroendocrine neoplasms of appendix –––– 2B81.Y Other specified malignant neoplasms of appendix –––– 2B81.Z Malignant neoplasms of appendix, unspecified ––––– 2B81.00 Mucinous adenocarcinoma of appendix –––– 2B90 Malignant neoplasms of colon ––––– 2B90.0 Malignant neoplasm of ascending colon and right flexure of colon ––––– 2B90.1 Malignant neoplasm of descending colon and splenic flexure of colon ––––– 2B90.2 Malignant neoplasm of transverse colon ––––– 2B90.3 Malignant neoplasm of sigmoid colon ––––– 2B90.Y Other specified malignant neoplasms of colon ––––– 2B90.Z Malignant neoplasms of colon, unspecified –––––– 2B90.00 Adenocarcinoma of ascending colon or right flexure of colon –––––– 2B90.0Y Other specified malignant neoplasm of ascending colon and right flexure of colon –––––– 2B90.0Z Malignant neoplasm of ascending colon and right flexure of colon, unspecified –––––– 2B90.10 Adenocarcinoma of descending colon or splenic flexure of colon –––––– 2B90.1Y Other specified malignant neoplasm of descending colon and splenic flexure of colon –––––– 2B90.1Z Malignant neoplasm of descending colon and splenic flexure of colon, unspecified –––––– 2B90.20 Adenocarcinoma of transverse colon –––––– 2B90.2Y Other specified malignant neoplasm of transverse colon –––––– 2B90.2Z Malignant neoplasm of transverse colon, unspecified –––––– 2B90.30 Adenocarcinoma of sigmoid colon –––––– 2B90.3Y Other specified malignant neoplasm of sigmoid colon –––––– 2B90.3Z Malignant neoplasm of sigmoid colon, unspecified –––– 2B91 Malignant neoplasms of rectosigmoid junction ––––– 2B91.0 Adenocarcinoma of rectosigmoid junction ––––– 2B91.Y Other specified malignant neoplasms of rectosigmoid junction ––––– 2B91.Z Malignant neoplasms of rectosigmoid junction, unspecified –––– 2B92 Malignant neoplasms of rectum ––––– 2B92.0 Adenocarcinomas of rectum ––––– 2B92.1 Neuroendocrine neoplasms of rectum ––––– 2B92.Y Other specified malignant neoplasms of rectum ––––– 2B92.Z Malignant neoplasms of rectum, unspecified –––– 2B93 Malignant neoplasms of large intestine, site unspecified ––––– 2B93.0 Adenocarcinoma of large intestine, site unspecified ––––– 2B93.Y Other specified malignant neoplasms of large intestine, site unspecified ––––– 2B93.Z Malignant neoplasms of large intestine, site and type unspecified –––– 2B9Y Other specified malignant neoplasms of large intestine ––– 2C00 Malignant neoplasms of anus or anal canal –––– 2C00.0 Adenocarcinoma of anus or anal canal –––– 2C00.1 Melanoma of anus or anal canal –––– 2C00.2 Neuroendocrine neoplasm of anus or anal canal –––– 2C00.3 Squamous cell carcinoma of anus or anal canal –––– 2C00.Y Other specified malignant neoplasms of anus and anal canal –––– 2C00.Z Malignant neoplasms of anus or anal canal, unspecified ––– 2C0Y Other specified malignant neoplasms of intestine ––– 2C0Z Malignant neoplasms of intestine, unspecified –– 2C10 Malignant neoplasm of pancreas ––– 2C10.0 Adenocarcinoma of pancreas ––– 2C10.1 Neuroendocrine neoplasms of pancreas ––– 2C10.Y Other specified malignant neoplasms of pancreas ––– 2C10.Z Malignant neoplasm of pancreas, unspecified –– 2C11 Malignant neoplasms of other or ill-defined digestive organs ––– 2C11.0 Adenocarcinoma of other or ill-defined digestive organs ––– 2C11.1 Mucinous carcinoma of other or ill-defined digestive organs ––– 2C11.2 Other specified malignant neoplasms of other or ill-defined digestive organs ––– 2C11.Z Malignant neoplasms of other or ill-defined digestive organs, unspecified –– 2C12 Malignant neoplasms of liver or intrahepatic bile ducts ––– 2C12.0 Malignant neoplasm of liver ––– 2C12.1 Malignant neoplasm of intrahepatic bile ducts –––– 2C12.00 Combined hepatocellular-cholangiocarcinoma –––– 2C12.01 Hepatoblastoma –––– 2C12.02 Hepatocellular carcinoma of liver –––– 2C12.03 Mesothelial carcinoma of liver –––– 2C12.0Y Other specified malignant neoplasm of liver –––– 2C12.0Z Malignant neoplasm of liver, unspecified –––– 2C12.10 Intrahepatic cholangiocarcinoma –––– 2C12.1Y Other specified malignant neoplasms of intrahepatic bile ducts –––– 2C12.1Z Malignant neoplasm of intrahepatic bile ducts, unspecified –– 2C13 Malignant neoplasms of gallbladder ––– 2C13.0 Adenocarcinoma of the gallbladder ––– 2C13.Y Other specified malignant neoplasm of gallbladder ––– 2C13.Z Malignant neoplasms of gallbladder, unspecified –– 2C14 Malignant neoplasms of proximal biliary tract, cystic duct ––– 2C14.0 Adenocarcinoma of proximal biliary tract, cystic duct ––– 2C14.1 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct ––– 2C14.2 Neuroendocrine neoplasms of cystic duct ––– 2C14.Y Other specified malignant neoplasms of biliary tract, cystic duct ––– 2C14.Z Malignant neoplasms of proximal biliary tract, cystic duct, unspecified –– 2C15 Malignant neoplasms of biliary tract, distal bile duct ––– 2C15.0 Adenocarcinoma of biliary tract, distal bile duct ––– 2C15.1 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct ––– 2C15.2 Neuroendocrine neoplasms of distal bile duct ––– 2C15.Y Other specified malignant neoplasms of biliary tract, distal bile duct ––– 2C15.Z Malignant neoplasms of biliary tract, distal bile duct, unspecified –– 2C16 Malignant neoplasms of ampulla of Vater ––– 2C16.0 Adenocarcinoma of ampulla of Vater ––– 2C16.1 Neuroendocrine neoplasms of ampulla of Vater ––– 2C16.Y Other specified malignant neoplasms of ampulla of Vater ––– 2C16.Z Malignant neoplasms of ampulla of Vater, unspecified –– 2C17 Malignant neoplasms of other or unspecified parts of biliary tract ––– 2C17.0 Adenocarcinoma of other or unspecified parts of biliary tract ––– 2C17.1 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract ––– 2C17.2 Neuroendocrine neoplasms of other or unspecified parts of biliary tract ––– 2C17.Y Other specified malignant neoplasms of overlapping lesion of biliary tract ––– 2C17.Z Malignant neoplasms of other or unspecified parts of biliary tract, unspecified –– 2C18 Malignant neoplasms of perihilar bile duct ––– 2C18.0 Hilar cholangiocarcinoma ––– 2C18.1 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct ––– 2C18.2 Neuroendocrine neoplasm of perihilar bile duct ––– 2C18.Y Other specified malignant neoplasms of perihilar bile duct ––– 2C18.Z Malignant neoplasms of perihilar bile duct, unspecified –– 2C1Z Malignant neoplasms of digestive organs, unspecified –– 2C20 Malignant neoplasms of nasal cavity ––– 2C20.0 Adenocarcinoma of nasal cavity ––– 2C20.1 Malignant neuroepitheliomatous neoplasm of nasal cavity ––– 2C20.2 Melanoma of nasal cavity ––– 2C20.3 Olfactory neuroblastoma ––– 2C20.4 Squamous cell carcinoma of nasal cavity ––– 2C20.Y Other specified malignant neoplasm of nasal cavity ––– 2C20.Z Malignant neoplasms of nasal cavity, unspecified –– 2C21 Malignant neoplasms of middle ear ––– 2C21.0 Adenocarcinoma of middle ear ––– 2C21.1 Squamous cell carcinoma of middle ear ––– 2C21.2 Unspecified malignant epithelial neoplasm of middle ear ––– 2C21.Y Other specified malignant neoplasm of middle ear ––– 2C21.Z Malignant neoplasms of middle ear, unspecified –– 2C22 Malignant neoplasms of accessory sinuses ––– 2C22.0 Adenocarcinoma of accessory sinuses ––– 2C22.1 Squamous cell carcinoma of accessory sinuses ––– 2C22.2 Malignant epithelial neoplasms of accessory sinuses, unspecified type ––– 2C22.3 Melanomas of accessory sinuses ––– 2C22.Y Other specified malignant neoplasms of accessory sinuses ––– 2C22.Z Malignant neoplasms of accessory sinuses, unspecified –––– 2C22.10 Squamous cell carcinoma of sphenoidal sinus –––– 2C22.1Y Squamous cell carcinoma of other specified accessory sinuses –– 2C23 Malignant neoplasms of larynx ––– 2C23.1 Malignant neoplasms of glottis of larynx ––– 2C23.2 Malignant neoplasms of supraglottis of larynx ––– 2C23.3 Malignant neoplasms of subglottis of larynx ––– 2C23.4 Malignant neoplasm of laryngeal cartilage ––– 2C23.5 Malignant neoplasm of overlapping lesion of larynx ––– 2C23.Z Malignant neoplasms of larynx, unspecified –––– 2C23.10 Squamous cell carcinoma of larynx, glottis –––– 2C23.1Y Other specified malignant neoplasms of larynx, glottis –––– 2C23.20 Squamous cell carcinoma of larynx, supraglottis –––– 2C23.2Y Other specified malignant neoplasms of larynx, supraglottis –––– 2C23.30 Squamous cell carcinoma of larynx, subglottis –––– 2C23.31 Adenocarcinoma of larynx, subglottis –––– 2C23.3Y Other specified malignant neoplasms of larynx, subglottis –– 2C24 Malignant neoplasms of trachea ––– 2C24.0 Adenocarcinoma of trachea ––– 2C24.1 Squamous cell carcinoma of trachea ––– 2C24.2 Malignant epithelial neoplasms of trachea, unspecified type ––– 2C24.Y Other specified malignant neoplasms of trachea ––– 2C24.Z Malignant neoplasms of trachea, unspecified –– 2C25 Malignant neoplasms of bronchus or lung ––– 2C25.0 Adenocarcinoma of bronchus or lung ––– 2C25.1 Small cell carcinoma of bronchus or lung ––– 2C25.2 Squamous cell carcinoma of bronchus or lung ––– 2C25.3 Large cell carcinoma of bronchus or lung ––– 2C25.4 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung ––– 2C25.5 Unspecified malignant epithelial neoplasm of bronchus or lung ––– 2C25.Y Other specified malignant neoplasms of bronchus or lung ––– 2C25.Z Malignant neoplasms of bronchus or lung, unspecified –– 2C26 Malignant neoplasms of the pleura ––– 2C26.0 Mesothelioma of pleura ––– 2C26.Y Other specified malignant neoplasms of the pleura ––– 2C26.Z Malignant neoplasms of the pleura, unspecified –– 2C27 Malignant neoplasms of thymus ––– 2C27.0 Carcinoma of thymus ––– 2C27.1 Carcinoid tumour or other neuroendocrine neoplasms of thymus ––– 2C27.2 Malignant thymoma ––– 2C27.Y Other specified malignant neoplasms of thymus ––– 2C27.Z Malignant neoplasms of thymus, unspecified –– 2C28 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.0 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.1 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.Z Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified –– 2C29 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.0 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs ––– 2C29.1 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.Z Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified –– 2C2Y Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs –– 2C2Z Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified –– 2C30 Melanoma of skin ––– 2C30.0 Superficial spreading melanoma, primary ––– 2C30.1 Nodular melanoma, primary ––– 2C30.2 Lentigo maligna melanoma, primary ––– 2C30.3 Acral lentiginous melanoma, primary ––– 2C30.Y Other specified melanoma of skin ––– 2C30.Z Melanoma of skin, unspecified –– 2C31 Squamous cell carcinoma of skin ––– 2C31.0 Verrucous squamous cell carcinoma of skin ––– 2C31.1 Keratoacanthoma ––– 2C31.Z Cutaneous squamous cell carcinoma –– 2C32 Basal cell carcinoma of skin ––– 2C32.0 Nodular basal cell carcinoma of skin ––– 2C32.1 Sclerosing basal cell carcinoma of skin ––– 2C32.2 Superficial basal cell carcinoma of skin ––– 2C32.Y Other specified basal cell carcinoma of skin ––– 2C32.Z Basal cell carcinoma of skin, unspecified –– 2C33 Adnexal carcinoma of skin –– 2C34 Cutaneous neuroendocrine carcinoma –– 2C35 Cutaneous sarcoma –– 2C3Y Other specified malignant neoplasms of skin –– 2C3Z Malignant neoplasm of skin of unknown or unspecified type –– 2C40 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system –– 2C41 Malignant perineurioma –– 2C4Y Other specified malignant neoplasms of peripheral nerves and autonomic nervous system –– 2C4Z Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified –– 2C50 Malignant neoplasms of retroperitoneum ––– 2C50.0 Cystic, mucinous or serous carcinoma of retroperitoneum ––– 2C50.Y Other specified malignant neoplasms of retroperitoneum ––– 2C50.Z Malignant neoplasms of retroperitoneum, unspecified –– 2C51 Malignant neoplasms of peritoneum ––– 2C51.0 Adenocarcinomas of peritoneum ––– 2C51.1 Cystic, mucinous or serous carcinoma of peritoneum ––– 2C51.2 Mesotheliomas of peritoneum ––– 2C51.Y Other specified malignant neoplasms of peritoneum ––– 2C51.Z Malignant neoplasms of peritoneum, unspecified –––– 2C51.20 Mesothelioma of mesocolon –––– 2C51.21 Mesothelioma of mesentery –––– 2C51.2Y Mesotheliomas of other specified sites of peritoneum –––– 2C51.2Z Mesotheliomas of peritoneum, site unspecified –– 2C52 Malignant neoplasms of omentum ––– 2C52.0 Cystic, mucinous or serous carcinoma of omentum ––– 2C52.Y Other specified malignant neoplasms of omentum ––– 2C52.Z Malignant neoplasms of omentum, unspecified –– 2C53 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.0 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.1 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Y Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Z Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified –– 2C5Y Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum –– 2C5Z Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified –– 2C60 Carcinoma of breast, specialised type –– 2C61 Invasive carcinoma of breast ––– 2C61.0 Invasive ductal carcinoma of breast ––– 2C61.1 Invasive lobular carcinoma of breast ––– 2C61.2 Invasive pleomorphic lobular carcinoma of breast ––– 2C61.3 Invasive carcinoma of breast with mixed ductal and lobular features ––– 2C61.4 Invasive carcinoma of breast, unidentifiable type –– 2C62 Inflammatory carcinoma of breast –– 2C63 Malignant phyllodes tumour of breast –– 2C64 Solid papillary carcinoma of breast with evidence of invasion –– 2C65 Hereditary breast and ovarian cancer syndrome –– 2C6Y Other specified malignant neoplasms of breast –– 2C6Z Malignant neoplasms of breast, unspecified –– 2C70 Malignant neoplasms of vulva ––– 2C70.0 Basal cell carcinoma of vulva ––– 2C70.1 Melanoma of vulva ––– 2C70.2 Squamous cell carcinoma of vulva ––– 2C70.Y Other specified malignant neoplasms of vulva ––– 2C70.Z Malignant neoplasms of vulva, unspecified –– 2C71 Malignant neoplasms of vagina ––– 2C71.0 Adenocarcinoma of vagina ––– 2C71.1 Melanoma of vagina ––– 2C71.2 Squamous cell carcinoma of vagina ––– 2C71.Y Other specified malignant neoplasms of vagina ––– 2C71.Z Malignant neoplasms of vagina, unspecified –– 2C72 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa ––– 2C72.0 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.1 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.3 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa ––– 2C72.Y Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa ––– 2C72.Z Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified –– 2C73 Malignant neoplasms of ovary ––– 2C73.0 Carcinomas of ovary ––– 2C73.1 Dysgerminoma of ovary ––– 2C73.2 Granulosa cell malignant tumour of ovary ––– 2C73.3 Malignant teratoma of ovary ––– 2C73.4 Serous cystadenoma, borderline malignancy of ovary ––– 2C73.5 Endodermal sinus tumour, unspecified site, female ––– 2C73.Y Other specified malignant neoplasms of the ovary ––– 2C73.Z Malignant neoplasms of ovary, unspecified –––– 2C73.00 Clear cell adenocarcinoma of ovary –––– 2C73.01 Endometrioid adenocarcinoma of ovary –––– 2C73.02 Low grade serous adenocarcinoma of ovary –––– 2C73.03 High grade serous adenocarcinoma of ovary –––– 2C73.04 Mucinous adenocarcinoma of ovary –––– 2C73.0Y Other specified carcinomas of ovary –––– 2C73.0Z Carcinomas of ovary, unspecified –– 2C74 Malignant neoplasms of fallopian tube ––– 2C74.0 Adenocarcinoma of fallopian tube ––– 2C74.Y Other specified malignant neoplasms of fallopian tube ––– 2C74.Z Malignant neoplasms of fallopian tube, unspecified –– 2C75 Malignant neoplasms of placenta ––– 2C75.0 Malignant trophoblastic neoplasms of placenta ––– 2C75.Y Other specified malignant neoplasms of placenta ––– 2C75.Z Malignant neoplasms of placenta, unspecified –– 2C76 Malignant neoplasms of corpus uteri ––– 2C76.0 Endometrial endometrioid adenocarcinoma ––– 2C76.1 Endometrial mucinous adenocarcinoma ––– 2C76.2 Endometrial clear cell adenocarcinoma ––– 2C76.3 Endometrial serous adenocarcinoma ––– 2C76.4 Endometrial mixed adenocarcinoma ––– 2C76.Y Other specified malignant neoplasms of corpus uteri ––– 2C76.Z Malignant neoplasms of corpus uteri, unspecified –––– 2C76.40 Endometrial squamous cell carcinoma –––– 2C76.41 Endometrial small cell carcinoma –––– 2C76.42 Endometrial undifferentiated carcinoma –––– 2C76.43 Carcinosarcoma of uterus –––– 2C76.4Z Endometrial mixed adenocarcinoma, unspecified –– 2C77 Malignant neoplasms of cervix uteri ––– 2C77.0 Squamous cell carcinoma of cervix uteri ––– 2C77.1 Adenocarcinoma of cervix uteri ––– 2C77.2 Adenosquamous carcinoma of cervix uteri ––– 2C77.3 Neuroendocrine carcinoma of cervix uteri ––– 2C77.Y Other specified malignant neoplasms of cervix uteri ––– 2C77.Z Malignant neoplasms of cervix uteri, unspecified –– 2C78 Malignant neoplasms of uterus, part not specified –– 2C79 Malignant neoplasm involving overlapping sites of female genital organs –– 2C7Y Other specified malignant neoplasms of female genital organs –– 2C7Z Malignant neoplasms of female genital organs, unspecified –– 2C80 Malignant neoplasms of testis ––– 2C80.2 Germ cell tumour of testis ––– 2C80.Y Other specified malignant neoplasms of testis ––– 2C80.Z Malignant neoplasms of testis, unspecified –– 2C81 Malignant neoplasms of penis ––– 2C81.0 Squamous cell carcinoma of penis ––– 2C81.1 Melanoma of penis ––– 2C81.Y Other specified malignant neoplasm of penis ––– 2C81.Z Malignant neoplasms of penis, unspecified –– 2C82 Malignant neoplasms of prostate ––– 2C82.0 Adenocarcinoma of prostate ––– 2C82.Y Other specified malignant neoplasms of prostate ––– 2C82.Z Malignant neoplasms of prostate, unspecified –– 2C83 Malignant neoplasms of scrotum ––– 2C83.0 Squamous cell carcinoma of scrotum ––– 2C83.Y Other specified malignant neoplasms of scrotum ––– 2C83.Z Malignant neoplasms of scrotum, unspecified –– 2C84 Malignant neoplasms of other specified male genital organs –– 2C8Z Malignant neoplasms of male genital organs, unspecified –– 2C90 Malignant neoplasms of kidney, except renal pelvis ––– 2C90.0 Renal cell carcinoma of kidney, except renal pelvis ––– 2C90.Y Other specified malignant neoplasms of kidney, except renal pelvis ––– 2C90.Z Malignant neoplasms of kidney, except renal pelvis, unspecified –– 2C91 Malignant neoplasms of renal pelvis ––– 2C91.0 Urothelial carcinoma of renal pelvis ––– 2C91.Y Other specified malignant neoplasms of renal pelvis ––– 2C91.Z Malignant neoplasms of renal pelvis, unspecified –– 2C92 Malignant neoplasms of ureter ––– 2C92.0 Urothelial carcinoma of ureter ––– 2C92.Y Other specified malignant neoplasms of ureter ––– 2C92.Z Malignant neoplasms of ureter, unspecified –– 2C93 Malignant neoplasms of urethra or paraurethral gland ––– 2C93.0 Adenocarcinoma of urethra or paraurethral gland ––– 2C93.1 Squamous cell carcinoma of urethra or paraurethral gland ––– 2C93.2 Urothelial carcinoma of urethra or paraurethral gland ––– 2C93.Y Other specified malignant neoplasms of urethra and paraurethral gland ––– 2C93.Z Malignant neoplasms of urethra or paraurethral gland, unspecified –– 2C94 Malignant neoplasms of bladder ––– 2C94.0 Adenocarcinoma of urinary bladder ––– 2C94.1 Squamous cell carcinoma of urinary bladder ––– 2C94.2 Urothelial carcinoma of bladder ––– 2C94.Y Other specified malignant neoplasms of bladder ––– 2C94.Z Malignant neoplasms of bladder, unspecified –– 2C95 Malignant neoplasm involving overlapping sites of urinary organs ––– 2C95.0 Adenocarcinoma involving overlapping sites of urinary organs ––– 2C95.1 Squamous cell carcinomas involving overlapping sites of urinary organs ––– 2C95.2 Urothelial carcinoma involving overlapping sites of urinary organs ––– 2C95.Y Other specified malignant neoplasms of overlapping lesion of urinary organs ––– 2C95.Z Malignant neoplasm involving overlapping sites of urinary organs, unspecified –– 2C9Y Other specified malignant neoplasms of urinary tract –– 2C9Z Malignant neoplasms of urinary tract, unspecified –– 2D00 Malignant neoplasm of conjunctiva ––– 2D00.0 Melanoma of conjunctiva ––– 2D00.1 Malignant neoplasm of caruncle ––– 2D00.2 Squamous cell carcinoma of conjunctiva ––– 2D00.Y Other specified malignant neoplasm of conjunctiva ––– 2D00.Z Malignant neoplasm of conjunctiva, unspecified –– 2D01 Malignant neoplasm of cornea ––– 2D01.0 Melanoma of cornea ––– 2D01.1 Squamous cell carcinoma of cornea ––– 2D01.Y Other specified malignant neoplasms of cornea ––– 2D01.Z Malignant neoplasm of cornea, unspecified –– 2D02 Malignant neoplasm of retina ––– 2D02.0 Adenocarcinoma of retinal pigment epithelium ––– 2D02.1 Malignant neuroepithelial tumours of retina ––– 2D02.2 Retinoblastoma ––– 2D02.Y Other specified malignant neoplasm of retina ––– 2D02.Z Malignant neoplasm of retina, unspecified –– 2D03 Malignant neoplasm of lacrimal apparatus ––– 2D03.0 Adenocarcinoma of the lacrimal apparatus ––– 2D03.1 Mucoepidermoid carcinoma of lacrimal apparatus ––– 2D03.2 Squamous cell carcinoma of the lacrimal apparatus ––– 2D03.Y Other specified malignant neoplasm of lacrimal apparatus ––– 2D03.Z Malignant neoplasm of lacrimal apparatus, unspecified –– 2D04 Malignant neoplasm of orbit –– 2D05 Malignant neoplasm of choroid ––– 2D05.0 Melanoma of choroid ––– 2D05.Y Other specified malignant neoplasm of choroid ––– 2D05.Z Malignant neoplasm of choroid, unspecified –– 2D06 Malignant neoplasm of ciliary body ––– 2D06.0 Adenocarcinoma of ciliary epithelium ––– 2D06.1 Malignant medulloepithelioma of ciliary body ––– 2D06.3 Malignant neuroepithelial tumours of ciliary body ––– 2D06.4 Melanoma of ciliary body ––– 2D06.Y Other specified malignant neoplasm of ciliary body ––– 2D06.Z Malignant neoplasm of ciliary body, unspecified –– 2D07 Malignant neoplasm of iris ––– 2D07.0 Adenocarcinoma of iris epithelium ––– 2D07.1 Malignant neuroepithelial tumours of iris ––– 2D07.2 Melanoma of iris ––– 2D07.Y Other specified malignant neoplasm of iris ––– 2D07.Z Malignant neoplasm of iris, unspecified –– 2D0Y Other specified malignant neoplasms of eye and ocular adnexa –– 2D0Z Malignant neoplasms of eye or ocular adnexa, unspecified –– 2D10 Malignant neoplasms of thyroid gland ––– 2D10.0 Follicular carcinoma of thyroid gland ––– 2D10.1 Papillary carcinoma of thyroid gland ––– 2D10.2 Poorly differentiated carcinoma of thyroid gland ––– 2D10.3 Undifferentiated carcinoma of thyroid gland ––– 2D10.4 Medullary carcinoma of thyroid gland ––– 2D10.Y Other specified malignant neoplasms of thyroid gland ––– 2D10.Z Malignant neoplasms of thyroid gland, unspecified –– 2D11 Malignant neoplasms of adrenal gland ––– 2D11.0 Adenocarcinoma of adrenal gland ––– 2D11.1 Malignant phaeochromocytoma of adrenal gland ––– 2D11.2 Neuroblastoma of adrenal gland ––– 2D11.Y Other specified malignant neoplasms of adrenal gland ––– 2D11.Z Malignant neoplasms of adrenal gland, unspecified –– 2D12 Malignant neoplasms of other endocrine glands or related structures ––– 2D12.0 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type ––– 2D12.1 Adenocarcinoma of other endocrine glands or related structures ––– 2D12.Y Other specified malignant neoplasms of other endocrine glands or related structures ––– 2D12.Z Malignant neoplasms of other endocrine glands or related structures, unspecified –– 2D1Z Malignant neoplasms of endocrine glands, unspecified – 2D3Y Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues – 2D3Z Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified – 2D40 Adenocarcinoma of unspecified site – 2D41 Unspecified carcinoma of unspecified site – 2D42 Malignant neoplasms of ill-defined sites – 2D43 Malignant neoplasms of independent, multiple primary sites – 2D44 Malignant neoplasm, primary site unknown, so stated – 2D4Y Other specified malignant neoplasms of unspecified primary sites – 2D4Z Unspecified malignant neoplasms of unspecified sites – 2D50 Malignant neoplasm metastasis in brain – 2D51 Malignant neoplasm metastasis in meninges – 2D52 Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system –– 2D60 Malignant neoplasm metastasis in lymph node of a single region ––– 2D60.0 Malignant neoplasm metastasis in lymph nodes of head, face or neck ––– 2D60.1 Malignant neoplasm metastasis in intrathoracic lymph nodes ––– 2D60.2 Malignant neoplasm metastasis in intra-abdominal lymph nodes ––– 2D60.3 Malignant neoplasm metastasis in axillary lymph nodes ––– 2D60.4 Malignant neoplasm metastasis in inguinal lymph nodes ––– 2D60.5 Malignant neoplasm metastasis in intrapelvic lymph nodes ––– 2D60.Y Other specified malignant neoplasm metastasis in lymph node of a single region ––– 2D60.Z Malignant neoplasm metastasis in lymph node of a single region, unspecified –– 2D61 Malignant neoplasm metastases in lymph nodes of multiple regions –– 2D6Z Metastatic malignant neoplasm to unspecified lymph node –– 2D70 Malignant neoplasm metastasis in lung –– 2D71 Malignant neoplasm metastasis in mediastinum –– 2D72 Malignant neoplasm metastasis in pleura –– 2D73 Malignant neoplasm metastasis in upper respiratory tract organs –– 2D7Y Malignant neoplasm metastasis in other specified thoracic organs –– 2D7Z Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified –– 2D80 Malignant neoplasm metastasis in liver or intrahepatic bile duct ––– 2D80.0 Malignant neoplasm metastasis in liver ––– 2D80.1 Malignant neoplasm metastasis in intrahepatic bile duct –– 2D81 Malignant neoplasm metastasis in pancreas –– 2D82 Malignant neoplasm metastasis in extrahepatic bile ducts –– 2D83 Malignant neoplasm metastasis in ampulla of Vater –– 2D84 Malignant neoplasm metastasis in the small intestine –– 2D85 Malignant neoplasm metastasis in large intestine –– 2D86 Malignant neoplasm metastasis in anus –– 2D8Y Malignant neoplasm metastasis in other specified digestive system organ –– 2D8Z Malignant neoplasm metastasis in unspecified digestive system organ –– 2D90 Malignant neoplasm metastasis in retroperitoneum –– 2D91 Malignant neoplasm metastasis in peritoneum –– 2E00 Malignant neoplasm metastasis in kidney or renal pelvis –– 2E01 Malignant neoplasm metastasis in bladder –– 2E02 Malignant neoplasm metastasis in other or unspecified urinary system organs –– 2E03 Malignant neoplasm metastasis in bone or bone marrow –– 2E04 Malignant neoplasm metastasis in soft tissue –– 2E05 Malignant neoplasm metastasis in female reproductive system ––– 2E05.0 Malignant neoplasm metastasis in ovary ––– 2E05.Y Malignant neoplasm metastasis in other female reproductive system organs ––– 2E05.Z Malignant neoplasm metastasis in female reproductive system, unspecified –– 2E06 Malignant neoplasm metastasis in male genital organs –– 2E07 Malignant neoplasm metastasis in adrenal gland –– 2E08 Metastatic malignant neoplasm involving skin –– 2E09 Malignant neoplasm metastasis in peripheral nervous system –– 2E0Y Malignant neoplasm metastasis in other specified sites – 2E2Z Malignant neoplasm metastasis, unspecified 2E60 Carcinoma in situ of oral cavity, oesophagus or stomach – 2E60.0 Carcinoma in situ of lip, oral cavity or pharynx – 2E60.1 Carcinoma in situ of oesophagus – 2E60.2 Carcinoma in situ of stomach 2E61 Carcinoma in situ of other or unspecified digestive organs – 2E61.0 Carcinoma in situ of colon – 2E61.1 Carcinoma in situ of rectum – 2E61.2 Carcinoma in situ of anal canal – 2E61.3 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater – 2E61.Y Carcinoma in situ of other specified digestive organs – 2E61.Z Carcinoma in situ of unspecified digestive organs 2E62 Carcinoma in situ of middle ear or respiratory system – 2E62.0 Carcinoma in situ of larynx – 2E62.1 Carcinoma in situ of trachea – 2E62.2 Carcinoma in situ of bronchus or lung – 2E62.Y Carcinoma in situ of other specified sites of middle ear and respiratory system – 2E62.Z Carcinoma in situ of unspecified sites of middle ear and respiratory system 2E63 Melanoma in situ neoplasms – 2E63.0 Melanoma in situ of skin – 2E63.1 Melanoma in situ of conjunctiva – 2E63.Y Melanoma in situ neoplasms, other specified site – 2E63.Z Melanoma in situ neoplasms, unspecified site –– 2E63.00 Lentigo maligna –– 2E63.0Z Melanoma in situ of skin, unspecified 2E64 Carcinoma in situ of skin – 2E64.0 Intraepidermal squamous cell carcinoma – 2E64.1 Extramammary Paget disease of skin – 2E64.2 Carcinoma in situ of anal margin or perianal skin – 2E64.Y Other specified carcinoma in situ of skin – 2E64.Z Carcinoma in situ of skin, unspecified –– 2E64.00 Bowen disease of skin –– 2E64.01 Actinic intraepidermal squamous cell carcinoma –– 2E64.0Y Other specified intraepidermal squamous cell carcinoma –– 2E64.0Z Intraepidermal squamous cell carcinoma, unspecified 2E65 Carcinoma in situ of breast – 2E65.0 Lobular carcinoma in situ of breast – 2E65.1 Lobular carcinoma in situ of breast, pleomorphic subtype – 2E65.2 Ductal carcinoma in situ of breast – 2E65.3 Ductal carcinoma in situ of breast, comedo subtype – 2E65.4 Mixed ductal and lobular carcinoma in situ of breast – 2E65.5 Paget disease of nipple – 2E65.Y Other specified carcinoma in situ of breast – 2E65.Z Carcinoma in situ of breast, unspecified 2E66 Carcinoma in situ of cervix uteri – 2E66.2 High grade squamous intraepithelial lesion of cervix uteri – 2E66.Y Other specified carcinoma in situ of cervix uteri – 2E66.Z Carcinoma in situ of cervix uteri, unspecified 2E67 Carcinoma in situ of other or unspecified genital organs – 2E67.0 Carcinoma in situ of endometrium – 2E67.1 Carcinoma in situ of vulva – 2E67.2 Carcinoma in situ of vagina – 2E67.3 Carcinoma in situ of other or unspecified female genital organs – 2E67.4 Carcinoma in situ of penis – 2E67.5 High grade intraepithelial lesion of prostate – 2E67.6 Carcinoma in situ of other or unspecified male genital organs –– 2E67.11 Vulvar Paget disease –– 2E67.12 Vulvar intraepithelial neoplasia, HPV-independent –– 2E67.13 High grade squamous intraepithelial lesion of vulva, HPV-associated –– 2E67.22 High grade squamous intraepithelial lesion of vagina –– 2E67.2Y Other specified carcinoma in situ of vagina –– 2E67.2Z Carcinoma in situ of vagina, unspecified –– 2E67.40 Squamous cell carcinoma in situ of skin of penis –– 2E67.41 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis 2E68 Carcinoma in situ of bladder 2E69 Carcinoma in situ of other or unspecified urinary organs 2E6A Carcinoma in situ of the eye or ocular adnexa – 2E6A.0 Carcinoma in situ of the conjunctiva – 2E6A.1 Carcinoma in situ of the cornea – 2E6A.Y Carcinoma in situ of other and unspecified part of the eye and adnexa 2E6B Carcinoma in situ of thyroid and other endocrine glands 2E6Y Carcinoma in situ of other specified site 2E6Z Carcinoma in situ of unspecified site – 2E80 Benign lipomatous neoplasm –– 2E80.0 Lipoma –– 2E80.1 Lipoblastoma –– 2E80.Y Other specified benign lipomatous neoplasm –– 2E80.Z Benign lipomatous neoplasm, unspecified ––– 2E80.00 Superficial subcutaneous lipoma ––– 2E80.01 Deep subfascial lipoma ––– 2E80.02 Deep internal or visceral lipoma ––– 2E80.0Y Lipoma, other specified site ––– 2E80.0Z Lipoma, unspecified site – 2E81 Benign vascular neoplasms –– 2E81.0 Neoplastic haemangioma –– 2E81.1 Benign lymphatic neoplasms –– 2E81.2 Benign vascular neoplasms of infancy and childhood –– 2E81.Y Other specified benign vascular neoplasms –– 2E81.Z Benign vascular neoplasms, unspecified ––– 2E81.00 Umbilical cord haemangioma ––– 2E81.01 Conjunctival haemangioma or haemolymphangioma ––– 2E81.0Y Neoplastic haemangioma of other specified site ––– 2E81.0Z Neoplastic haemangioma, unspecified site ––– 2E81.10 Disseminated lymphangiomatosis ––– 2E81.11 Acquired progressive lymphangioma ––– 2E81.1Y Other specified benign lymphatic neoplasms ––– 2E81.1Z Benign lymphatic neoplasms, unspecified ––– 2E81.20 Focal infantile haemangioma ––– 2E81.21 Multifocal infantile haemangioma ––– 2E81.2Y Other specified benign vascular neoplasms of infancy and childhood ––– 2E81.2Z Benign vascular neoplasms of infancy and childhood, unspecified – 2E82 Benign chondrogenic tumours –– 2E82.0 Benign chondrogenic tumours of bone or articular cartilage of limbs –– 2E82.1 Benign chondrogenic tumours of bone or articular cartilage of other specified sites –– 2E82.Z Benign chondrogenic tumours, site unspecified – 2E83 Benign osteogenic tumours –– 2E83.0 Benign osteogenic tumours of bone or articular cartilage of skull or face –– 2E83.1 Benign osteogenic tumours of bone or articular cartilage of lower jaw –– 2E83.2 Benign osteogenic tumours of bone or articular cartilage of vertebral column –– 2E83.3 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle –– 2E83.4 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx –– 2E83.5 Benign osteogenic tumours of bone or articular cartilage of limbs –– 2E83.Y Benign osteogenic tumour of other specified site –– 2E83.Z Benign osteogenic tumour of unspecified site – 2E84 Benign fibrogenic or myofibrogenic tumour –– 2E84.0 Benign fibrogenic or myofibrogenic tumour of skin –– 2E84.Y Benign fibrogenic or myofibrogenic tumour of other specified sites –– 2E84.Z Benign fibrogenic or myofibrogenic tumour, site unknown – 2E85 Benign fibrohistiocytic tumour –– 2E85.0 Benign fibrohistiocytic tumour of soft tissues of limbs –– 2E85.1 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum –– 2E85.2 Benign fibrohistiocytic tumour of skin –– 2E85.Y Benign fibrohistiocytic tumour of other specified sites –– 2E85.Z Benign fibrohistiocytic tumour, site unspecified – 2E86 Benign smooth muscle or skeletal muscle tumour –– 2E86.0 Leiomyoma of uterus –– 2E86.1 Leiomyoma of other or unspecified sites –– 2E86.2 Rhabdomyoma –– 2E86.Y Other specified benign smooth muscle or skeletal muscle tumour –– 2E86.Z Benign smooth muscle or skeletal muscle tumour, unspecified – 2E87 Benign gastrointestinal stromal tumour – 2E88 Benign endometrial stromal nodule – 2E89 Benign mesenchymal tumours of uncertain differentiation –– 2E89.0 Benign tumours of uncertain differentiation, bone or cartilage –– 2E89.1 Benign tumours of uncertain differentiation, soft tissue –– 2E89.Y Benign mesenchymal tumours of uncertain differentiation of other specified site –– 2E89.Z Benign mesenchymal tumours of uncertain differentiation of unspecified site – 2E8A Other mixed or unspecified benign mesenchymal tumours – 2E8Y Other specified benign mesenchymal neoplasm – 2E8Z Benign mesenchymal neoplasms, unspecified – 2E90 Benign neoplasm of lip, oral cavity or pharynx –– 2E90.0 Benign neoplasm of lip –– 2E90.1 Benign neoplasm of tongue –– 2E90.2 Benign neoplasm of floor of mouth –– 2E90.3 Benign neoplasm of other or unspecified parts of mouth –– 2E90.4 Benign neoplasm of tonsil –– 2E90.5 Benign neoplasm of oropharynx –– 2E90.6 Benign neoplasm of nasopharynx –– 2E90.7 Benign neoplasm of hypopharynx –– 2E90.8 Benign neoplasm of pharynx, unspecified – 2E91 Benign neoplasm of major salivary glands –– 2E91.0 Benign neoplasm of parotid gland –– 2E91.1 Benign neoplasm of other specified major salivary glands –– 2E91.Z Benign neoplasm of unspecified major salivary glands – 2E92 Benign neoplasm of digestive organs –– 2E92.0 Benign neoplasm of oesophagus –– 2E92.1 Benign neoplasm of stomach –– 2E92.2 Benign neoplasm of duodenum –– 2E92.3 Benign neoplasm of other or unspecified parts of small intestine –– 2E92.4 Benign neoplasm of the large intestine –– 2E92.5 Benign neoplasm of anus or anal canal –– 2E92.6 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater –– 2E92.7 Benign neoplasm of liver or intrahepatic bile ducts –– 2E92.8 Benign neoplasm of pancreas –– 2E92.9 Benign neoplasm of endocrine pancreas –– 2E92.Y Benign neoplasm of other specified digestive organs –– 2E92.Z Benign neoplasm of unspecified digestive organs ––– 2E92.40 Polyposis syndrome ––– 2E92.4Y Other specified benign neoplasm of the large intestine ––– 2E92.4Z Benign neoplasm of the large intestine, unspecified –– 2F00 Benign neoplasm of middle ear or respiratory system ––– 2F00.0 Middle ear endocrine tumour ––– 2F00.1 Recurrent respiratory papillomatosis ––– 2F00.2 Laryngeal endocrine tumour ––– 2F00.Y Other specified benign neoplasm of middle ear or respiratory system ––– 2F00.Z Benign neoplasm of middle ear or respiratory system, unspecified –– 2F01 Benign neoplasm of intrathoracic organs –– 2F0Y Benign neoplasms of other specified respiratory and intrathoracic organs –– 2F0Z Benign neoplasms of unspecified respiratory and intrathoracic organs – 2F10 Benign neoplasm of mesothelial tissue –– 2F20 Benign cutaneous melanocytic neoplasms ––– 2F20.0 Common acquired melanocytic naevus ––– 2F20.1 Atypical melanocytic naevus ––– 2F20.2 Congenital melanocytic naevus ––– 2F20.3 Generalised eruptive melanocytic naevi ––– 2F20.Y Other specific types of melanocytic naevus ––– 2F20.Z Melanocytic naevus, unspecified –––– 2F20.00 Multiple benign melanocytic naevi –––– 2F20.0Y Other specified common acquired melanocytic naevus –––– 2F20.0Z Common acquired melanocytic naevus, unspecified –––– 2F20.20 Giant congenital melanocytic naevus –––– 2F20.2Y Other specified congenital melanocytic naevus –––– 2F20.2Z Congenital melanocytic naevus, unspecified –– 2F21 Benign keratinocytic acanthomas ––– 2F21.0 Seborrhoeic keratosis ––– 2F21.Y Other specified benign keratinocytic acanthomas –– 2F22 Benign neoplasms of epidermal appendages –– 2F23 Benign dermal fibrous or fibrohistiocytic neoplasms ––– 2F23.0 Dermatofibroma ––– 2F23.Y Other specified benign dermal fibrous or fibrohistiocytic neoplasms –– 2F24 Benign cutaneous neoplasms of neural or nerve sheath origin –– 2F25 Cherry angioma –– 2F26 Lobular capillary haemangioma –– 2F2Y Other specified benign cutaneous neoplasms –– 2F2Z Benign cutaneous neoplasm of unspecified type – 2F30 Benign neoplasm of breast –– 2F30.0 Tubular adenoma of breast –– 2F30.1 Lactating adenoma of breast –– 2F30.2 Intraductal papilloma of breast –– 2F30.3 Benign phyllodes tumour of breast –– 2F30.4 Fibromatosis of breast –– 2F30.5 Fibroadenoma of breast –– 2F30.6 Extensive adenomatosis of nipple –– 2F30.Y Other specified benign neoplasm of breast –– 2F30.Z Benign neoplasm of breast, unspecified – 2F31 Benign non-mesenchymal neoplasms of uterus –– 2F31.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri –– 2F31.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri –– 2F31.2 Benign non-mesenchymal neoplasms of uterus, other parts – 2F32 Benign neoplasm of ovary –– 2F32.0 Cystic teratoma –– 2F32.1 Ovarian fibroma –– 2F32.2 Meigs' syndrome –– 2F32.3 Serous ovarian cystadenoma –– 2F32.Y Other specified benign neoplasm of ovary –– 2F32.Z Benign neoplasm of ovary, unspecified – 2F33 Benign neoplasm of other or unspecified female genital organs – 2F34 Benign neoplasm of male genital organs – 2F35 Benign neoplasm of urinary organs – 2F36 Benign neoplasm of eye or ocular adnexa –– 2F36.0 Benign neoplasm of choroid –– 2F36.1 Benign neoplasm of iris –– 2F36.2 Benign neoplasm of ciliary body –– 2F36.3 Teratoma of orbit –– 2F36.4 Cysts of eyelid –– 2F36.Y Other specified benign neoplasm of eye or ocular adnexa –– 2F36.Z Benign neoplasm of eye or ocular adnexa, unspecified – 2F37 Benign neoplasm of endocrine glands –– 2F37.0 Non-secreting pituitary adenoma –– 2F37.Y Other specified benign neoplasm of endocrine glands –– 2F37.Z Benign neoplasm of endocrine glands, unspecified – 2F3Y Benign non-mesenchymal neoplasms of other specified site – 2F3Z Benign non-mesenchymal neoplasms of unspecified site 2F5Y Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues 2F5Z Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified 2F70 Neoplasms of uncertain behaviour of oral cavity or digestive organs – 2F70.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx – 2F70.1 Neoplasms of uncertain behaviour of stomach – 2F70.2 Neoplasms of uncertain behaviour of small intestine – 2F70.3 Neoplasms of uncertain behaviour of colon – 2F70.4 Neoplasms of uncertain behaviour of rectum – 2F70.5 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts – 2F70.Y Neoplasms of uncertain behaviour of oral cavity and digestive organs, other specified site – 2F70.Z Neoplasms of uncertain behaviour of oral cavity and digestive organs, unspecified site 2F71 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs – 2F71.0 Neoplasms of uncertain behaviour of thymus – 2F71.1 Neoplasms of uncertain behaviour of larynx – 2F71.2 Neoplasms of uncertain behaviour of pleura – 2F71.3 Neoplasms of uncertain behaviour of trachea, bronchus or lung – 2F71.4 Neoplasms of uncertain behaviour of mediastinum – 2F71.Y Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, other specified site – 2F71.Z Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, unspecified site 2F72 Neoplasms of uncertain behaviour of skin – 2F72.1 Spitzoid tumour of uncertain malignant potential – 2F72.2 Melanocytic naevus with severe melanocytic dysplasia – 2F72.Y Other specified neoplasms of uncertain behaviour of skin 2F73 Neoplasms of uncertain behaviour of retroperitoneum 2F74 Neoplasms of uncertain behaviour of peritoneum 2F75 Neoplasms of uncertain behaviour of breast 2F76 Neoplasms of uncertain behaviour of female genital organs 2F77 Neoplasms of uncertain behaviour of male genital organs 2F78 Neoplasms of uncertain behaviour of urinary organs 2F79 Neoplasms of uncertain behaviour of eye or ocular adnexa 2F7A Neoplasms of uncertain behaviour of endocrine glands – 2F7A.0 Multiple polyglandular tumours – 2F7A.Y Other specified neoplasms of uncertain behaviour of endocrine glands – 2F7A.Z Neoplasms of uncertain behaviour of endocrine glands, unspecified 2F7B Neoplasms of uncertain behaviour of bone or articular cartilage 2F7C Neoplasms of uncertain behaviour of connective or other soft tissue 2F7Y Neoplasms of uncertain behaviour of other specified site 2F7Z Neoplasms of uncertain behaviour of unspecified site 2F90 Neoplasms of unknown behaviour of oral cavity or digestive organs – 2F90.0 Neoplasms of unknown behaviour of colon – 2F90.1 Neoplasms of unknown behaviour of rectum – 2F90.Y Neoplasms of unknown behaviour of oral cavity and digestive organs, other specified site – 2F90.Z Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site 2F91 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs – 2F91.0 Neoplasms of unknown behaviour of larynx – 2F91.1 Neoplasms of unknown behaviour of trachea, bronchus or lung – 2F91.Y Neoplasms of unknown behaviour of other specified respiratory organ, intrathoracic organ or middle ear – 2F91.Z Neoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ 2F92 Neoplasms of unknown behaviour of skin 2F93 Neoplasms of unknown behaviour of retroperitoneum 2F94 Neoplasms of unknown behaviour of peritoneum 2F95 Neoplasms of unknown behaviour of breast 2F96 Neoplasms of unknown behaviour of female genital organs 2F97 Neoplasms of unknown behaviour of male genital organs 2F98 Neoplasms of unknown behaviour of urinary organs 2F99 Neoplasms of unknown behaviour of eye or ocular adnexa 2F9A Neoplasms of unknown behaviour of endocrine glands 2F9B Neoplasms of unknown behaviour of bone or articular cartilage 2F9C Neoplasms of unknown behaviour of connective or other soft tissue 2F9Y Neoplasms of unknown behaviour of other specified site 2F9Z Neoplasms of unknown behaviour of unspecified site – 3A00 Iron deficiency anaemia –– 3A00.0 Acquired iron deficiency anaemia due to blood loss –– 3A00.1 Acquired iron deficiency anaemia due to low intake –– 3A00.2 Acquired iron deficiency anaemia due to decreased absorption –– 3A00.3 Acquired iron deficiency anaemia due to increased requirement –– 3A00.Y Other specified iron deficiency anaemia –– 3A00.Z Iron deficiency anaemia, unspecified ––– 3A00.01 Chronic posthaemorrhagic anaemia ––– 3A00.0Z Acquired iron deficiency anaemia due to blood loss, unspecified – 3A01 Megaloblastic anaemia due to vitamin B12 deficiency –– 3A01.0 Hereditary vitamin B12 deficiency anaemia –– 3A01.1 Neonatal vitamin B12 deficiency anaemia –– 3A01.2 Vitamin B12 deficiency anaemia due to low intake –– 3A01.3 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency –– 3A01.4 Vitamin B12 deficiency anaemia due to intestinal disease –– 3A01.5 Drug-induced vitamin B12 deficiency anaemia –– 3A01.Y Other specified megaloblastic anaemia due to vitamin B12 deficiency –– 3A01.Z Megaloblastic anaemia due to vitamin B12 deficiency, unspecified ––– 3A01.30 Pernicious anaemia ––– 3A01.3Y Other specified vitamin B12 deficiency anaemia due to intrinsic factor deficiency – 3A02 Folate deficiency anaemia –– 3A02.0 Hereditary folate deficiency anaemia –– 3A02.1 Folate deficiency anaemia due to low intake –– 3A02.2 Folate deficiency anaemia due to increased requirements –– 3A02.3 Folate deficiency anaemia due to decreased intestinal absorption –– 3A02.4 Drug-induced folate deficiency anaemia –– 3A02.Y Other specified folate deficiency anaemia –– 3A02.Z Folate deficiency anaemia, unspecified – 3A03 Other nutritional or metabolic anaemias –– 3A03.0 Hereditary orotic aciduria –– 3A03.1 Protein deficiency anaemia –– 3A03.2 Scorbutic anaemia –– 3A03.3 Copper deficiency anaemia –– 3A03.4 Acquired other vitamin B deficiency anaemia –– 3A03.5 Acquired vitamin A deficiency anaemia –– 3A03.6 Acquired vitamin E deficiency anaemia –– 3A03.Y Other and unspecified nutritional or metabolic anaemia ––– 3A03.40 Acquired pyridoxine deficiency anaemia ––– 3A03.41 Acquired riboflavin deficiency anaemia ––– 3A03.42 Acquired thiamine deficiency anaemia ––– 3A03.4Y Other specified acquired other vitamin B deficiency anaemia –– 3A10 Hereditary haemolytic anaemia ––– 3A10.0 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies ––– 3A10.1 Haemolytic anaemia due to adenosine deaminase excess ––– 3A10.2 Hereditary elliptocytosis ––– 3A10.3 Familial pseudohyperkalaemia ––– 3A10.Y Other specified hereditary haemolytic anaemia ––– 3A10.Z Hereditary haemolytic anaemia, unspecified –––– 3A10.00 Haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency –––– 3A10.0Y Other specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies –––– 3A10.0Z Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies, unspecified –– 3A1Y Other specified congenital haemolytic anaemia –– 3A20 Acquired haemolytic anaemia, immune ––– 3A20.0 Autoimmune haemolytic anaemia, warm type ––– 3A20.1 Autoimmune haemolytic anaemia, cold type ––– 3A20.2 Autoimmune haemolytic anaemia, mixed type, cold and warm ––– 3A20.3 Paroxysmal cold haemoglobinuria ––– 3A20.4 Alloimmune haemolytic anaemia ––– 3A20.5 Evans syndrome ––– 3A20.Y Other specified acquired haemolytic anaemia, immune –– 3A21 Acquired haemolytic anaemia, non-immune ––– 3A21.0 Paroxysmal nocturnal haemoglobinuria ––– 3A21.1 Microangiopathic haemolytic anaemia ––– 3A21.2 Haemolytic uraemic syndrome ––– 3A21.Y Other specified acquired haemolytic anaemia, non-immune –– 3A2Z Acquired haemolytic anaemia, unspecified – 3A4Z Haemolytic anaemias, unspecified 3A50 Thalassaemias – 3A50.0 Alpha thalassaemia – 3A50.1 Alpha thalassaemia related syndromes – 3A50.2 Beta thalassaemia – 3A50.3 Delta, delta-beta or gamma-delta-beta thalassaemia – 3A50.4 Hereditary persistence of fetal haemoglobin – 3A50.Y Other specified thalassaemias – 3A50.Z Thalassaemias, unspecified –– 3A50.00 Mild alpha thalassaemia diseases –– 3A50.01 Thalassaemic alpha-chain variants –– 3A50.02 Haemoglobin H disease (– α/– – included) –– 3A50.03 Homozygous or compound heterozygous alpha0 thalassaemia –– 3A50.0Y Other specified alpha thalassaemia –– 3A50.0Z Alpha thalassaemia, unspecified 3A51 Sickle cell disorders or other haemoglobinopathies – 3A51.0 Sickle cell trait – 3A51.1 Sickle cell disease without crisis – 3A51.2 Sickle cell disease with crisis – 3A51.3 Compound heterozygous sickling disorders without crisis – 3A51.4 Compound heterozygous sickling disorders with crisis – 3A51.5 Haemoglobin C disease – 3A51.6 Haemoglobin D disease – 3A51.7 High affinity haemoglobin – 3A51.8 Low affinity haemoglobin – 3A51.9 Haemoglobin O disease – 3A51.A Haemoglobin E disease – 3A51.B Haemoglobin C/beta thalassaemia compound heterozygosity – 3A51.Y Other specified sickle cell disorders or other haemoglobinopathies – 3A51.Z Sickle cell disorders or other haemoglobinopathies, unspecified – 3A60 Congenital pure red cell aplasia –– 3A60.0 Congenital non-inherited pure red cell aplasia –– 3A60.1 Hereditary pure red cell aplasia –– 3A60.Z Congenital pure red cell aplasia, unspecified – 3A61 Acquired pure red cell aplasia –– 3A61.0 Acute acquired pure red cell aplasia –– 3A61.1 Chronic acquired pure red cell aplasia –– 3A61.Y Other specified acquired pure red cell aplasia –– 3A61.Z Acquired pure red cell aplasia, unspecified – 3A6Z Pure red cell aplasia, unspecified 3A70 Aplastic anaemia – 3A70.0 Congenital aplastic anaemia – 3A70.1 Acquired aplastic anaemias – 3A70.Z Aplastic anaemia, unspecified –– 3A70.10 Drug-induced aplastic anaemia –– 3A70.11 Aplastic anaemia due to other external agents –– 3A70.12 Idiopathic aplastic anaemia –– 3A70.1Y Other specified acquired aplastic anaemias –– 3A70.1Z Acquired aplastic anaemias, unspecified 3A71 Anaemia due to chronic disease – 3A71.0 Anaemia in neoplastic disease – 3A71.1 Anaemia in chronic infectious diseases – 3A71.2 Anaemia in chronic kidney disease – 3A71.Y Anaemia due to other specified chronic disease – 3A71.Z Anaemia due to chronic disease, unspecified 3A72 Sideroblastic anaemia – 3A72.0 Congenital sideroblastic anaemias – 3A72.1 Acquired sideroblastic anaemias – 3A72.Z Sideroblastic anaemia, unspecified –– 3A72.00 Hereditary sideroblastic anaemias –– 3A72.01 Hereditary syndromic sideroblastic anaemia –– 3A72.0Y Other specified congenital sideroblastic anaemias –– 3A72.0Z Congenital sideroblastic anaemias, unspecified 3A73 Congenital dyserythropoietic anaemia – 3A80 Congenital polycythaemia –– 3A80.0 Primary inherited erythrocytosis –– 3A80.Y Other specified congenital polycythaemia –– 3A80.Z Congenital polycythaemia, unspecified – 3A81 Acquired polycythaemia –– 3A81.0 Polycythaemia due to hypoxia, including high altitude –– 3A81.1 Polycythaemia due to over-transfusion or blood doping –– 3A81.2 Relative polycythaemia –– 3A81.Y Other specified acquired polycythaemia –– 3A81.Z Acquired polycythaemia, unspecified – 3A8Z Polycythaemia, unspecified 3A90 Anaemia due to acute disease 3A91 Congenital methaemoglobinaemia 3A92 Hereditary methaemoglobinaemia 3A93 Acquired methaemoglobinaemia 3A94 Acute posthaemorrhagic anaemia 3A9Y Other specified anaemias or erythrocyte disorders 3A9Z Anaemias or other erythrocyte disorders, unspecified –– 3B10 Hereditary factor VIII deficiency ––– 3B10.0 Haemophilia A ––– 3B10.1 Hereditary factor VIII deficiency with anti-factor VIII inhibitor ––– 3B10.Y Other specified hereditary factor VIII deficiency ––– 3B10.Z Hereditary factor VIII deficiency, unspecified –– 3B11 Hereditary factor IX deficiency ––– 3B11.0 Haemophilia B ––– 3B11.Y Other specified hereditary factor IX deficiency ––– 3B11.Z Hereditary factor IX deficiency, unspecified –– 3B12 Von Willebrand disease –– 3B13 Haemophilia C –– 3B14 Other inherited coagulation factor deficiency with bleeding tendency ––– 3B14.0 Hereditary deficiency of factor I ––– 3B14.1 Hereditary factor X deficiency ––– 3B14.2 Combined deficiency of vitamin K-dependent clotting factors ––– 3B14.Z Other inherited coagulation factor deficiency with bleeding tendency, unspecified –– 3B15 Inherited coagulation factor deficiency without bleeding tendency –– 3B1Z Congenital or constitutional haemorrhagic condition, unspecified –– 3B20 Disseminated intravascular coagulation –– 3B21 Haemorrhagic disorder due to circulating anticoagulants and coagulation factors ––– 3B21.0 Haemorrhage due to thrombin inhibitor other than heparin ––– 3B21.1 Haemorrhage due to factor Xa inhibitor ––– 3B21.Y Haemorrhagic disorder due to other specified circulating anticoagulants ––– 3B21.Z Haemorrhagic disorder due to unspecified circulating anticoagulants –– 3B22 Acquired haemophilia –– 3B2Y Other specified haemorrhagic diseases due to acquired coagulation factor defects – 3B4Z Coagulation defects, unspecified – 3B50 Inherited fibrinolytic defects –– 3B50.0 Congenital alpha-2 antiplasmin deficiency –– 3B50.1 Congenital plasminogen activator inhibitor type 1 deficiency –– 3B50.Y Other specified inherited fibrinolytic defects –– 3B50.Z Inherited fibrinolytic defects, unspecified – 3B51 Acquired fibrinolytic defects 3B60 Non-thrombocytopenic purpura – 3B60.0 Hereditary vascular purpura – 3B60.1 Acquired vascular purpura 3B61 Thrombophilia – 3B61.0 Hereditary thrombophilia – 3B61.1 Acquired thrombophilia – 3B61.Y Other specified thrombophilia – 3B61.Z Thrombophilia, unspecified –– 3B61.00 Hyperhomocysteinaemia –– 3B61.0Y Other specified hereditary thrombophilia –– 3B61.0Z Hereditary thrombophilia, unspecified 3B62 Qualitative platelet defects – 3B62.0 Inherited qualitative platelet defects – 3B62.1 Bleeding diathesis due to thromboxane synthesis deficiency – 3B62.2 Isolated thrombocytopenia – 3B62.3 Dense granule disease – 3B62.4 Alpha-delta dense granule deficiency – 3B62.5 Haemophagocytic syndrome associated with infection – 3B62.Y Other specified qualitative platelet defects – 3B62.Z Qualitative platelet defects, unspecified –– 3B62.00 Alpha-granule diseases –– 3B62.01 Inherited giant platelet disorder –– 3B62.0Y Other specified inherited qualitative platelet defects –– 3B62.0Z Inherited qualitative platelet defects, unspecified 3B63 Thrombocytosis – 3B63.0 Congenital thrombocytosis – 3B63.1 Acquired thrombocytosis – 3B63.Y Other specified thrombocytosis – 3B63.Z Thrombocytosis, unspecified –– 3B63.10 Secondary thrombocytosis –– 3B63.1Y Other specified acquired thrombocytosis –– 3B63.1Z Acquired thrombocytosis, unspecified 3B64 Thrombocytopenia – 3B64.0 Congenital thrombocytopenia – 3B64.1 Acquired thrombocytopenia – 3B64.Z Thrombocytopenia, unspecified –– 3B64.00 Congenital non-inherited thrombocytopenia –– 3B64.01 Hereditary thrombocytopenia –– 3B64.0Z Congenital thrombocytopenia, unspecified –– 3B64.10 Immune thrombocytopenic purpura –– 3B64.11 Secondary thrombocytopenic purpura –– 3B64.12 Drug-induced thrombocytopenic purpura –– 3B64.13 Alloimmune thrombocytopenia –– 3B64.14 Thrombotic thrombocytopenic purpura –– 3B64.1Y Other specified acquired thrombocytopenia 3B65 Thrombotic microangiopathy, not elsewhere classified 3B6Y Other specified coagulation defects, purpura or other haemorrhagic or related conditions 3B6Z Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified 3B80 Congenital disorders of spleen – 3B80.0 Splenomegaly in storage diseases 3B81 Acquired disorders of spleen – 3B81.0 Tumour-like conditions of spleen – 3B81.1 Postsurgical asplenia – 3B81.2 Atrophy of spleen – 3B81.3 Nontraumatic laceration or rupture of spleen – 3B81.4 Splenosis – 3B81.5 Splenic cyst or pseudocyst – 3B81.6 Infarction of spleen – 3B81.7 Infection of spleen – 3B81.8 Torsion of spleen – 3B81.9 Fibrosis of spleen – 3B81.A Perisplenitis – 3B81.B Hypersplenism – 3B81.C Chronic congestive splenomegaly – 3B81.Y Other specified acquired disorders of spleen – 3B81.Z Acquired disorders of spleen, unspecified –– 3B81.50 Pseudocyst of spleen –– 3B81.51 Epithelial cyst of spleen –– 3B81.5Y Other specified splenic cyst –– 3B81.5Z Splenic cyst, unspecified –– 3B81.70 Acute septic splenitis –– 3B81.71 Abscess of spleen –– 3B81.7Y Other specified infection of spleen –– 3B81.7Z Infection of spleen, unspecified 3B8Z Diseases of spleen, unspecified 3C0Y Other specified diseases of the blood or blood-forming organs 3C0Z Diseases of the blood or blood-forming organs, unspecified 4A00 Primary immunodeficiencies due to disorders of innate immunity – 4A00.0 Functional neutrophil defects – 4A00.1 Defects in the complement system – 4A00.2 Genetic susceptibility to particular pathogens – 4A00.3 Immunodeficiency with natural-killer cell deficiency – 4A00.Y Other specified primary immunodeficiencies due to disorders of innate immunity – 4A00.Z Primary immunodeficiencies due to disorders of innate immunity, unspecified –– 4A00.00 Neutrophil immunodeficiency syndrome –– 4A00.0Y Other specified functional neutrophil defects –– 4A00.0Z Functional neutrophil defects, unspecified –– 4A00.10 Immunodeficiency with an early component of complement deficiency –– 4A00.11 Immunodeficiency with a late component of complement deficiency –– 4A00.12 Immunodeficiency with factor B deficiency –– 4A00.13 Immunodeficiency with factor D anomaly –– 4A00.14 Hereditary angioedema –– 4A00.15 Acquired angioedema –– 4A00.1Y Other specified defects in the complement system –– 4A00.1Z Defects in the complement system, unspecified 4A01 Primary immunodeficiencies due to disorders of adaptive immunity – 4A01.0 Immunodeficiencies with predominantly antibody defects – 4A01.1 Combined immunodeficiencies – 4A01.2 Diseases of immune dysregulation – 4A01.3 Other well-defined immunodeficiency syndromes due to defects in adaptive immunity – 4A01.Z Primary immunodeficiencies due to disorders of adaptive immunity, unspecified –– 4A01.00 Hereditary agammaglobulinaemia with profoundly reduced or absent B cells –– 4A01.01 Immunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells –– 4A01.02 Specific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells –– 4A01.03 Transient hypogammaglobulinaemia of infancy –– 4A01.04 Immunodeficiencies with isotype or light chain deficiencies with normal number of B cells –– 4A01.05 Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells –– 4A01.0Y Other specified immunodeficiencies with predominantly antibody defects –– 4A01.0Z Immunodeficiencies with predominantly antibody defects, unspecified –– 4A01.10 Severe combined immunodeficiencies –– 4A01.11 Major histocompatibility complex class I deficiency –– 4A01.12 Major histocompatibility complex class II deficiency –– 4A01.1Y Other specified combined immunodeficiencies –– 4A01.1Z Combined immunodeficiencies, unspecified –– 4A01.20 Immune dysregulation syndromes with hypopigmentation –– 4A01.21 Immune dysregulation syndromes presenting primarily with autoimmunity –– 4A01.22 Immune dysregulation syndromes presenting primarily with lymphoproliferation –– 4A01.23 Primary haemophagocytic lymphohistiocytosis –– 4A01.2Y Other specified diseases of immune dysregulation –– 4A01.2Z Diseases of immune dysregulation, unspecified –– 4A01.30 Immunodeficiency due to defects of the thymus –– 4A01.31 DNA repair defects other than combined T-cell or B-cell immunodeficiencies –– 4A01.32 Immuno-osseous dysplasia –– 4A01.33 Hepatic veno-occlusive disease - immunodeficiency syndrome –– 4A01.34 Hyperimmunoglobulin E syndromes 4A0Y Other specified primary immunodeficiencies 4A0Z Primary immunodeficiencies, unspecified 4A20 Acquired immunodeficiencies 4A20.0 Adult-onset immunodeficiency 4A20.1 Acquired immunodeficiency due to loss of immunoglobulin 4A20.Y Other specified acquired immunodeficiencies 4A20.Z Acquired immunodeficiencies, unspecified 4A40 Lupus erythematosus – 4A40.0 Systemic lupus erythematosus – 4A40.1 Drug-induced lupus erythematosus – 4A40.Y Other specified lupus erythematosus – 4A40.Z Lupus erythematosus, unspecified –– 4A40.00 Systemic lupus erythematosus with skin involvement –– 4A40.0Y Other specified systemic lupus erythematosus –– 4A40.0Z Systemic lupus erythematosus, unspecified 4A41 Idiopathic inflammatory myopathy – 4A41.0 Dermatomyositis – 4A41.1 Polymyositis – 4A41.2 Inclusion body myopathy – 4A41.Y Other specified idiopathic inflammatory myopathy – 4A41.Z Idiopathic inflammatory myopathy, unspecified –– 4A41.00 Adult dermatomyositis –– 4A41.01 Juvenile dermatomyositis –– 4A41.0Z Dermatomyositis, unspecified –– 4A41.10 Juvenile polymyositis –– 4A41.11 Paraneoplastic polymyositis –– 4A41.1Y Other specified polymyositis –– 4A41.1Z Polymyositis, unspecified –– 4A41.20 Inflammatory inclusion body myositis –– 4A41.21 Noninflammatory inclusion body myopathy –– 4A41.2Z Inclusion body myopathy, unspecified 4A42 Systemic sclerosis – 4A42.0 Paediatric onset systemic sclerosis – 4A42.1 Diffuse systemic sclerosis – 4A42.2 Limited systemic sclerosis – 4A42.Z Systemic sclerosis, unspecified 4A43 Overlap or undifferentiated nonorgan specific systemic autoimmune disease – 4A43.0 IgG4 related disease – 4A43.1 Mikulicz disease – 4A43.2 Sjögren syndrome – 4A43.3 Mixed connective tissue disease – 4A43.4 Diffuse eosinophilic fasciitis – 4A43.Y Other specified overlap non-organ specific systemic autoimmune disease – 4A43.Z Undifferentiated non-organ specific systemic autoimmune disease –– 4A43.20 Primary Sjögren syndrome –– 4A43.21 Secondary Sjögren syndrome –– 4A43.22 Paediatric onset Sjögren syndrome –– 4A43.2Y Other specified sjögren syndrome –– 4A43.2Z Sjögren syndrome, unspecified 4A44 Vasculitis – 4A44.0 Rhizomelic pseudopolyarthritis – 4A44.1 Aortic arch syndrome – 4A44.2 Giant cell arteritis – 4A44.3 Single organ vasculitis – 4A44.4 Polyarteritis nodosa – 4A44.5 Mucocutaneous lymph node syndrome – 4A44.6 Sneddon syndrome – 4A44.7 Primary angiitis of the central nervous system – 4A44.8 Thromboangiitis obliterans – 4A44.9 Immune complex small vessel vasculitis – 4A44.A Antineutrophil cytoplasmic antibody-associated vasculitis – 4A44.B Leukocytoclastic vasculitis – 4A44.Y Other specified vasculitis – 4A44.Z Vasculitis, unspecified –– 4A44.90 Cryoglobulinaemic vasculitis –– 4A44.91 Hypocomplementaemic urticarial vasculitis –– 4A44.92 IgA vasculitis –– 4A44.9Y Other specified immune complex small vessel vasculitis –– 4A44.9Z Immune complex small vessel vasculitis, unspecified –– 4A44.A0 Microscopic polyangiitis –– 4A44.A1 Granulomatosis with polyangiitis –– 4A44.A2 Eosinophilic granulomatosis with polyangiitis –– 4A44.AY Other specified antineutrophil cytoplasmic antibody-associated vasculitis –– 4A44.AZ Antineutrophil cytoplasmic antibody-associated vasculitis, unspecified –– 4A44.B0 Cutaneous leukocytoclastic vasculitis –– 4A44.BY Other specified leukocytoclastic vasculitis –– 4A44.BZ Leukocytoclastic vasculitis, unspecified 4A45 Antiphospholipid syndrome – 4A45.0 Primary antiphospholipid syndrome – 4A45.1 Secondary antiphospholipid syndrome – 4A45.2 Antiphospholipid syndrome in pregnancy – 4A45.3 Lupus anticoagulant-hypoprothrombinaemia syndrome – 4A45.Z Antiphospholipid syndrome, unspecified 4A4Y Other specified nonorgan specific systemic autoimmune disorders 4A4Z Nonorgan specific systemic autoimmune disorders, unspecified 4A60 Monogenic autoinflammatory syndromes – 4A60.0 Familial Mediterranean fever – 4A60.1 Cryopyrin-associated periodic syndromes – 4A60.2 Tumour necrosis factor receptor 1 associated periodic syndrome – 4A60.Y Other specified monogenic autoinflammatory syndromes – 4A60.Z Autoimflammatory syndrome, unspecified 4A61 SAPHO syndrome 4A62 Behçet disease 4A6Y Other specified autoinflammatory disorders 4A6Z Autoinflammatory disorders, unspecified 4A80 Allergic or hypersensitivity disorders involving the respiratory tract – 4A80.0 Drug-induced bronchospasm – 4A80.1 Bronchospasm provoked by allergy to food substance – 4A80.Y Other specified allergic or hypersensitivity disorders involving the respiratory tract – 4A80.Z Allergic or hypersensitivity disorders involving the respiratory tract, unspecified 4A81 Allergic or hypersensitivity disorders involving the eye 4A82 Allergic or hypersensitivity disorders involving skin or mucous membranes 4A83 Allergic or hypersensitivity disorders involving the gastrointestinal tract – 4A83.0 Food-induced eosinophilic gastroenteritis – 4A83.1 Food-induced eosinophilic oesophagitis – 4A83.Y Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract – 4A83.Z Allergic or hypersensitivity disorders involving the gastrointestinal tract, unspecified 4A84 Anaphylaxis – 4A84.0 Anaphylaxis due to allergic reaction to food – 4A84.1 Drug-induced anaphylaxis – 4A84.2 Anaphylaxis due to insect venom – 4A84.3 Anaphylaxis provoked by physical factors – 4A84.4 Anaphylaxis due to inhaled allergens – 4A84.5 Anaphylaxis due to contact with allergens – 4A84.6 Anaphylaxis secondary to mast cell disorder – 4A84.Y Other specified anaphylaxis – 4A84.Z Anaphylaxis, unspecified –– 4A84.30 Exercise-induced anaphylaxis –– 4A84.31 Cold-induced anaphylaxis –– 4A84.3Y Anaphylaxis provoked by other specified physical factors –– 4A84.3Z Anaphylaxis provoked by unspecified physical factors 4A85 Complex allergic or hypersensitivity conditions – 4A85.0 Drug or pharmacological agents hypersensitivity – 4A85.1 Hypersensitivity to herbal and alternative medical therapies – 4A85.2 Food hypersensitivity – 4A85.3 Allergic or hypersensitivity reactions to arthropods – 4A85.Y Other specified complex allergic or hypersensitivity conditions – 4A85.Z Complex allergic or hypersensitivity conditions, unspecified –– 4A85.00 Drug-induced liver hypersensitivity disease –– 4A85.01 Drug-induced kidney hypersensitivity –– 4A85.02 Drug-induced cytopenia –– 4A85.03 Drug-induced vasculitis –– 4A85.04 Multiple drug hypersensitivity syndrome –– 4A85.0Y Drug hypersensitivity of other specified type –– 4A85.0Z Drug hypersensitivity of unspecified type –– 4A85.20 Food-induced gastrointestinal hypersensitivity –– 4A85.21 Food-induced urticaria or angioedema –– 4A85.22 Allergic contact dermatitis due to food allergen –– 4A85.2Y Other specified food hypersensitivity –– 4A85.2Z Food hypersensitivity, unspecified –– 4A85.30 Systemic allergic reaction due to Hymenoptera venom –– 4A85.31 Cutaneous allergic or hypersensitivity reactions to Hymenoptera venom –– 4A85.32 Cutaneous allergic or hypersensitivity reactions to arthropods 4A8Y Allergic or hypersensitivity conditions of other specified type 4A8Z Allergic or hypersensitivity conditions of unspecified type 4B00 Disorders of neutrophil number – 4B00.0 Neutropaenia – 4B00.1 Neutrophilia – 4B00.Y Other specified disorders of neutrophil number –– 4B00.00 Constitutional neutropaenia –– 4B00.01 Acquired neutropaenia –– 4B00.0Z Neutropaenia, unspecified –– 4B00.10 Constitutional neutrophilia –– 4B00.11 Acquired neutrophilia –– 4B00.1Z Neutrophilia, unspecified 4B01 Disorders of neutrophil function – 4B01.0 Constitutional disorders of neutrophil function – 4B01.1 Acquired disorders of neutrophil function – 4B01.Z Disorders of neutrophil function, unspecified –– 4B01.00 Disorders of neutrophil adhesion –– 4B01.01 Disorders of neutrophil chemotaxis –– 4B01.02 Disorders of neutrophil granule formation or release –– 4B01.03 Disorders of neutrophil oxidative metabolism –– 4B01.0Y Other specified constitutional disorders of neutrophil function –– 4B01.0Z Constitutional disorders of neutrophil function, unspecified 4B02 Eosinopenia – 4B02.0 Constitutional decrease in eosinophil number – 4B02.1 Acquired decrease in eosinophil number – 4B02.Z Eosinopenia, unspecified 4B03 Eosinophilia – 4B03.0 Constitutional eosinophilia – 4B03.1 Acquired eosinophilia – 4B03.Z Eosinophilia, unspecified 4B04 Disorders with decreased monocyte counts 4B05 Disorders with increased monocyte counts 4B06 Acquired lymphopenia 4B07 Acquired lymphocytosis 4B0Y Other specified immune system disorders involving white cell lineages 4B0Z Immune system disorders involving white cell lineages, unspecified 4B20 Sarcoidosis – 4B20.0 Sarcoidosis of lung – 4B20.1 Sarcoidosis of lymph nodes – 4B20.2 Sarcoidosis of the digestive system – 4B20.3 Neurosarcoidosis – 4B20.4 Ocular sarcoidosis – 4B20.5 Cutaneous sarcoidosis – 4B20.Y Other specified sarcoidosis – 4B20.Z Sarcoidosis, unspecified 4B21 Polyclonal hypergammaglobulinaemia 4B22 Cryoglobulinaemia 4B23 Immune reconstitution inflammatory syndrome 4B24 Graft-versus-host disease – 4B24.0 Acute graft-versus-host disease – 4B24.1 Chronic graft-versus-host disease – 4B24.Y Other specified graft-versus-host disease – 4B24.Z Graft-versus-host disease, unspecified 4B2Y Other specified disorders involving the immune system 4B40 Diseases of thymus 4B40.0 Persistent hyperplasia of thymus 4B40.1 Abscess of thymus 4B40.2 Good syndrome 4B40.Y Other specified diseases of thymus 4B40.Z Diseases of thymus, unspecified 4B4Y Other specified diseases of the immune system 4B4Z Diseases of the immune system, unspecified 4A40 Lupus erythematosus – 4A40.0 Systemic lupus erythematosus – 4A40.1 Drug-induced lupus erythematosus – 4A40.Y Other specified lupus erythematosus – 4A40.Z Lupus erythematosus, unspecified –– 4A40.00 Systemic lupus erythematosus with skin involvement –– 4A40.0Y Other specified systemic lupus erythematosus –– 4A40.0Z Systemic lupus erythematosus, unspecified 4A41 Idiopathic inflammatory myopathy – 4A41.0 Dermatomyositis – 4A41.1 Polymyositis – 4A41.2 Inclusion body myopathy – 4A41.Y Other specified idiopathic inflammatory myopathy – 4A41.Z Idiopathic inflammatory myopathy, unspecified –– 4A41.00 Adult dermatomyositis –– 4A41.01 Juvenile dermatomyositis –– 4A41.0Z Dermatomyositis, unspecified –– 4A41.10 Juvenile polymyositis –– 4A41.11 Paraneoplastic polymyositis –– 4A41.1Y Other specified polymyositis –– 4A41.1Z Polymyositis, unspecified –– 4A41.20 Inflammatory inclusion body myositis –– 4A41.21 Noninflammatory inclusion body myopathy –– 4A41.2Z Inclusion body myopathy, unspecified 4A42 Systemic sclerosis – 4A42.0 Paediatric onset systemic sclerosis – 4A42.1 Diffuse systemic sclerosis – 4A42.2 Limited systemic sclerosis – 4A42.Z Systemic sclerosis, unspecified 4A43 Overlap or undifferentiated nonorgan specific systemic autoimmune disease – 4A43.0 IgG4 related disease – 4A43.1 Mikulicz disease – 4A43.2 Sjögren syndrome – 4A43.3 Mixed connective tissue disease – 4A43.4 Diffuse eosinophilic fasciitis – 4A43.Y Other specified overlap non-organ specific systemic autoimmune disease – 4A43.Z Undifferentiated non-organ specific systemic autoimmune disease –– 4A43.20 Primary Sjögren syndrome –– 4A43.21 Secondary Sjögren syndrome –– 4A43.22 Paediatric onset Sjögren syndrome –– 4A43.2Y Other specified sjögren syndrome –– 4A43.2Z Sjögren syndrome, unspecified 4A44 Vasculitis – 4A44.0 Rhizomelic pseudopolyarthritis – 4A44.1 Aortic arch syndrome – 4A44.2 Giant cell arteritis – 4A44.3 Single organ vasculitis – 4A44.4 Polyarteritis nodosa – 4A44.5 Mucocutaneous lymph node syndrome – 4A44.6 Sneddon syndrome – 4A44.7 Primary angiitis of the central nervous system – 4A44.8 Thromboangiitis obliterans – 4A44.9 Immune complex small vessel vasculitis – 4A44.A Antineutrophil cytoplasmic antibody-associated vasculitis – 4A44.B Leukocytoclastic vasculitis – 4A44.Y Other specified vasculitis – 4A44.Z Vasculitis, unspecified –– 4A44.90 Cryoglobulinaemic vasculitis –– 4A44.91 Hypocomplementaemic urticarial vasculitis –– 4A44.92 IgA vasculitis –– 4A44.9Y Other specified immune complex small vessel vasculitis –– 4A44.9Z Immune complex small vessel vasculitis, unspecified –– 4A44.A0 Microscopic polyangiitis –– 4A44.A1 Granulomatosis with polyangiitis –– 4A44.A2 Eosinophilic granulomatosis with polyangiitis –– 4A44.AY Other specified antineutrophil cytoplasmic antibody-associated vasculitis –– 4A44.AZ Antineutrophil cytoplasmic antibody-associated vasculitis, unspecified –– 4A44.B0 Cutaneous leukocytoclastic vasculitis –– 4A44.BY Other specified leukocytoclastic vasculitis –– 4A44.BZ Leukocytoclastic vasculitis, unspecified 4A45 Antiphospholipid syndrome – 4A45.0 Primary antiphospholipid syndrome – 4A45.1 Secondary antiphospholipid syndrome – 4A45.2 Antiphospholipid syndrome in pregnancy – 4A45.3 Lupus anticoagulant-hypoprothrombinaemia syndrome – 4A45.Z Antiphospholipid syndrome, unspecified 4A4Y Other specified nonorgan specific systemic autoimmune disorders 4A4Z Nonorgan specific systemic autoimmune disorders, unspecified 4A60 Monogenic autoinflammatory syndromes – 4A60.0 Familial Mediterranean fever – 4A60.1 Cryopyrin-associated periodic syndromes – 4A60.2 Tumour necrosis factor receptor 1 associated periodic syndrome – 4A60.Y Other specified monogenic autoinflammatory syndromes – 4A60.Z Autoimflammatory syndrome, unspecified – 5A00 Hypothyroidism –– 5A00.0 Congenital hypothyroidism –– 5A00.1 Iodine-deficiency-related thyroid disorders or allied conditions –– 5A00.2 Acquired hypothyroidism –– 5A00.Z Hypothyroidism, unspecified ––– 5A00.00 Permanent congenital hypothyroidism with diffuse goitre ––– 5A00.01 Permanent congenital hypothyroidism without goitre ––– 5A00.02 Pendred syndrome ––– 5A00.03 Transient congenital hypothyroidism ––– 5A00.04 Congenital hypothyroidism due to iodine deficiency ––– 5A00.0Y Other specified congenital hypothyroidism ––– 5A00.0Z Congenital hypothyroidism, unspecified ––– 5A00.10 Iodine-deficiency-related diffuse goitre ––– 5A00.11 Iodine-deficiency-related multinodular goitre ––– 5A00.1Z Iodine-deficiency-related thyroid disorders or allied conditions, unspecified ––– 5A00.20 Hypothyroidism due to medicaments or other exogenous substances ––– 5A00.21 Myxoedema coma ––– 5A00.22 Subclinical iodine-deficiency hypothyroidism ––– 5A00.2Y Other specified acquired hypothyroidism ––– 5A00.2Z Acquired hypothyroidism, unspecified – 5A01 Nontoxic goitre –– 5A01.0 Nontoxic diffuse goitre –– 5A01.1 Nontoxic single thyroid nodule –– 5A01.2 Nontoxic multinodular goitre –– 5A01.Z Nontoxic goitre, unspecified – 5A02 Thyrotoxicosis –– 5A02.0 Thyrotoxicosis with diffuse goitre –– 5A02.1 Thyrotoxicosis with toxic single thyroid nodule –– 5A02.2 Thyrotoxicosis with toxic multinodular goitre –– 5A02.3 Thyrotoxicosis from ectopic thyroid tissue –– 5A02.4 Thyrotoxicosis factitia –– 5A02.5 Thyroid crisis –– 5A02.6 Secondary hyperthyroidism –– 5A02.Y Other specified thyrotoxicosis –– 5A02.Z Thyrotoxicosis, unspecified – 5A03 Thyroiditis –– 5A03.0 Acute thyroiditis –– 5A03.1 Subacute thyroiditis –– 5A03.2 Autoimmune thyroiditis –– 5A03.Y Other specified thyroiditis –– 5A03.Z Thyroiditis, unspecified ––– 5A03.20 Hashimoto thyroiditis ––– 5A03.21 Painless thyroiditis ––– 5A03.2Y Other specified autoimmune thyroiditis ––– 5A03.2Z Autoimmune thyroiditis, unspecified – 5A04 Hypersecretion of calcitonin – 5A05 Generalised resistance to thyroid hormone – 5A06 Sick-euthyroid syndrome – 5A0Y Other specified disorders of the thyroid gland or thyroid hormones system – 5A0Z Disorders of the thyroid gland or thyroid hormones system, unspecified – 5A10 Type 1 diabetes mellitus – 5A11 Type 2 diabetes mellitus – 5A12 Malnutrition-related diabetes mellitus – 5A13 Diabetes mellitus, other specified type –– 5A13.0 Diabetes mellitus due to genetic defects of beta cell function –– 5A13.1 Diabetes mellitus due to genetic defects in insulin action –– 5A13.2 Diabetes mellitus due to diseases of the exocrine pancreas –– 5A13.3 Diabetes mellitus due to endocrinopathies –– 5A13.4 Diabetes mellitus due to drug or chemical –– 5A13.5 Diabetes mellitus due to uncommon forms of immune-mediated diabetes –– 5A13.6 Diabetes mellitus due to other genetic syndromes –– 5A13.7 Diabetes mellitus due to clinically defined subtypes or syndromes –– 5A13.Y Diabetes mellitus due to other specified cause – 5A14 Diabetes mellitus, type unspecified –– 5A20 Diabetic hyperosmolar hyperglycaemic state ––– 5A20.0 Hyperosmolar hyperglycaemic state without coma ––– 5A20.1 Hyperosmolar hyperglycaemic state with coma ––– 5A20.Z Diabetic hyperosmolar hyperglycaemic state, unspecified –– 5A21 Hypoglycaemia in the context of diabetes mellitus ––– 5A21.0 Hypoglycaemia in the context of diabetes mellitus without coma ––– 5A21.1 Hypoglycaemia in the context of diabetes mellitus with coma ––– 5A21.Z Hypoglycaemia in the context of diabetes, unspecified –– 5A22 Diabetic acidosis ––– 5A22.0 Diabetic ketoacidosis without coma ––– 5A22.1 Diabetic lactic acidosis ––– 5A22.2 Diabetic metabolic acidosis ––– 5A22.3 Diabetic ketoacidosis with coma ––– 5A22.Y Other specified diabetic acidosis ––– 5A22.Z Diabetic acidosis, unspecified –– 5A23 Diabetic coma –– 5A24 Uncontrolled or unstable diabetes mellitus –– 5A2Y Other specified acute complications of diabetes mellitus – 5A40 Intermediate hyperglycaemia –– 5A40.0 Impaired fasting glucose –– 5A40.1 Impaired glucose tolerance –– 5A40.Y Other specified intermediate hyperglycaemia –– 5A40.Z Intermediate hyperglycaemia, unspecified – 5A41 Hypoglycaemia without associated diabetes – 5A42 Increased secretion of glucagon – 5A43 Abnormal secretion of gastrin –– 5A43.0 Drug-induced hypergastrinaemia –– 5A43.1 Zollinger-Ellison syndrome –– 5A43.Y Other specified abnormal secretion of gastrin –– 5A43.Z Abnormal secretion of gastrin, unspecified – 5A44 Insulin-resistance syndromes – 5A45 Persistent hyperinsulinaemic hypoglycaemia of infancy – 5A4Y Other specified disorders of glucose regulation or pancreatic internal secretion – 5A4Z Disorders of glucose regulation or pancreatic internal secretion, unspecified – 5A50 Hypoparathyroidism –– 5A50.0 Hypoparathyroidism due to impaired parathyroid hormone secretion –– 5A50.1 Pseudohypoparathyroidism –– 5A50.Y Other specified hypoparathyroidism –– 5A50.Z Hypoparathyroidism, unspecified ––– 5A50.00 Idiopathic hypoparathyroidism ––– 5A50.01 Secondary hypoparathyroidism ––– 5A50.02 Hypoparathyroidism due to destruction of the parathyroid glands ––– 5A50.03 Autoimmune hypoparathyroidism ––– 5A50.0Y Other specified hypoparathyroidism due to impaired parathyroid hormone secretion ––– 5A50.0Z Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified – 5A51 Hyperparathyroidism –– 5A51.0 Primary hyperparathyroidism –– 5A51.1 Secondary hyperparathyroidism –– 5A51.2 Familial hypocalciuric hypercalcaemia –– 5A51.Y Other specified hyperparathyroidism –– 5A51.Z Hyperparathyroidism, unspecified – 5A5Y Other specified disorders of the parathyroids or parathyroid hormone system – 5A5Z Disorders of the parathyroids or parathyroid hormone system, unspecified – 5A60 Hyperfunction of pituitary gland –– 5A60.0 Acromegaly or pituitary gigantism –– 5A60.1 Hyperprolactinaemia –– 5A60.2 Syndrome of inappropriate secretion of antidiuretic hormone –– 5A60.3 Central precocious puberty –– 5A60.Y Other specified hyperfunction of pituitary gland –– 5A60.Z Hyperfunction of pituitary gland, unspecified ––– 5A60.20 Nephrogenic syndrome of inappropriate antidiuresis ––– 5A60.2Y Other specified syndrome of inappropriate secretion of antidiuretic hormone ––– 5A60.2Z Syndrome of inappropriate secretion of antidiuretic hormone, unspecified – 5A61 Hypofunction or certain other specified disorders of pituitary gland –– 5A61.0 Hypopituitarism –– 5A61.1 Adrenocorticotropic hormone deficiency –– 5A61.2 Gonadotropin deficiency –– 5A61.3 Growth hormone deficiency –– 5A61.4 Thyroid stimulating hormone deficiency –– 5A61.5 Central diabetes insipidus –– 5A61.6 Oxytocin deficiency –– 5A61.Y Other specified hypofunction or disorders of pituitary gland ––– 5A61.40 Acquired central hypothyroidism ––– 5A61.41 Congenital central hypothyroidism ––– 5A61.4Y Other specified thyroid stimulating hormone deficiency ––– 5A61.4Z Thyroid stimulating hormone deficiency, unspecified – 5A6Z Disorders of the pituitary hormone system, unspecified – 5A70 Cushing syndrome –– 5A70.0 Pituitary-dependent Cushing disease –– 5A70.1 Ectopic ACTH syndrome –– 5A70.2 Pseudo-Cushing syndrome –– 5A70.3 Nelson syndrome –– 5A70.Y Other specified Cushing syndrome –– 5A70.Z Cushing syndrome, unspecified – 5A71 Adrenogenital disorders –– 5A71.0 46,XX disorders of sex development induced by androgens of fetal origin –– 5A71.1 46,XX disorders of sex development induced by androgens of maternal origin –– 5A71.Y Other specified adrenogenital disorders –– 5A71.Z Adrenogenital disorders, unspecified ––– 5A71.00 Glucocorticoid resistance ––– 5A71.01 Congenital adrenal hyperplasia ––– 5A71.0Y Other specified 46,XX disorders of sex development induced by androgens of fetal origin ––– 5A71.0Z 46,XX disorders of sex development induced by androgens of fetal origin, unspecified – 5A72 Hyperaldosteronism –– 5A72.0 Primary hyperaldosteronism –– 5A72.1 Secondary hyperaldosteronism –– 5A72.Z Hyperaldosteronism, unspecified – 5A73 Hypoaldosteronism – 5A74 Adrenocortical insufficiency –– 5A74.0 Acquired adrenocortical insufficiency –– 5A74.1 Adrenal crisis –– 5A74.Y Other specified adrenocortical insufficiency –– 5A74.Z Adrenocortical insufficiency, unspecified – 5A75 Adrenomedullary hyperfunction – 5A76 Certain specified disorders of adrenal gland –– 5A76.0 Premature adrenarche –– 5A76.Y Other specified disorders of adrenal gland – 5A7Z Disorders of the adrenal glands or adrenal hormone system, unspecified – 5A80 Ovarian dysfunction –– 5A80.0 Clinical hyperandrogenism –– 5A80.1 Polycystic ovary syndrome –– 5A80.2 Polycystic ovary –– 5A80.3 Anovulation –– 5A80.4 Oligo-ovulation –– 5A80.5 Diminished ovarian reserve –– 5A80.Y Other specified ovarian dysfunction –– 5A80.Z Ovarian dysfunction, unspecified – 5A81 Testicular dysfunction or testosterone-related disorders –– 5A81.0 Testicular hyperfunction –– 5A81.1 Testicular hypofunction –– 5A81.Y Other specified testicular dysfunction or testosterone-related disorders –– 5A81.Z Testicular dysfunction or testosterone-related disorders, unspecified – 5A8Z Disorders of the gonadal hormone system, unspecified – 5A90 Disorder of puberty due to oestrogen resistance – 5A91 Delayed puberty – 5A92 Peripheral precocious puberty – 5A9Y Other disorders of puberty – 5A9Z Disorders of puberty, unspecified – 5B00 Autoimmune polyendocrinopathy – 5B01 Polyglandular hyperfunction – 5B0Y Other specified polyglandular dysfunction – 5B0Z Polyglandular dysfunction, unspecified – 5B10 Carcinoid syndrome – 5B11 Short stature, not elsewhere classified – 5B12 Constitutional tall stature – 5B1Y Other specified endocrine disorders, not elsewhere classified 5B3Y Other specified endocrine diseases 5B3Z Endocrine diseases, unspecified – 5B50 Underweight in infants, children or adolescents – 5B51 Wasting in infants, children or adolescents – 5B52 Acute malnutrition in infants, children or adolescents – 5B53 Stunting in infants, children or adolescents – 5B54 Underweight in adults – 5B55 Vitamin A deficiency –– 5B55.0 Vitamin A deficiency with night blindness –– 5B55.1 Vitamin A deficiency with conjunctival xerosis –– 5B55.2 Vitamin A deficiency with conjunctival xerosis and Bitot's spots –– 5B55.3 Vitamin A deficiency with corneal xerosis –– 5B55.4 Vitamin A deficiency with corneal ulceration or keratomalacia –– 5B55.5 Vitamin A deficiency with xerophthalmic scars of cornea or blindness –– 5B55.Y Vitamin A deficiency with other specified manifestations –– 5B55.Z Vitamin A deficiency, unspecified – 5B56 Vitamin C deficiency –– 5B56.0 Scurvy –– 5B56.Y Other specified vitamin C deficiency –– 5B56.Z Vitamin C deficiency, unspecified – 5B57 Vitamin D deficiency –– 5B57.0 Vitamin D deficiency rickets –– 5B57.1 Vitamin D deficiency osteomalacia –– 5B57.Y Other specified vitamin D deficiency –– 5B57.Z Vitamin D deficiency, unspecified – 5B58 Vitamin E deficiency – 5B59 Vitamin K deficiency – 5B5A Vitamin B1 deficiency –– 5B5A.0 Beriberi –– 5B5A.1 Wernicke-Korsakoff Syndrome –– 5B5A.Y Other specified vitamin B1 deficiency –– 5B5A.Z Vitamin B1 deficiency, unspecified ––– 5B5A.00 Dry beriberi ––– 5B5A.01 Wet beriberi ––– 5B5A.0Z Beriberi, unspecified ––– 5B5A.10 Wernicke encephalopathy ––– 5B5A.11 Korsakoff syndrome ––– 5B5A.1Y Other specified Wernicke-Korsakoff Syndrome ––– 5B5A.1Z Wernicke-Korsakoff Syndrome, unspecified – 5B5B Vitamin B2 deficiency – 5B5C Vitamin B3 deficiency –– 5B5C.0 Pellagra –– 5B5C.Y Other specified vitamin B3 deficiency –– 5B5C.Z Vitamin B3 deficiency, unspecified – 5B5D Vitamin B6 deficiency – 5B5E Folate deficiency – 5B5F Vitamin B12 deficiency – 5B5G Biotin deficiency – 5B5H Pantothenic acid deficiency – 5B5J Choline deficiency – 5B5K Mineral deficiencies –– 5B5K.0 Iron deficiency –– 5B5K.1 Calcium deficiency –– 5B5K.2 Zinc deficiency –– 5B5K.3 Iodine deficiency –– 5B5K.4 Fluorine deficiency –– 5B5K.5 Sodium chloride deficiency –– 5B5K.6 Copper deficiency –– 5B5K.7 Selenium deficiency –– 5B5K.8 Chromium deficiency –– 5B5K.9 Manganese deficiency –– 5B5K.A Molybdenum deficiency –– 5B5K.B Vanadium deficiency –– 5B5K.Y Other specified mineral deficiency –– 5B5K.Z Mineral deficiency, unspecified ––– 5B5K.10 Tetany due to acute calcium deficiency ––– 5B5K.1Y Other specified calcium deficiency ––– 5B5K.1Z Calcium deficiency, unspecified –– 5B60 Sequelae of protein-energy malnutrition –– 5B61 Sequelae of vitamin A deficiency –– 5B62 Sequelae of vitamin C deficiency –– 5B63 Sequelae of rickets –– 5B6Y Other specified sequelae of malnutrition or certain specified nutritional deficiencies –– 5B6Z Sequelae of malnutrition or certain specified nutritional deficiencies, unspecified – 5B70 Essential fatty acid deficiency – 5B71 Protein deficiency – 5B7Y Other specified undernutrition – 5B7Z Unspecified undernutrition –– 5B80 Overweight or localised adiposity ––– 5B80.0 Overweight ––– 5B80.1 Localised adiposity –––– 5B80.00 Overweight in infants, children or adolescents –––– 5B80.01 Overweight in adults –––– 5B80.0Z Overweight, unspecified –– 5B81 Obesity ––– 5B81.0 Obesity due to energy imbalance ––– 5B81.1 Drug-induced obesity ––– 5B81.Y Other specified obesity ––– 5B81.Z Obesity, unspecified –––– 5B81.00 Obesity in children or adolescents –––– 5B81.01 Obesity in adults –– 5B90 Vitamin excesses ––– 5B90.0 Hypervitaminosis A ––– 5B90.1 Hypercarotenaemia ––– 5B90.2 Hypervitaminosis D ––– 5B90.3 Megavitamin-B6 syndrome ––– 5B90.Y Other specified vitamin excess ––– 5B90.Z Unspecified vitamin excesses –– 5B91 Mineral excesses ––– 5B91.0 Hypercalcaemia ––– 5B91.1 Zinc excess ––– 5B91.2 Sodium chloride excess ––– 5B91.3 Fluorine excess ––– 5B91.4 Aluminium excess ––– 5B91.5 Manganese excess ––– 5B91.Y Other specified mineral excess ––– 5B91.Z Unspecified mineral excess –– 5B9Y Other specified nutrient excesses –– 5B9Z Certain specified nutrient excesses, unspecified – 5C1Y Other specified overweight, obesity or specific nutrient excesses – 5C1Z Overweight, obesity or specific nutrient excesses, unspecified 5C3Y Other specified nutritional disorders 5C3Z Nutritional disorders, unspecified – 5C50 Inborn errors of amino acid or other organic acid metabolism –– 5C50.0 Phenylketonuria –– 5C50.1 Disorders of tyrosine metabolism –– 5C50.2 Disorders of histidine metabolism –– 5C50.3 Disorders of tryptophan metabolism –– 5C50.4 Disorders of lysine or hydroxylysine metabolism –– 5C50.5 Disorders of the gamma-glutamyl cycle –– 5C50.6 Disorders of serine metabolism –– 5C50.7 Disorders of glycine metabolism –– 5C50.8 Disorders of proline or hydroxyproline metabolism –– 5C50.9 Disorders of ornithine metabolism –– 5C50.A Disorders of urea cycle metabolism –– 5C50.B Disorders of methionine cycle or sulphur amino acid metabolism –– 5C50.C Disorders of beta or omega amino acid metabolism –– 5C50.D Disorders of branched-chain amino acid metabolism –– 5C50.E Organic aciduria –– 5C50.F Disorders of peptide metabolism –– 5C50.G Trimethylaminuria –– 5C50.Y Other specified inborn errors of amino acid or other organic acid metabolism –– 5C50.Z Inborn errors of amino acid or other organic acid metabolism, unspecified ––– 5C50.00 Classical phenylketonuria ––– 5C50.01 Nonclassical phenylketonuria ––– 5C50.02 Embryofetopathy due to maternal phenylketonuria ––– 5C50.0Y Other specified phenylketonuria ––– 5C50.0Z Phenylketonuria, unspecified ––– 5C50.10 Alkaptonuria ––– 5C50.11 Tyrosinaemia type 1 ––– 5C50.12 Tyrosinaemia type 2 ––– 5C50.1Y Other specified disorders of tyrosine metabolism ––– 5C50.1Z Disorders of tyrosine metabolism, unspecified ––– 5C50.20 Histidinaemia ––– 5C50.21 Urocanic aciduria ––– 5C50.2Y Other specified disorders of histidine metabolism ––– 5C50.2Z Disorders of histidine metabolism, unspecified ––– 5C50.70 Glycine encephalopathy ––– 5C50.71 Sarcosinaemia ––– 5C50.7Y Other specified disorders of glycine metabolism ––– 5C50.7Z Disorders of glycine metabolism, unspecified ––– 5C50.A0 Argininosuccinic aciduria ––– 5C50.A1 Carbamoylphosphate synthetase deficiency ––– 5C50.A2 Argininaemia ––– 5C50.A3 Citrullinaemia ––– 5C50.AY Other specified disorders of urea cycle metabolism ––– 5C50.AZ Disorders of urea cycle metabolism, unspecified ––– 5C50.D0 Maple-syrup-urine disease ––– 5C50.DY Other specified disorders of branched-chain amino acid metabolism ––– 5C50.DZ Disorders of branched-chain amino acid metabolism, unspecified ––– 5C50.E0 Classical organic aciduria ––– 5C50.E1 Cerebral organic aciduria ––– 5C50.EY Other specified organic aciduria ––– 5C50.EZ Organic aciduria, unspecified ––– 5C50.F0 Prolidase deficiency ––– 5C50.F1 Carnosinaemia ––– 5C50.F2 Homocarnosinosis ––– 5C50.FY Other specified disorders of peptide metabolism ––– 5C50.FZ Disorders of peptide metabolism, unspecified – 5C51 Inborn errors of carbohydrate metabolism –– 5C51.0 Disorders of the pentose phosphate pathway –– 5C51.1 Disorders of glycerol metabolism –– 5C51.2 Disorders of glyoxylate metabolism –– 5C51.3 Glycogen storage disease –– 5C51.4 Disorders of galactose metabolism –– 5C51.5 Disorders of fructose metabolism –– 5C51.Y Other specified inborn errors of carbohydrate metabolism –– 5C51.Z Inborn errors of carbohydrate metabolism, unspecified ––– 5C51.20 Primary hyperoxaluria type 1 ––– 5C51.2Y Other specified disorders of glyoxylate metabolism ––– 5C51.2Z Disorders of glyoxylate metabolism, unspecified ––– 5C51.40 Galactose-1-phosphate uridyltransferase deficiency ––– 5C51.41 Galactokinase deficiency ––– 5C51.42 Glucose or galactose intolerance of newborn ––– 5C51.4Y Other specified disorders of galactose metabolism ––– 5C51.4Z Disorders of galactose metabolism, unspecified ––– 5C51.50 Hereditary fructose intolerance ––– 5C51.5Y Other specified disorders of fructose metabolism ––– 5C51.5Z Disorders of fructose metabolism, unspecified – 5C52 Inborn errors of lipid metabolism –– 5C52.0 Inborn errors of fatty acid oxidation or ketone body metabolism –– 5C52.1 Inborn errors of sterol metabolism –– 5C52.2 Neutral lipid storage disease –– 5C52.Y Other specified inborn errors of lipid metabolism –– 5C52.Z Inborn errors of lipid metabolism, unspecified ––– 5C52.00 Disorders of carnitine transport or the carnitine cycle ––– 5C52.01 Disorders of mitochondrial fatty acid oxidation ––– 5C52.02 Disorders of ketone body metabolism ––– 5C52.03 Sjögren-Larsson syndrome ––– 5C52.0Y Other specified inborn errors of fatty acid oxidation or ketone body metabolism ––– 5C52.0Z Inborn errors of fatty acid oxidation or ketone body metabolism, unspecified ––– 5C52.10 Disorders of cholesterol synthesis ––– 5C52.11 Bile acid synthesis defect with cholestasis ––– 5C52.1Y Other specified inborn errors of sterol metabolism ––– 5C52.1Z Inborn errors of sterol metabolism, unspecified – 5C53 Inborn errors of energy metabolism –– 5C53.0 Disorders of pyruvate metabolism –– 5C53.1 Disorders of the citric acid cycle –– 5C53.2 Disorders of mitochondrial oxidative phosphorylation –– 5C53.3 Disorders of mitochondrial membrane transport –– 5C53.4 Disorders of creatine metabolism –– 5C53.Y Other specified inborn errors of energy metabolism –– 5C53.Z Inborn errors of energy metabolism, unspecified ––– 5C53.00 Pyruvate kinase deficiency ––– 5C53.01 Lactate dehydrogenase deficiency ––– 5C53.02 Pyruvate dehydrogenase complex deficiency ––– 5C53.03 Pyruvate carboxylase deficiency ––– 5C53.0Y Other specified disorders of pyruvate metabolism ––– 5C53.0Z Disorders of pyruvate metabolism, unspecified ––– 5C53.20 Mitochondrial DNA depletion syndromes ––– 5C53.21 Multiple mitochondrial DNA deletion syndromes ––– 5C53.22 Coenzyme Q10 deficiency ––– 5C53.23 Mitochondrial protein translation defects ––– 5C53.24 Leigh syndrome ––– 5C53.25 Isolated ATP synthase deficiency ––– 5C53.2Y Other specified disorders of mitochondrial oxidative phosphorylation ––– 5C53.2Z Disorders of mitochondrial oxidative phosphorylation, unspecified ––– 5C53.30 Mitochondrial substrate carrier disorders ––– 5C53.31 Mitochondrial protein import disorders ––– 5C53.3Y Other specified disorders of mitochondrial membrane transport ––– 5C53.3Z Disorders of mitochondrial membrane transport, unspecified – 5C54 Inborn errors of glycosylation or other specified protein modification –– 5C54.0 Disorders of protein N-glycosylation –– 5C54.1 Disorders of protein O-glycosylation –– 5C54.2 Disorders of multiple glycosylation or other pathways –– 5C54.Y Other specified congenital disorders of glycosylation and protein modification –– 5C54.Z Congenital disorders of glycosylation and protein modification, unspecified – 5C55 Inborn errors of purine, pyrimidine or nucleotide metabolism –– 5C55.0 Disorders of purine metabolism –– 5C55.1 Disorders of pyrimidine metabolism –– 5C55.2 Disorders of nucleotide metabolism –– 5C55.Y Other specified inborn errors of purine, pyrimidine or nucleotide metabolism –– 5C55.Z Inborn errors of purine, pyrimidine or nucleotide metabolism, unspecified ––– 5C55.00 Xanthinuria ––– 5C55.01 Lesch-Nyhan syndrome ––– 5C55.0Y Other specified disorders of purine metabolism ––– 5C55.0Z Disorders of purine metabolism, unspecified – 5C56 Lysosomal diseases –– 5C56.0 Sphingolipidosis –– 5C56.1 Neuronal ceroid lipofuscinosis –– 5C56.2 Glycoproteinosis –– 5C56.3 Mucopolysaccharidosis –– 5C56.4 Disorders of sialic acid metabolism –– 5C56.Y Other specified lysosomal diseases –– 5C56.Z Lysosomal diseases, unspecified ––– 5C56.00 Gangliosidosis ––– 5C56.01 Fabry disease ––– 5C56.02 Metachromatic leukodystrophy ––– 5C56.0Y Other specified sphingolipidosis ––– 5C56.0Z Sphingolipidosis, unspecified ––– 5C56.20 Mucolipidosis ––– 5C56.21 Oligosaccharidosis ––– 5C56.2Y Other specified glycoproteinosis ––– 5C56.2Z Glycoproteinosis, unspecified ––– 5C56.30 Mucopolysaccharidosis type 1 ––– 5C56.31 Mucopolysaccharidosis type 2 ––– 5C56.32 Mucopolysaccharidosis type 4 ––– 5C56.33 Mucopolysaccharidosis type 6 ––– 5C56.3Y Other specified mucopolysaccharidosis ––– 5C56.3Z Mucopolysaccharidosis, unspecified – 5C57 Peroxisomal diseases –– 5C57.0 Disorders of peroxisome biogenesis –– 5C57.1 Disorders of peroxisomal alpha-, beta- or omega-oxidation –– 5C57.Y Other specified peroxisomal diseases –– 5C57.Z Peroxisomal diseases, unspecified – 5C58 Inborn errors of porphyrin or heme metabolism –– 5C58.0 Disorders of bilirubin metabolism or excretion –– 5C58.1 Porphyrias –– 5C58.Y Other specified inborn errors of porphyrin or heme metabolism –– 5C58.Z Inborn errors of porphyrin or heme metabolism, unspecified ––– 5C58.00 Crigler-Najjar syndrome ––– 5C58.01 Gilbert syndrome ––– 5C58.02 Dubin-Johnson syndrome ––– 5C58.03 Progressive familial intrahepatic cholestasis ––– 5C58.04 Benign recurrent intrahepatic cholestasis ––– 5C58.0Y Other specified disorders of bilirubin metabolism or excretion ––– 5C58.0Z Disorders of bilirubin metabolism or excretion, unspecified ––– 5C58.10 Porphyria cutanea tarda ––– 5C58.12 Erythropoietic porphyrias ––– 5C58.13 Variegate porphyria ––– 5C58.1Y Other specified porphyrias ––– 5C58.1Z Porphyrias, unspecified – 5C59 Inborn errors of neurotransmitter metabolism –– 5C59.0 Disorders of biogenic amine metabolism –– 5C59.1 Disorders of gamma aminobutyric acid metabolism –– 5C59.2 Disorders of pyridoxine metabolism –– 5C59.Y Other specified inborn errors of neurotransmitter metabolism –– 5C59.Z Inborn errors of neurotransmitter metabolism, unspecified ––– 5C59.00 Disorders of catecholamine synthesis ––– 5C59.01 Disorders of pterin metabolism ––– 5C59.0Y Other specified disorders of biogenic amine metabolism ––– 5C59.0Z Disorders of biogenic amine metabolism, unspecified – 5C5A Alpha-1-antitrypsin deficiency – 5C5Y Other specified inborn errors of metabolism – 5C5Z Inborn errors of metabolism, unspecified – 5C60 Disorders of amino acid absorption or transport –– 5C60.0 Oculocerebrorenal syndrome –– 5C60.1 Cystinosis –– 5C60.2 Cystinuria –– 5C60.Y Other specified disorders of amino acid absorption or transport –– 5C60.Z Disorders of amino acid absorption or transport, unspecified – 5C61 Disorders of carbohydrate absorption or transport –– 5C61.0 Glucose-galactose malabsorption –– 5C61.1 Maltase-glucoamylase deficiency –– 5C61.2 Congenital sucrase-isomaltase deficiency –– 5C61.3 Alpha, alpha trehalase deficiency –– 5C61.4 Acquired monosaccharide malabsorption –– 5C61.5 Disorders of facilitated glucose transport –– 5C61.6 Lactose intolerance –– 5C61.Y Other specified disorders of carbohydrate absorption or transport –– 5C61.Z Disorders of carbohydrate absorption or transport, unspecified ––– 5C61.40 Fructose malabsorption ––– 5C61.4Y Other specified acquired monosaccharide malabsorption ––– 5C61.4Z Acquired monosaccharide malabsorption, unspecified ––– 5C61.60 Primary lactase deficiency ––– 5C61.61 Congenital lactase deficiency ––– 5C61.62 Secondary lactase deficiency ––– 5C61.6Z Lactose intolerance, unspecified – 5C62 Disorders of lipid absorption or transport – 5C63 Disorders of vitamin or non-protein cofactor absorption or transport –– 5C63.0 Disorders of cobalamin metabolism or transport –– 5C63.1 Disorders of folate metabolism or transport –– 5C63.2 Disorders of vitamin D metabolism or transport –– 5C63.Y Other specified disorders of vitamin or non-protein cofactor absorption or transport –– 5C63.Z Disorders of vitamin or non-protein cofactor absorption or transport, unspecified ––– 5C63.20 Hypocalcaemic vitamin D dependent rickets ––– 5C63.21 Hypocalcaemic vitamin D resistant rickets ––– 5C63.22 Hypophosphataemic rickets ––– 5C63.2Y Other specified disorders of vitamin D metabolism or transport ––– 5C63.2Z Disorders of vitamin D metabolism or transport, unspecified – 5C64 Disorders of mineral absorption or transport –– 5C64.0 Disorders of copper metabolism –– 5C64.1 Disorders of iron metabolism –– 5C64.2 Disorders of zinc metabolism –– 5C64.3 Disorders of phosphorus metabolism or phosphatases –– 5C64.4 Disorders of magnesium metabolism –– 5C64.5 Disorders of calcium metabolism –– 5C64.6 Disorders of sodium metabolism –– 5C64.7 Disorders of chloride metabolism –– 5C64.Y Disorders of other specified mineral absorption and transport –– 5C64.Z Disorders of mineral absorption or transport, unspecified ––– 5C64.00 Wilson disease ––– 5C64.0Y Other specified disorders of copper metabolism ––– 5C64.0Z Disorders of copper metabolism, unspecified ––– 5C64.10 Iron overload diseases ––– 5C64.1Y Other specified disorders of iron metabolism ––– 5C64.1Z Disorders of iron metabolism, unspecified ––– 5C64.20 Acrodermatitis enteropathica ––– 5C64.21 Zinc deficiency syndromes ––– 5C64.2Y Other specified disorders of zinc metabolism ––– 5C64.2Z Disorders of zinc metabolism, unspecified ––– 5C64.40 Hypermagnesaemia ––– 5C64.41 Hypomagnesaemia ––– 5C64.4Z Disorders of magnesium metabolism, unspecified – 5C6Y Other specified disorders of metabolite absorption or transport – 5C6Z Disorders of metabolite absorption or transport, unspecified – 5C70 Volume depletion –– 5C70.0 Dehydration –– 5C70.1 Hypovolaemia –– 5C70.Y Other specified volume depletion –– 5C70.Z Volume depletion, unspecified – 5C71 Hyperosmolality or hypernatraemia – 5C72 Hypo-osmolality or hyponatraemia – 5C73 Acidosis –– 5C73.0 Acute respiratory acidosis –– 5C73.1 Chronic respiratory acidosis –– 5C73.2 Anion gap metabolic acidosis –– 5C73.Y Other specified acidosis –– 5C73.Z Acidosis, unspecified – 5C74 Alkalosis – 5C75 Mixed disorder of acid-base balance – 5C76 Hyperkalaemia – 5C77 Hypokalaemia – 5C78 Fluid overload – 5C7Y Other specified disorders of fluid, electrolyte or acid-base balance – 5C7Z Disorders of fluid, electrolyte or acid-base balance, unspecified – 5C80 Hyperlipoproteinaemia –– 5C80.0 Hypercholesterolaemia –– 5C80.1 Hypertriglyceridaemia –– 5C80.2 Mixed hyperlipidaemia –– 5C80.3 Hyperalphalipoproteinaemia –– 5C80.Y Other specified hyperlipoproteinaemia –– 5C80.Z Hyperlipoproteinaemia, unspecified ––– 5C80.00 Primary hypercholesterolaemia ––– 5C80.01 Secondary hypercholesterolaemia ––– 5C80.0Z Hypercholesterolaemia, unspecified – 5C81 Hypolipoproteinaemia –– 5C81.0 Hypoalphalipoproteinaemia –– 5C81.1 Hypobetalipoproteinaemia –– 5C81.Y Other specified hypolipoproteinaemia –– 5C81.Z Hypolipoproteinaemia, unspecified – 5C8Y Other specified disorders of lipoprotein metabolism or lipidaemias – 5C8Z Unspecified disorders of lipoprotein metabolism or lipidaemias 5C90 Metabolic or transporter liver disease – 5C90.0 Liver diseases due to urea cycle defects – 5C90.1 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport – 5C90.2 Liver diseases due to disorders of amino acid metabolism – 5C90.3 Liver disease due to disorders of lysosomal storage – 5C90.4 Liver diseases due to mitochondrial disorders – 5C90.5 Liver diseases due to disorders of mineral metabolism – 5C90.Y Other specified metabolic or transporter liver disease – 5C90.Z Metabolic or transporter liver disease, unspecified – 5D00 Amyloidosis –– 5D00.0 AL amyloidosis –– 5D00.1 AA amyloidosis –– 5D00.2 Hereditary amyloidosis –– 5D00.3 Dialysis-associated amyloidosis –– 5D00.Y Other specified amyloidosis –– 5D00.Z Amyloidosis, unspecified ––– 5D00.20 Hereditary ATTR amyloidosis ––– 5D00.21 Non-neuropathic heredofamilial amyloidosis ––– 5D00.2Y Other specified hereditary amyloidosis ––– 5D00.2Z Hereditary amyloidosis, unspecified – 5D01 Tumour lysis syndrome – 5D0Y Other specified metabolic disorders 5D2Z Metabolic disorders, unspecified 5D40 Postprocedural hypothyroidism – 5D40.0 Postirridation hypothyroidism – 5D40.Y Other specified postprocedural hypothyroidism – 5D40.Z Postprocedural hypothyroidism, unspecified –– 5D40.00 Hypothyroidism postradioactive iodine ablation –– 5D40.0Y Other specified postirridation hypothyroidism –– 5D40.0Z Postirridation hypothyroidism, unspecified 5D41 Postprocedural hypoinsulinaemia 5D42 Postprocedural hypoparathyroidism 5D43 Postprocedural hypopituitarism 5D44 Postprocedural ovarian failure 5D45 Postprocedural testicular hypofunction 5D46 Postprocedural adrenocortical hypofunction 8A00 Parkinsonism – 8A00.0 Parkinson disease – 8A00.1 Atypical parkinsonism – 8A00.2 Secondary parkinsonism – 8A00.3 Functional parkinsonism – 8A00.Y Other specified parkinsonism – 8A00.Z Parkinsonism, unspecified –– 8A00.00 Sporadic Parkinson disease –– 8A00.01 Familial Parkinson disease –– 8A00.0Y Other specified Parkinson disease –– 8A00.0Z Parkinson disease, unspecified –– 8A00.10 Progressive supranuclear palsy –– 8A00.1Y Other specified atypical parkinsonism –– 8A00.1Z Atypical parkinsonism, unspecified –– 8A00.20 Parkinsonism due to heredodegenerative disorders –– 8A00.21 Hemiparkinsonism hemiatrophy syndrome –– 8A00.22 Infectious or postinfectious parkinsonism –– 8A00.23 Vascular parkinsonism –– 8A00.24 Drug-induced parkinsonism –– 8A00.25 Post traumatic Parkinsonism –– 8A00.26 Parkinsonism due to structural lesions –– 8A00.2Y Other specified secondary parkinsonism –– 8A00.2Z Secondary parkinsonism, unspecified 8A01 Choreiform disorders – 8A01.0 Benign hereditary chorea – 8A01.1 Secondary Chorea – 8A01.2 Hemichorea or hemiballismus – 8A01.Y Other specified choreiform disorders – 8A01.Z Choreiform disorders, unspecified –– 8A01.10 Huntington disease –– 8A01.11 Chorea due to Huntington disease-like conditions –– 8A01.12 Chorea due to Dentatorubral pallidoluysian atrophy –– 8A01.13 Chorea due to Wilson disease –– 8A01.14 Chorea due to infectious or para-infectious causes –– 8A01.15 Chorea due to systemic lupus erythematosus –– 8A01.16 Drug-induced chorea –– 8A01.1Y Other specified secondary chorea –– 8A01.1Z Secondary chorea, unspecified –– 8A01.20 Hemichorea –– 8A01.21 Ballism –– 8A01.22 Hemiballism –– 8A01.2Y Other specified hemichorea or hemiballismus –– 8A01.2Z Hemichorea or hemiballismus, unspecified 8A02 Dystonic disorders – 8A02.0 Primary dystonia – 8A02.1 Secondary dystonia – 8A02.2 Paroxysmal dystonia – 8A02.3 Functional dystonia or spasms – 8A02.Y Other specified dystonic disorders – 8A02.Z Dystonic disorders, unspecified –– 8A02.00 Benign essential blepharospasm –– 8A02.0Y Other specified primary dystonia –– 8A02.0Z Primary dystonia, unspecified –– 8A02.10 Drug-induced dystonia –– 8A02.11 Dystonia-plus –– 8A02.12 Dystonia associated with heredodegenerative disorders –– 8A02.1Y Other specified secondary dystonia –– 8A02.1Z Secondary dystonia, unspecified 8A03 Ataxic disorders – 8A03.0 Congenital ataxia – 8A03.1 Hereditary ataxia – 8A03.2 Non-hereditary degenerative ataxia – 8A03.3 Acquired ataxia – 8A03.Y Other specified ataxic disorders – 8A03.Z Ataxic disorders, unspecified –– 8A03.10 Friedreich ataxia –– 8A03.11 Ataxia due to Cerebrotendinous xanthomatosis –– 8A03.12 Ataxia due to Refsum disease –– 8A03.13 Ataxia due to abetalipoproteinemia –– 8A03.14 Hereditary episodic ataxia –– 8A03.15 Ataxia due to mitochondrial mutations –– 8A03.16 Spinocerebellar ataxia –– 8A03.1Y Other specified hereditary ataxia –– 8A03.1Z Hereditary ataxia, unspecified –– 8A03.20 Late onset cerebellar cortical atrophy –– 8A03.2Y Other specified non-hereditary degenerative ataxia –– 8A03.2Z Non-hereditary degenerative ataxia, unspecified –– 8A03.30 Ataxia due to alcoholic cerebellar degeneration –– 8A03.3Y Other specified acquired ataxia –– 8A03.3Z Acquired ataxia, unspecified 8A04 Disorders associated with tremor – 8A04.0 Enhanced physiological tremor – 8A04.1 Essential tremor or related tremors – 8A04.2 Rest tremor – 8A04.3 Secondary tremor – 8A04.4 Functional tremor – 8A04.Y Other specified disorders associated with tremor – 8A04.Z Disorders associated with tremor, unspecified –– 8A04.30 Tremor due to metabolic disorders –– 8A04.31 Tremor due to chronic or acute substance use –– 8A04.32 Tremor due to drug withdrawal –– 8A04.33 Tremor due to certain specified central nervous system diseases –– 8A04.3Y Other specified secondary tremor –– 8A04.3Z Secondary tremor, unspecified 8A05 Tic disorders – 8A05.0 Primary tics or tic disorders – 8A05.1 Secondary tics – 8A05.Y Other specified tic disorders – 8A05.Z Tic disorders, unspecified –– 8A05.00 Tourette syndrome –– 8A05.01 Chronic motor tic disorder –– 8A05.02 Chronic phonic tic disorder –– 8A05.03 Transient motor tics –– 8A05.0Y Other specified primary tics or tic disorders –– 8A05.0Z Primary tics or tic disorders, unspecified –– 8A05.10 Infectious or postinfectious tics –– 8A05.11 Tics associated with developmental disorders –– 8A05.1Y Other specified secondary tics –– 8A05.1Z Secondary tics, unspecified 8A06 Myoclonic disorders – 8A06.0 Essential myoclonus – 8A06.1 Segmental myoclonus – 8A06.2 Focal myoclonus – 8A06.Y Other specified myoclonic disorders – 8A06.Z Myoclonic disorders, unspecified –– 8A06.20 Palatal myoclonus –– 8A06.21 Chronic hiccups –– 8A06.2Y Other specified focal myoclonus –– 8A06.2Z Focal myoclonus, unspecified 8A07 Certain specified movement disorder – 8A07.0 Stereotypies – 8A07.1 Akathisia – 8A07.2 Excessive startle reflex –– 8A07.00 Primary stereotypy –– 8A07.01 Secondary stereotypy –– 8A07.0Y Other specified stereotypies –– 8A07.0Z Stereotypies, unspecified 8A0Y Other specified movement disorders 8A0Z Movement disorders, unspecified 8A20 Alzheimer disease 8A21 Progressive focal atrophies – 8A21.0 Posterior cortical atrophy – 8A21.Y Other specified progressive focal atrophies – 8A21.Z Progressive focal atrophies, unspecified 8A22 Lewy body disease 8A23 Frontotemporal lobar degeneration 8A2Y Other specified disorders with neurocognitive impairment as a major feature 8A2Z Disorders with neurocognitive impairment as a major feature, unspecified 8A40 Multiple sclerosis – 8A40.0 Relapsing-remitting multiple sclerosis – 8A40.1 Primary progressive multiple sclerosis – 8A40.2 Secondary progressive multiple sclerosis – 8A40.Y Other specified multiple sclerosis – 8A40.Z Multiple sclerosis, unspecified 8A41 Isolated demyelinating syndromes of the central nervous system – 8A41.0 Transverse myelitis – 8A41.1 Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive – 8A41.Y Other specified isolated demyelinating syndromes of the central nervous system – 8A41.Z Isolated demyelinating syndromes of the central nervous system, unspecified 8A42 Acute disseminated encephalomyelitis – 8A42.0 Acute haemorrhagic leukoencephalitis – 8A42.Y Other specified acute disseminated encephalomyelitis – 8A42.Z Acute disseminated encephalomyelitis, unspecified 8A43 Neuromyelitis optica – 8A43.0 Neuromyelitis optica aquaporin-4 antibody positive – 8A43.1 Neuromyelitis optica aquaporin-4 antibody negative – 8A43.2 Single transverse myelitis aquaporin-4 antibody positive – 8A43.3 Recurrent transverse myelitis aquaporin-4 antibody positive – 8A43.4 Single optic neuritis aquaporin-4 antibody positive – 8A43.5 Recurrent optic neuritis aquaporin-4 antibody positive – 8A43.Y Other specified neuromyelitis optica – 8A43.Z Neuromyelitis optica, unspecified 8A44 Leukodystrophies – 8A44.0 Pelizaeus-Merzbacher disease – 8A44.1 Adrenoleukodystrophy – 8A44.2 Alexander disease – 8A44.3 Certain specified leukodystrophies – 8A44.4 Krabbe disease – 8A44.Z Leukodystrophies, unspecified 8A45 Secondary white matter disorders – 8A45.0 White matter disorders due to infections – 8A45.1 White matter disorders due to toxicity – 8A45.2 White matter disorders due to vascular abnormality or ischemia – 8A45.3 White matter disorders due to nutritional deficiency – 8A45.4 White matter disorders due to certain specified systemic disease – 8A45.Y Other specified secondary white matter disorders – 8A45.Z Secondary white matter disorders, unspecified –– 8A45.00 Human T-cell lymphotropic virus-associated myelopathy –– 8A45.01 Subacute sclerosing panencephalitis –– 8A45.02 Progressive multifocal leukoencephalopathy –– 8A45.0Y Other specified white matter disorders due to infections –– 8A45.0Z White matter disorders due to infections, unspecified –– 8A45.20 White matter disorder due to CADASIL –– 8A45.21 Subacute necrotising myelitis –– 8A45.2Y Other specified white matter disorders due to vascular abnormality or ischemia –– 8A45.2Z White matter disorders due to vascular abnormality or ischemia, unspecified –– 8A45.30 White matter disorder due to vitamin B12 deficiency –– 8A45.31 Central pontine myelinolysis –– 8A45.3Y Other specified white matter disorders due to nutritional deficiency –– 8A45.3Z White matter disorders due to nutritional deficiency, unspecified –– 8A45.40 Demyelination due to sarcoidosis –– 8A45.41 Demyelination due to systemic lupus erythematosus –– 8A45.42 Demyelination due to Sjögren disease –– 8A45.43 Demyelination due to Behcet disease –– 8A45.44 Demyelination due to systemic vasculitis –– 8A45.45 Demyelination due to mitochondrial disease –– 8A45.4Z White matter disorders due to certain specified systemic disease, unspecified 8A46 Central demyelination of corpus callosum 8A4Y Other specified multiple sclerosis or other white matter disorders 8A4Z Multiple sclerosis or other white matter disorders, unspecified 8A60 Epilepsy due to structural or metabolic conditions or diseases – 8A60.0 Epilepsy due to prenatal or perinatal brain insults – 8A60.1 Epilepsy due to cerebrovascular disorders – 8A60.2 Epilepsy due to degenerative brain disorders – 8A60.3 Epilepsy due to dementias – 8A60.4 Epilepsy due to central nervous system infections or infestations – 8A60.5 Epilepsy due to injuries to the head – 8A60.6 Epilepsy due to tumours of the nervous system – 8A60.7 Epilepsy with mesial temporal sclerosis – 8A60.8 Epilepsy due to immune disorders – 8A60.9 Epilepsy due to abnormalities of brain development – 8A60.A Epilepsy due to genetic syndromes with widespread or progressive effects – 8A60.B Epilepsy due to multiple sclerosis or other demyelinating disorders – 8A60.Y Epilepsy due to other structural or metabolic condition or disease – 8A60.Z Epilepsy due to unspecified structural or metabolic condition or disease –– 8A60.00 Epilepsy due to prenatal or perinatal vascular insults –– 8A60.01 Epilepsy due to neonatal hypoxic ischemic encephalopathy –– 8A60.0Y Epilepsy due to other prenatal or perinatal brain insults –– 8A60.0Z Epilepsy due to unspecified prenatal or perinatal brain insults 8A61 Genetic or presumed genetic syndromes primarily expressed as epilepsy – 8A61.0 Genetic epileptic syndromes with neonatal onset – 8A61.1 Genetic epileptic syndromes with onset in infancy – 8A61.2 Genetic epileptic syndromes with childhood onset – 8A61.3 Genetic epileptic syndrome with adolescent or adult onset – 8A61.4 Genetic epileptic syndromes with variable age of onset – 8A61.Y Other specified genetic or presumed genetic syndromes primarily expressed as epilepsy – 8A61.Z Genetic or presumed genetic syndromes primarily expressed as epilepsy, unspecified –– 8A61.00 Pyridoxal dependent epilepsy –– 8A61.0Y Other specified genetic epileptic syndromes with neonatal onset –– 8A61.0Z Genetic epileptic syndromes with neonatal onset, unspecified –– 8A61.10 Benign familial infantile epilepsy –– 8A61.11 Dravet syndrome –– 8A61.12 Epilepsy of infancy with migrating focal seizures –– 8A61.1Y Other specified genetic epileptic syndromes with onset in infancy –– 8A61.1Z Genetic epileptic syndromes with onset in infancy, unspecified –– 8A61.20 Benign childhood epilepsy with centro-temporal spikes –– 8A61.21 Childhood absence epilepsy –– 8A61.22 Epilepsy with myoclonic-astatic seizures –– 8A61.23 Myoclonic absences or absences with myoclonias –– 8A61.2Y Other specified genetic epileptic syndromes with childhood onset –– 8A61.2Z Genetic epileptic syndromes with childhood onset, unspecified –– 8A61.30 Juvenile myoclonic epilepsy –– 8A61.31 Juvenile absence epilepsy –– 8A61.32 Benign adult familial myoclonus epilepsy –– 8A61.3Y Other specified genetic epileptic syndrome with adolescent or adult onset –– 8A61.3Z Genetic epileptic syndrome with adolescent or adult onset, unspecified –– 8A61.40 Reflex epilepsies –– 8A61.41 Progressive myoclonic epilepsy –– 8A61.4Y Other specified genetic epileptic syndromes with variable age of onset –– 8A61.4Z Genetic epileptic syndromes with variable age of onset, unspecified 8A62 Epileptic encephalopathies – 8A62.0 Infantile spasms – 8A62.1 Lennox-Gastaut syndrome – 8A62.2 Acquired epileptic aphasia – 8A62.Y Other specified epileptic encephalopathies – 8A62.Z Epileptic encephalopathies, unspecified 8A63 Seizure due to acute causes – 8A63.0 Febrile seizures – 8A63.Y Seizure due to other acute cause – 8A63.Z Seizure due to unspecified acute cause –– 8A63.00 Simple febrile seizures –– 8A63.01 Complex febrile seizures –– 8A63.0Y Other specified febrile seizures –– 8A63.0Z Febrile seizures, unspecified 8A64 Single seizure due to remote causes 8A65 Single unprovoked seizure 8A66 Status epilepticus – 8A66.0 Convulsive status epilepticus – 8A66.1 Non-convulsive status epilepticus – 8A66.Y Other specified status epilepticus – 8A66.Z Status epilepticus, unspecified –– 8A66.10 Absence status epilepticus –– 8A66.1Y Other specified non-convulsive status epilepticus –– 8A66.1Z Non-convulsive status epilepticus, unspecified 8A67 Acute repetitive seizures 8A68 Types of seizures – 8A68.0 Focal unaware seizure – 8A68.1 Absence seizures, atypical – 8A68.2 Absence seizures, typical – 8A68.3 Focal aware seizure – 8A68.4 Generalised tonic-clonic seizure – 8A68.5 Generalised myoclonic seizure – 8A68.6 Generalised tonic seizure – 8A68.7 Generalised atonic seizure – 8A68.Y Other specified type of seizure – 8A68.Z Type of seizure, unspecified 8A6Y Other specified epilepsy or seizures 8A6Z Epilepsy or seizures, unspecified 8A80 Migraine – 8A80.0 Migraine without aura – 8A80.1 Migraine with aura – 8A80.2 Chronic migraine – 8A80.3 Complications related to migraine – 8A80.4 Cyclic vomiting syndrome – 8A80.Y Other specified migraine – 8A80.Z Migraine, unspecified –– 8A80.10 Hemiplegic migraine –– 8A80.1Y Other specified migraine with aura –– 8A80.1Z Migraine with aura, unspecified –– 8A80.30 Status migrainosus –– 8A80.3Y Other specified complications related to migraine 8A81 Tension-type headache – 8A81.0 Infrequent episodic tension-type headache – 8A81.1 Frequent episodic tension-type headache – 8A81.2 Chronic tension-type headache – 8A81.Y Other specified tension-type headache – 8A81.Z Tension-type headache, unspecified 8A82 Trigeminal autonomic cephalalgias 8A83 Other primary headache disorder 8A84 Secondary headache – 8A84.0 Acute headache associated with traumatic injury to the head – 8A84.1 Persistent headache associated with traumatic injury to the head – 8A84.Y Other specified secondary headache – 8A84.Z Secondary headache, unspecified 8A85 Painful cranial neuropathies or other facial pains 8A8Y Other specified headache disorders 8A8Z Headache disorders, unspecified – 8B00 Intracerebral haemorrhage –– 8B00.0 Deep hemispheric haemorrhage –– 8B00.1 Lobar haemorrhage –– 8B00.2 Brainstem haemorrhage –– 8B00.3 Cerebellar haemorrhage –– 8B00.4 Intraventricular haemorrhage without parenchymal haemorrhage –– 8B00.5 Haemorrhage of multiple sites –– 8B00.Z Intracerebral haemorrhage, site unspecified – 8B01 Subarachnoid haemorrhage –– 8B01.0 Aneurysmal subarachnoid haemorrhage –– 8B01.1 Non-aneurysmal subarachnoid haemorrhage –– 8B01.2 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal – 8B02 Nontraumatic subdural haemorrhage – 8B03 Nontraumatic epidural haemorrhage – 8B0Z Intracranial haemorrhage, unspecified – 8B10 Transient ischaemic attack –– 8B10.0 Amaurosis fugax –– 8B10.Y Other specified transient ischaemic attack –– 8B10.Z Transient ischaemic attack, unspecified – 8B11 Cerebral ischaemic stroke –– 8B11.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis –– 8B11.1 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis –– 8B11.2 Cerebral ischaemic stroke due to embolic occlusion –– 8B11.3 Cerebral ischaemic stroke due to small artery occlusion –– 8B11.4 Cerebral ischaemic stroke due to other known cause –– 8B11.5 Cerebral ischaemic stroke of unknown cause ––– 8B11.20 Cerebral ischaemic stroke due to cardiac embolism ––– 8B11.21 Cerebral ischaemic stroke due to aortic arch embolism ––– 8B11.22 Cerebral ischaemic stroke due to paradoxical embolism ––– 8B11.2Y Cerebral ischaemic stroke due to other specified embolic occlusion ––– 8B11.2Z Cerebral ischaemic stroke due to embolic occlusion, unspecified ––– 8B11.40 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct ––– 8B11.41 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy ––– 8B11.42 Cerebral ischaemic stroke due to hypercoagulable state ––– 8B11.43 Cerebral ischaemic stroke in association with subarachnoid haemorrhage ––– 8B11.44 Cerebral ischemic stroke from dissection ––– 8B11.50 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery ––– 8B11.51 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery ––– 8B11.5Z Cerebral ischaemic stroke, unspecified – 8B1Y Other specified cerebral ischaemia – 8B1Z Cerebral ischaemia, unspecified 8B20 Stroke not known if ischaemic or haemorrhagic 8B21 Cerebrovascular disease with no acute cerebral symptom – 8B21.0 Silent cerebral infarct – 8B21.1 Silent cerebral microbleed – 8B21.Y Other specified cerebrovascular disease with no acute cerebral symptom – 8B21.Z Cerebrovascular disease with no acute cerebral symptom, unspecified 8B22 Certain specified cerebrovascular diseases – 8B22.0 Dissection of cerebral arteries – 8B22.1 Cerebral venous thrombosis – 8B22.2 Cerebral vasoconstriction syndromes – 8B22.3 Isolated cerebral amyloid angiopathy – 8B22.4 Intracranial vascular malformation – 8B22.5 Cerebral aneurysm, nonruptured – 8B22.6 Familial cerebral saccular aneurysm – 8B22.7 Cerebral arteritis, not elsewhere classified – 8B22.8 Hypertensive encephalopathy – 8B22.9 Migraine-induced stroke – 8B22.A Subclavian steal syndrome – 8B22.B Moyamoya syndrome – 8B22.C Hereditary cerebrovascular diseases – 8B22.Y Other specified cerebrovascular disease –– 8B22.40 Arteriovenous malformation of cerebral vessels –– 8B22.41 Cerebral cavernous malformation –– 8B22.42 Dural arteriovenous fistula –– 8B22.43 Carotid cavernous fistula –– 8B22.4Y Other specified intracranial vascular malformation –– 8B22.4Z Intracranial vascular malformation, unspecified –– 8B22.70 Primary cerebral arteritis –– 8B22.7Y Other specified cerebral arteritis, not elsewhere classified –– 8B22.7Z Cerebral arteritis, not elsewhere classified, unspecified –– 8B22.C0 CADASIL - [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome –– 8B22.C1 CARASIL - [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome –– 8B22.CY Other specified hereditary cerebrovascular diseases –– 8B22.CZ Hereditary cerebrovascular diseases, unspecified 8B23 Cerebrovascular abnormalities 8B24 Hypoxic-ischaemic encephalopathy – 8B24.0 Anoxic-ischaemic encephalopathy – 8B24.Y Other specified hypoxic-ischaemic encephalopathy – 8B24.Z Hypoxic-ischaemic encephalopathy, unspecified 8B25 Late effects of cerebrovascular disease – 8B25.0 Late effects of cerebral ischemic stroke – 8B25.1 Late effects of intracerebral haemorrhage – 8B25.2 Late effects of subarachnoid haemorrhage – 8B25.3 Late effects of other nontraumatic intracranial haemorrhage – 8B25.4 Late effects of stroke not known if ischaemic or haemorrhagic – 8B25.Y Late effects of other specified cerebrovascular disease – 8B25.Z Late effects of cerebrovascular disease, unspecified 8B26 Vascular syndromes of brain in cerebrovascular diseases – 8B26.0 Brainstem stroke syndrome – 8B26.1 Cerebellar stroke syndrome – 8B26.2 Middle cerebral artery syndrome – 8B26.3 Anterior cerebral artery syndrome – 8B26.4 Posterior cerebral artery syndrome – 8B26.5 Lacunar syndromes – 8B26.Y Other specified vascular syndromes of brain in cerebrovascular diseases – 8B26.Z Vascular syndromes of brain in cerebrovascular diseases, unspecified –– 8B26.50 Pure motor lacunar syndrome –– 8B26.51 Pure sensory lacunar syndrome –– 8B26.5Y Other specified lacunar syndromes –– 8B26.5Z Lacunar syndromes, unspecified 8B2Z Cerebrovascular diseases, unspecified 8B40 Cauda equina syndrome 8B41 Myelitis 8B42 Myelopathy 8B43 Non-compressive vascular myelopathies – 8B43.0 Acute arterial infarction of the spinal cord – 8B43.1 Acute venous infarction of the spinal cord – 8B43.2 Chronic venous infarction of the spinal cord – 8B43.Y Other specified non-compressive vascular myelopathies – 8B43.Z Non-compressive vascular myelopathies, unspecified 8B44 Degenerative myelopathic disorders – 8B44.0 Hereditary spastic paraplegia – 8B44.Y Other specified degenerative myelopathic disorders – 8B44.Z Degenerative myelopathic disorders, unspecified –– 8B44.00 Autosomal dominant hereditary spastic paraplegia –– 8B44.01 Autosomal recessive hereditary spastic paraplegia –– 8B44.02 X-linked hereditary spastic paraplegia –– 8B44.0Y Other specified hereditary spastic paraplegia –– 8B44.0Z Hereditary spastic paraplegia, unspecified 8B4Y Other specified spinal cord disorders excluding trauma 8B4Z Spinal cord disorders excluding trauma, unspecified 8B60 Motor neuron disease – 8B60.0 Amyotrophic lateral sclerosis – 8B60.1 Progressive bulbar palsy – 8B60.2 Progressive pseudobulbar palsy – 8B60.3 Progressive muscular atrophy – 8B60.4 Primary lateral sclerosis – 8B60.5 Amyotrophic lateral sclerosis-Plus – 8B60.6 Monomelic amyotrophy – 8B60.7 Madras type motor neuron disease – 8B60.Y Other specified motor neuron disease – 8B60.Z Motor neuron disease, unspecified 8B61 Spinal muscular atrophy – 8B61.0 Infantile spinal muscular atrophy, Type I – 8B61.1 Late infantile spinal muscular atrophy, Type II – 8B61.2 Juvenile form spinal muscular dystrophy, Type III – 8B61.3 Adult onset spinal muscular atrophy, Type IV – 8B61.4 Localised spinal muscular atrophy – 8B61.Y Other specified spinal muscular atrophy – 8B61.Z Spinal muscular atrophy, unspecified 8B62 Post polio progressive muscular atrophy 8B6Y Other specified motor neuron diseases or related disorders 8B6Z Motor neuron diseases or related disorders, unspecified – 8B80 Disorders of olfactory nerve – 8B81 Disorders of vestibulocochlear nerve –– 8B81.0 Brainstem lesion –– 8B81.Y Other specified disorders of vestibulocochlear nerve –– 8B81.Z Disorders of vestibulocochlear nerve, unspecified – 8B82 Disorders of trigeminal nerve –– 8B82.0 Trigeminal neuralgia –– 8B82.Z Disorders of trigeminal nerve, unspecified – 8B83 Disorders of spinal accessory nerve – 8B84 Disorders of hypoglossal nerve – 8B85 Disorders of multiple cranial nerves – 8B86 Disorders of vagus nerve – 8B87 Disorders of glossopharyngeal nerve – 8B88 Disorders of facial nerve –– 8B88.0 Bell palsy –– 8B88.1 Facial myokymia –– 8B88.2 Hemifacial spasm –– 8B88.3 Facial neuritis –– 8B88.Y Other specified disorders of facial nerve –– 8B88.Z Disorders of facial nerve, unspecified – 8B8Y Other specified disorders of cranial nerves – 8B8Z Disorders of cranial nerves, unspecified – 8B90 Nerve root and plexus compressions – 8B91 Brachial plexus disorders –– 8B91.0 Neuralgic shoulder amyotrophy –– 8B91.1 Thoracic outlet syndrome due to cervical rib –– 8B91.Y Other specified brachial plexus disorders –– 8B91.Z Brachial plexus disorders, unspecified – 8B92 Lumbosacral plexus disorders –– 8B92.0 Post radiation lumbosacral plexopathy –– 8B92.1 Vasculitic lumbosacral plexopathy –– 8B92.2 Diabetic lumbosacral plexopathy –– 8B92.3 Lumbosacral radiculoplexopathy –– 8B92.Y Other specified lumbosacral plexus disorders –– 8B92.Z Lumbosacral plexus disorders, unspecified – 8B93 Radiculopathy –– 8B93.0 Radiculopathy due to compression –– 8B93.1 Radiculopathy due to metabolic disorders –– 8B93.2 Radiculopathy due to electric shock or lightning –– 8B93.3 Radiculopathy due to radiation injury –– 8B93.4 Radiculopathy due to nutritional deficiencies –– 8B93.5 Radiculopathy due to toxicity –– 8B93.6 Radiculopathy due to intervertebral disc disorders –– 8B93.7 Radiculopathy due to neoplastic disease –– 8B93.8 Radiculopathy due to spondylosis –– 8B93.Y Other specified radiculopathy –– 8B93.Z Radiculopathy, unspecified – 8B94 Diabetic radiculoplexoneuropathy – 8B95 Secondary brachial plexus lesion due to certain specified disorders – 8B9Y Other specified nerve root or plexus disorders – 8B9Z Nerve root or plexus disorders, unspecified – 8C00 Idiopathic progressive neuropathy – 8C01 Inflammatory polyneuropathy –– 8C01.0 Acute inflammatory demyelinating polyneuropathy –– 8C01.1 Post vaccinal neuropathy –– 8C01.2 Subacute inflammatory demyelinating polyneuropathy –– 8C01.3 Chronic inflammatory demyelinating polyneuropathy –– 8C01.Y Other specified inflammatory polyneuropathy –– 8C01.Z Inflammatory polyneuropathy, unspecified – 8C03 Other secondary polyneuropathy –– 8C03.0 Diabetic polyneuropathy –– 8C03.1 Polyneuropathy due to infectious diseases –– 8C03.2 Polyneuropathy in neoplastic disease –– 8C03.3 Polyneuropathy in nutritional deficiency –– 8C03.4 Polyneuropathy in systemic connective tissue disorders –– 8C03.Y Other specified secondary polyneuropathy –– 8C03.Z Other secondary polyneuropathy, unspecified – 8C0Y Other specified polyneuropathy – 8C0Z Polyneuropathy, unspecified – 8C10 Mononeuropathies of upper limb –– 8C10.0 Carpal tunnel syndrome –– 8C10.1 Lesion of ulnar nerve –– 8C10.2 Lesion of radial nerve –– 8C10.Y Other specified mononeuropathies of upper limb –– 8C10.Z Mononeuropathies of upper limb, unspecified – 8C11 Mononeuropathies of lower limb –– 8C11.0 Lesion of sciatic nerve –– 8C11.1 Meralgia paraesthetica –– 8C11.2 Lesion of femoral nerve –– 8C11.3 Lesion of common peroneal nerve –– 8C11.4 Lesion of tibial nerve –– 8C11.5 Tarsal tunnel syndrome –– 8C11.6 Lesion of plantar nerve –– 8C11.Y Other specified mononeuropathies of lower limb –– 8C11.Z Mononeuropathies of lower limb, unspecified ––– 8C11.00 Sciatic nerve piriformis syndrome ––– 8C11.0Y Other specified lesion of sciatic nerve ––– 8C11.0Z Lesion of sciatic nerve, unspecified – 8C12 Certain specified mononeuropathies –– 8C12.0 Intercostal neuropathy –– 8C12.1 Mononeuritis multiplex –– 8C12.2 Lesion of suprascapular nerve –– 8C12.3 Lesion of axillary nerve –– 8C12.4 Lesion of long thoracic nerve –– 8C12.5 Traumatic neuroma, not otherwise specified –– 8C12.Y Mononeuropathy of other specified nerve – 8C1Y Mononeuropathy of other specified site – 8C1Z Mononeuropathy of unspecified site – 8C20 Hereditary motor and sensory neuropathy –– 8C20.0 Charcot-Marie-Tooth disease 1 demyelinating –– 8C20.1 Charcot-Marie-Tooth disease 2 axonal –– 8C20.2 Intermediate Charcot-Marie-Tooth disease –– 8C20.Y Other specified hereditary motor and sensory neuropathy –– 8C20.Z Hereditary motor and sensory neuropathy, unspecified – 8C21 Hereditary sensory or autonomic neuropathy –– 8C21.0 Hereditary sensory and autonomic neuropathy type I –– 8C21.1 Hereditary sensory and autonomic neuropathy type III –– 8C21.2 Hereditary sensory and autonomic neuropathy type IV –– 8C21.3 Hereditary sensory and autonomic neuropathy type V –– 8C21.Y Other specified hereditary sensory or autonomic neuropathy –– 8C21.Z Hereditary sensory or autonomic neuropathy, unspecified – 8C2Y Other specified hereditary neuropathy – 8C2Z Hereditary neuropathy, unspecified 8C4Y Other specified disorders of nerve root, plexus or peripheral nerves 8C4Z Disorders of nerve root, plexus or peripheral nerves, unspecified – 8C60 Myasthenia gravis –– 8C60.0 Drug-induced myasthenia gravis –– 8C60.Y Other specified myasthenia gravis –– 8C60.Z Myasthenia gravis, unspecified – 8C61 Congenital myasthenic syndromes – 8C62 Lambert-Eaton syndrome – 8C6Y Other specified myasthenia gravis and neuromuscular junction disorders – 8C6Z Unspecified myasthenia gravis or neuromuscular junction disorders – 8C70 Muscular dystrophy –– 8C70.0 Becker muscular dystrophy –– 8C70.1 Duchenne muscular dystrophy –– 8C70.2 Emery-Dreifuss muscular dystrophy –– 8C70.3 Facioscapulohumeral muscular dystrophy –– 8C70.4 Limb-girdle muscular dystrophy –– 8C70.5 Scapuloperoneal muscular dystrophy –– 8C70.6 Congenital muscular dystrophy –– 8C70.Y Other specified muscular dystrophy –– 8C70.Z Muscular dystrophy, unspecified ––– 8C70.40 Dominant limb-girdle muscular dystrophy ––– 8C70.41 Recessive limb-girdle muscular dystrophy ––– 8C70.4Y Other specified limb-girdle muscular dystrophy ––– 8C70.4Z Limb-girdle muscular dystrophy, unspecified – 8C71 Myotonic disorders –– 8C71.0 Myotonic dystrophy –– 8C71.1 Chondrodystrophic myotonia –– 8C71.2 Myotonia congenita –– 8C71.3 Drug-induced myotonia –– 8C71.4 Neuromyotonia –– 8C71.5 Pseudomyotonia –– 8C71.Y Other specified myotonic disorders –– 8C71.Z Myotonic disorders, unspecified – 8C72 Congenital myopathies –– 8C72.0 Congenital myopathy with structural abnormalities –– 8C72.1 Congenital myopathy with no structural abnormalities –– 8C72.Y Other specified congenital myopathies –– 8C72.Z Congenital myopathies, unspecified ––– 8C72.00 Nemaline myopathy ––– 8C72.01 Centronuclear myopathy ––– 8C72.02 Central core disease ––– 8C72.0Y Other specified congenital myopathy with structural abnormalities ––– 8C72.0Z Congenital myopathy with structural abnormalities, unspecified – 8C73 Mitochondrial myopathies –– 8C73.0 Autosomal recessive cardiomyopathy or ophthalmoplegia –– 8C73.1 Neuropathy, ataxia, and retinitis pigmentosa –– 8C73.Y Other specified mitochondrial myopathies –– 8C73.Z Mitochondrial myopathies, unspecified – 8C74 Periodic paralyses or disorders of muscle membrane excitability –– 8C74.0 Paramyotonia congenita –– 8C74.1 Periodic paralysis –– 8C74.Y Other specified periodic paralyses or disorders of muscle membrane excitability –– 8C74.Z Periodic paralyses or disorders of muscle membrane excitability, unspecified ––– 8C74.10 Hypokalaemic periodic paralysis ––– 8C74.11 Hyperkalaemic periodic paralysis ––– 8C74.1Y Other specified periodic paralysis ––– 8C74.1Z Periodic paralysis, unspecified – 8C75 Distal myopathies – 8C76 Myofibrillar myopathy – 8C77 Ocular myopathy – 8C78 Malignant hyperthermia or hyperpyrexia – 8C7Y Other specified primary disorders of muscles – 8C7Z Primary disorders of muscles, unspecified – 8C80 Drug-induced myopathy – 8C81 Autoimmune myopathy – 8C82 Myopathy in certain specified infectious or parasitic disease – 8C83 Myopathy in certain specified endocrine disease – 8C84 Secondary rhabdomyolysis – 8C8Y Other specified secondary myopathies – 8C8Z Secondary myopathies, unspecified 8D0Y Other specified diseases of neuromuscular junction or muscle 8D0Z Diseases of neuromuscular junction or muscle, unspecified 8D20 Spastic cerebral palsy – 8D20.0 Spastic unilateral cerebral palsy – 8D20.1 Spastic bilateral cerebral palsy – 8D20.Y Other specified spastic cerebral palsy – 8D20.Z Spastic cerebral palsy, unspecified –– 8D20.10 Spastic quadriplegic cerebral palsy –– 8D20.11 Spastic diplegic cerebral palsy –– 8D20.1Z Spastic bilateral cerebral palsy, unspecified 8D21 Dyskinetic cerebral palsy 8D22 Ataxic cerebral palsy 8D23 Worster-Drought syndrome 8D2Y Other specified cerebral palsy 8D2Z Cerebral palsy, unspecified 8D40 Neurological disorders due to nutrient deficiency – 8D40.0 Encephalopathy due to nutritional deficiency – 8D40.1 Neuropathy due to nutritional deficiency – 8D40.2 Myopathy due to nutritional deficiency – 8D40.3 Intellectual developmental disorder due to nutritional deficiency – 8D40.Y Other specified neurological disorders due to nutrient deficiency – 8D40.Z Neurological disorders due to nutrient deficiency, unspecified 8D41 Neurological disorders due to an excess of micro or macro nutrients – 8D41.0 Peripheral neuropathy due to vitamin B6 hyperalimentation – 8D41.1 Myopathy due to hypercalcaemia – 8D41.2 Pseudotumour Cerebri related to Hypervitaminosis A – 8D41.Y Other specified neurological disorders due to an excess of micro or macro nutrients – 8D41.Z Neurological disorders due to an excess of micro or macro nutrients, unspecified 8D42 Neurological disorders due to overweight or obesity in adults or children 8D43 Neurological disorders due to toxicity – 8D43.0 Encephalopathy due to toxicity – 8D43.1 Cognitive impairment due to toxicity – 8D43.2 Neuropathy due to toxicity – 8D43.3 Myopathy due to toxicity – 8D43.4 Movement disorders due to toxicity – 8D43.5 Cassava poisoning – 8D43.Y Other specified neurological disorders due to toxicity – 8D43.Z Neurological disorders due to toxicity, unspecified –– 8D43.00 Encephalopathy due to ammonia –– 8D43.0Y Other specified encephalopathy due to toxicity –– 8D43.0Z Encephalopathy due to toxicity, unspecified –– 8D43.20 Drug-induced polyneuropathy –– 8D43.21 Post radiation polyneuropathy –– 8D43.2Y Other specified neuropathy due to toxicity –– 8D43.2Z Neuropathy due to toxicity, unspecified 8D44 Alcohol-related neurological disorders – 8D44.0 Alcoholic polyneuropathy – 8D44.1 Alcoholic myopathy – 8D44.Y Other specified alcohol-related neurological disorders – 8D44.Z Alcohol-related neurological disorders, unspecified 8D4Y Other specified nutritional or toxic disorders of the nervous system 8D4Z Nutritional or toxic disorders of the nervous system, unspecified 8D60 Increased intracranial pressure – 8D60.0 Brain herniation syndromes – 8D60.1 Cerebral oedema – 8D60.Y Other specified increased intracranial pressure – 8D60.Z Increased intracranial pressure, unspecified 8D61 Intracranial hypotension – 8D61.0 Spontaneous intracranial hypotension – 8D61.1 Secondary intracranial hypotension – 8D61.Y Other specified intracranial hypotension – 8D61.Z Intracranial hypotension, unspecified 8D62 Cerebrospinal fluid rhinorrhoea 8D63 Cerebrospinal fluid otorrhoea 8D64 Hydrocephalus – 8D64.0 Communicating hydrocephalus – 8D64.1 Non-communicating hydrocephalus – 8D64.2 Ex-vacuo hydrocephalus – 8D64.Z Hydrocephalus, unspecified –– 8D64.00 Increased cerebrospinal fluid production –– 8D64.01 Congenital agenesis of arachnoid villi –– 8D64.02 Post haemorrhagic hydrocephalus –– 8D64.03 Post traumatic hydrocephalus –– 8D64.04 Normal-pressure hydrocephalus –– 8D64.0Y Other specified communicating hydrocephalus –– 8D64.0Z Communicating hydrocephalus, unspecified –– 8D64.10 Hydrocephalus due to structural malformations –– 8D64.1Y Other specified non-communicating hydrocephalus –– 8D64.1Z Non-communicating hydrocephalus, unspecified 8D65 Cerebrospinal fluid fistula 8D66 Syringomyelia or syringobulbia – 8D66.0 Idiopathic syringomyelia – 8D66.1 Syringomyelia due to certain specified cause – 8D66.2 Syringobulbia – 8D66.Y Other specified syringomyelia or syringobulbia – 8D66.Z Syringomyelia or syringobulbia, unspecified 8D67 Intracranial arachnoid cyst 8D68 Porencephalic cyst 8D6Y Other specified disorders of cerebrospinal fluid pressure or flow 8D6Z Disorders of cerebrospinal fluid pressure or flow, unspecified 8D80 Congenital malformations of the autonomic nervous system 8D81 Inherited autonomic nervous system disorders 8D82 Autoimmune disorders involving the autonomic nervous system 8D83 Autonomic nervous system disorder due to infection 8D84 Pure autonomic nervous system failure 8D85 Autonomic nervous system disorder due to substances 8D86 Autonomic nervous system hyperactivity 8D87 Autonomic nervous system disorder due to certain specified neurodegenerative disorder – 8D87.0 Multiple system atrophy – 8D87.Y Other specified autonomic nervous system disorder due to specified neurodegenerative disorder –– 8D87.00 Multiple system atrophy, Cerebellar type –– 8D87.01 Multiple system atrophy, Parkinsonism –– 8D87.0Y Other specified multiple system atrophy –– 8D87.0Z Multiple system atrophy, unspecified 8D88 Autonomic neuropathies – 8D88.0 Autonomic neuropathy due to sodium channelopathies – 8D88.1 Autonomic neuropathy due to diabetes mellitus – 8D88.2 Immune mediated autonomic neuropathy – 8D88.3 Autonomic disorder due to toxins – 8D88.4 Autonomic neuropathy in endocrine and metabolic diseases – 8D88.Y Other specified autonomic neuropathies – 8D88.Z Autonomic neuropathies, unspecified 8D89 Disorders of orthostatic tolerance – 8D89.0 Reflex syncope – 8D89.1 Syncope due to autonomic failure – 8D89.2 Postural orthostatic tachycardia syndrome – 8D89.3 Baroreflex failure – 8D89.Y Other specified disorders of orthostatic tolerance – 8D89.Z Disorders of orthostatic tolerance, unspecified 8D8A Focal or segmental autonomic disorders – 8D8A.1 Horner syndrome – 8D8A.2 Episodic anisocoria – 8D8A.Y Other specified focal or segmental autonomic disorders – 8D8A.Z Focal or segmental autonomic disorders, unspecified 8D8B Disorders affecting autonomic synaptic neurotransmission 8D8C Autonomic dysreflexia 8D8D Hypoglycaemia unawareness 8D8Y Other specified disorders of autonomic nervous system 8D8Z Disorders of autonomic nervous system, unspecified 8E00 Sporadic Creutzfeldt-Jakob Disease 8E01 Acquired prion disease – 8E01.0 Iatrogenically acquired Creutzfeldt-Jakob Disease – 8E01.1 Kuru – 8E01.2 Variant Creutzfeldt-Jakob Disease – 8E01.3 Other acquired Creutzfeldt-Jakob Disease – 8E01.Z Acquired prion disease, unspecified 8E02 Genetic prion diseases – 8E02.0 Genetic Creutzfeldt-Jakob disease – 8E02.1 Gerstmann-Straussler-Scheinker syndrome – 8E02.2 Fatal familial insomnia – 8E02.3 Other genetic prion diseases – 8E02.Y Other specified Creutzfeldt-Jakob disease – 8E02.Z Creutzfeldt-Jakob disease, unspecified 8E03 Variably protease sensitive prionopathy 8E0Y Other specified human prion diseases 8E0Z Human prion diseases, unspecified 8E20 Persistent vegetative state 8E21 Permanent vegetative state 8E22 Minimally conscious state – 8E22.0 Minimally conscious state plus – 8E22.1 Minimally conscious state minus – 8E22.Y Other specified minimally conscious state – 8E22.Z Minimally conscious state, unspecified 8E2Y Other specified disorders of consciousness 8E2Z Disorders of consciousness, unspecified 8E40 Disorders of the meninges excluding infection – 8E40.0 Neoplastic meningitis – 8E40.1 Chemical meningitis – 8E40.2 Inflammatory meningitis – 8E40.3 Arachnoiditis – 8E40.Y Other specified disorders of the meninges excluding infection – 8E40.Z Disorders of the meninges excluding infection, unspecified 8E41 Pachymeningitis – 8E41.0 Pachymeningitis due to infection – 8E41.1 Idiopathic hypertrophic pachymeningitis – 8E41.Y Other specified pachymeningitis – 8E41.Z Pachymeningitis, unspecified 8E42 Superficial siderosis of the nervous system 8E43 Pain disorders – 8E43.0 Neuropathic pain – 8E43.Y Other specified pain disorders – 8E43.Z Pain disorders, unspecified –– 8E43.00 Phantom limb syndrome –– 8E43.0Y Other specified neuropathic pain –– 8E43.0Z Neuropathic pain, unspecified 8E44 Post anoxic brain damage 8E45 Locked-in syndrome 8E46 Reye syndrome 8E47 Encephalopathy, not elsewhere classified 8E48 Encephalitis, not elsewhere classified 8E49 Postviral fatigue syndrome 8E4A Paraneoplastic or autoimmune disorders of the nervous system – 8E4A.0 Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cord – 8E4A.1 Paraneoplastic or autoimmune disorders of the peripheral or autonomic nervous system – 8E4A.2 Paraneoplastic or autoimmune neuromuscular transmission disorders – 8E4A.3 Paraneoplastic or autoimmune disorders of the muscle – 8E4A.Y Other specified paraneoplastic or autoimmune disorders of the nervous system – 8E4A.Z Paraneoplastic or autoimmune disorders of the nervous system, unspecified 8E4Y Other specified disorders of the nervous system 8E60 Post ventricular shunting leak 8E61 Post radiation injury of the nervous system – 8E61.0 Radiation-induced brain injury – 8E61.1 Spinal cord irradiation – 8E61.Z Post radiation injury of the nervous system, unspecified 8E62 Postprocedural meningitis 8E63 Post pump encephalopathy 8E64 Multifocal cerebral infarctions 8E66 Intracranial hypotension due to lumbar puncture 8E7Y Other specified diseases of the nervous system 8E7Z Diseases of the nervous system, unspecified BA00 Essential hypertension – BA00.0 Combined diastolic and systolic hypertension – BA00.1 Isolated diastolic hypertension – BA00.2 Isolated systolic hypertension – BA00.Y Other specified essential hypertension – BA00.Z Essential hypertension, unspecified BA01 Hypertensive heart disease BA02 Hypertensive renal disease BA03 Hypertensive crisis BA04 Secondary hypertension – BA04.0 Combined diastolic and systolic secondary hypertension – BA04.1 Isolated diastolic secondary hypertension – BA04.2 Isolated systolic secondary hypertension – BA04.Y Other specified secondary hypertension – BA04.Z Secondary hypertension, unspecified BA20 Idiopathic hypotension BA21 Orthostatic hypotension BA2Y Other specified hypotension BA2Z Hypotension, unspecified – BA40 Angina pectoris –– BA40.0 Unstable angina –– BA40.1 Stable angina –– BA40.Y Other specified angina pectoris –– BA40.Z Angina pectoris, unspecified – BA41 Acute myocardial infarction –– BA41.0 Acute ST elevation myocardial infarction –– BA41.1 Acute non-ST elevation myocardial infarction –– BA41.Z Acute myocardial infarction, unspecified – BA42 Subsequent myocardial infarction –– BA42.0 Subsequent myocardial infarction, ST elevation myocardial infarction –– BA42.1 Subsequent myocardial infarction, non-ST elevation myocardial infarction –– BA42.Z Subsequent myocardial infarction, unspecified – BA43 Coronary thrombosis not resulting in myocardial infarction – BA4Z Acute ischaemic heart disease, unspecified – BA50 Old myocardial infarction – BA51 Ischaemic cardiomyopathy –– BA51.0 Dilated cardiomyopathy due to congenital anomaly of coronary artery –– BA51.Y Other specified ischaemic cardiomyopathy –– BA51.Z Ischaemic cardiomyopathy, unspecified – BA52 Coronary atherosclerosis –– BA52.0 Coronary atherosclerosis of native coronary artery –– BA52.1 Coronary atherosclerosis of autologous bypass graft –– BA52.2 Coronary atherosclerosis of non-autologous bypass graft –– BA52.Z Coronary atherosclerosis, unspecified site ––– BA52.10 Coronary atherosclerosis of arterial autologous bypass graft ––– BA52.11 Coronary atherosclerosis of venous autologous bypass graft ––– BA52.1Z Coronary atherosclerosis of unspecified autologous bypass graft – BA5Y Other specified chronic ischaemic heart disease – BA5Z Chronic ischaemic heart disease, unspecified BA60 Certain current complications following acute myocardial infarction – BA60.0 Dressler syndrome – BA60.1 Other pericarditis as current complication following acute myocardial infarction – BA60.2 Ventricular aneurysm as current complication following acute myocardial infarction – BA60.3 Ventricular septal defect as current complication following acute myocardial infarction – BA60.4 Cardiac rupture as current complication following acute myocardial infarction – BA60.5 Pulmonary embolism as current complication following acute myocardial infarction – BA60.6 Rupture of papillary muscle or chordae tendineae as current complication following acute myocardial infarction – BA60.7 Mural thrombus as current complication following acute myocardial infarction – BA60.8 Arrhythmia as current complication following acute myocardial infarction – BA60.9 Cardiogenic shock, unrelated to mechanical complications, as current complication following acute myocardial infarction – BA60.Y Other specified current complications following acute myocardial infarction – BA60.Z Certain current complications following acute myocardial infarction, unspecified BA6Z Ischaemic heart diseases, unspecified BA81 Coronary artery aneurysm – BA81.0 Coronary artery aneurysm with perforation – BA81.1 Coronary artery aneurysm with rupture – BA81.2 Coronary artery aneurysm without mention of perforation or rupture BA82 Coronary artery dissection BA83 Coronary artery fistula, acquired BA84 Chronic total occlusion of coronary artery BA85 Coronary vasospastic disease – BA85.0 Silent coronary vasospastic disease – BA85.Y Other specified coronary vasospastic disease – BA85.Z Coronary vasospastic disease, unspecified BA86 Coronary microvascular disease BA8Y Other specified diseases of coronary artery BA8Z Diseases of coronary artery, unspecified BB00 Pulmonary thromboembolism – BB00.0 Acute pulmonary thromboembolism – BB00.1 Chronic pulmonary thromboembolism – BB00.Z Pulmonary thromboembolism, unspecified BB01 Pulmonary hypertension – BB01.0 Pulmonary arterial hypertension – BB01.1 Pulmonary hypertension due to left heart disease – BB01.2 Pulmonary hypertension due to lung disease or hypoxia – BB01.3 Chronic thromboembolic pulmonary hypertension – BB01.4 Pulmonary hypertension with multifactorial mechanism – BB01.5 Cor pulmonale – BB01.Z Pulmonary hypertension, unspecified BB02 Certain specified diseases of pulmonary vessels – BB02.0 Arteriovenous fistula of pulmonary vessels – BB02.1 Aneurysm of pulmonary artery – BB02.2 Rupture of pulmonary vessels – BB02.3 Acquired pulmonary arterial tree abnormality –– BB02.10 Aneurysm of pulmonary artery with perforation –– BB02.11 Aneurysm of pulmonary artery with rupture –– BB02.12 Aneurysm of pulmonary artery without mention of perforation or rupture –– BB02.1Y Other specified aneurysm of pulmonary artery –– BB02.1Z Aneurysm of pulmonary artery, unspecified BB03 Acquired pulmonary venous abnormality – BB03.0 Acquired pulmonary venous obstruction – BB03.Y Other specified acquired pulmonary venous abnormality – BB03.Z Acquired pulmonary venous abnormality, unspecified BB0Y Other specified pulmonary heart disease or diseases of pulmonary circulation BB0Z Pulmonary heart disease or diseases of pulmonary circulation, unspecified BB20 Acute pericarditis – BB20.0 Infectious pericarditis – BB20.1 Neoplastic pericarditis – BB20.2 Myopericarditis – BB20.Y Other specified acute pericarditis – BB20.Z Acute pericarditis, unspecified BB21 Chronic rheumatic pericarditis BB22 Constrictive pericarditis BB23 Cardiac tamponade BB24 Haemopericardium BB25 Pericardial effusion BB2Y Other specified pericarditis BB2Z Pericarditis, unspecified BB40 Acute or subacute infectious endocarditis BB41 Myoendocarditis BB42 Periendocarditis BB4Y Other specified acute or subacute endocarditis BB4Z Acute or subacute endocarditis, unspecified – BB60 Mitral valve stenosis –– BB60.0 Rheumatic mitral valve stenosis –– BB60.1 Nonrheumatic mitral valve stenosis –– BB60.Z Mitral valve stenosis, unspecified – BB61 Mitral valve insufficiency –– BB61.0 Rheumatic mitral valve insufficiency –– BB61.Y Other specified mitral valve insufficiency –– BB61.Z Mitral valve insufficiency, unspecified – BB62 Mitral valve prolapse –– BB62.0 Rheumatic mitral valve prolapse –– BB62.1 Degenerative mitral valve prolapse –– BB62.Y Other specified nonrheumatic mitral valve prolapse –– BB62.Z Mitral valve prolapse, unspecified – BB63 Mitral valve stenosis with insufficiency –– BB63.0 Rheumatic mitral stenosis with insufficiency –– BB63.1 Nonrheumatic mitral stenosis with insufficiency –– BB63.Z Mitral valve stenosis with insufficiency, unspecified – BB64 Mitral valvar abscess – BB65 Mitral valve rupture – BB6Y Other specified mitral valve disease – BB6Z Mitral valve disease, unspecified – BB70 Aortic valve stenosis –– BB70.0 Rheumatic aortic valve stenosis –– BB70.1 Nonrheumatic aortic valve stenosis –– BB70.Y Other specified aortic valve stenosis –– BB70.Z Aortic valve stenosis, unspecified – BB71 Aortic valve insufficiency –– BB71.0 Rheumatic aortic valve insufficiency –– BB71.Y Other specified nonrheumatic aortic valve insufficiency –– BB71.Z Aortic valve insufficiency, unspecified – BB72 Aortic valve stenosis with insufficiency –– BB72.0 Rheumatic aortic stenosis with insufficiency –– BB72.1 Nonrheumatic aortic valve stenosis with insufficiency –– BB72.Z Aortic valve stenosis with insufficiency, unspecified – BB73 Aortic valvar abscess – BB74 Aortic valvar prolapse – BB7Y Other specified aortic valve disease – BB7Z Aortic valve disease, unspecified – BB80 Tricuspid valve stenosis –– BB80.0 Rheumatic tricuspid valve stenosis –– BB80.Y Other specified nonrheumatic tricuspid valve stenosis –– BB80.Z Tricuspid valve stenosis, unspecified – BB81 Tricuspid valve insufficiency –– BB81.0 Rheumatic tricuspid valve insufficiency –– BB81.Y Other specified nonrheumatic tricuspid valve insufficiency –– BB81.Z Tricuspid valve insufficiency, unspecified – BB82 Tricuspid valve stenosis with insufficiency –– BB82.0 Rheumatic tricuspid valve stenosis with insufficiency –– BB82.Y Other specified nonrheumatic tricuspid valve stenosis with insufficiency –– BB82.Z Tricuspid valve stenosis with insufficiency, unspecified – BB83 Tricuspid valvular abscess – BB84 Tricuspid valve rupture – BB8Y Other specified tricuspid valve disease – BB8Z Tricuspid valve disease, unspecified – BB90 Pulmonary valve stenosis –– BB90.0 Rheumatic pulmonary valve stenosis –– BB90.Y Other specified nonrheumatic pulmonary valve stenosis –– BB90.Z Pulmonary valve stenosis, unspecified – BB91 Pulmonary valve insufficiency –– BB91.0 Rheumatic pulmonary valve insufficiency –– BB91.Y Other specified nonrheumatic pulmonary valve insufficiency –– BB91.Z Pulmonary valve insufficiency, unspecified – BB92 Pulmonary valve stenosis with insufficiency –– BB92.0 Rheumatic pulmonary valve stenosis with insufficiency –– BB92.1 Nonrheumatic pulmonary valve stenosis with insufficiency –– BB92.Z Pulmonary valve stenosis with insufficiency, unspecified – BB93 Pulmonary valvar abscess – BB9Y Other specified pulmonary valve disease – BB9Z Pulmonary valve disease, unspecified BC00 Multiple valve disease BC01 Prosthetic valve disease BC02 Acquired abnormality of congenitally malformed valve – BC02.0 Acquired common atrioventricular valvar abnormality in biventricular connections – BC02.1 Acquired truncal valvar abnormality – BC02.2 Acquired common atrioventricular valvar abnormality in double inlet ventricle – BC02.3 Acquired abnormality of neoaortic valve of pulmonary origin – BC02.4 Acquired abnormality of the neoaortic valve of truncal origin – BC02.Y Other specified acquired abnormality of congenitally malformed valve – BC02.Z Acquired abnormality of congenitally malformed valve, unspecified –– BC02.30 Stenosis of the neoaortic valve of pulmonary origin –– BC02.31 Insufficiency of the neoaortic valve of pulmonary origin –– BC02.3Y Other specified acquired abnormality of neoaortic valve of pulmonary origin –– BC02.3Z Acquired abnormality of neoaortic valve of pulmonary origin, unspecified –– BC02.40 Acquired stenosis of the neoaortic valve of truncal origin –– BC02.41 Acquired regurgitation of the neoaortic valve of truncal origin –– BC02.4Y Other specified acquired abnormality of the neoaortic valve of truncal origin –– BC02.4Z Acquired abnormality of the neoaortic valve of truncal origin, unspecified BC0Z Heart valve diseases, unspecified BC20 Chronic rheumatic heart diseases, not elsewhere classified BC20.0 Rheumatic diseases of endocardium, valve unspecified BC20.1 Rheumatic heart disease, unspecified BC20.Y Other specified chronic rheumatic heart disease BC20.Z Chronic rheumatic heart disease, unspecified BC40 Acquired atrial abnormality – BC40.0 Acquired interatrial communication – BC40.Y Other specified acquired atrial abnormality – BC40.Z Acquired atrial abnormality, unspecified BC41 Acquired ventricular abnormality – BC41.0 Acquired interventricular communication – BC41.Y Other specified acquired ventricular abnormality – BC41.Z Acquired ventricular abnormality, unspecified BC42 Myocarditis – BC42.0 Giant cell myocarditis – BC42.1 Infectious myocarditis – BC42.2 Hypersensitivity myocarditis – BC42.3 Rheumatic myocarditis – BC42.Y Other specific myocarditis – BC42.Z Myocarditis, unspecified BC43 Cardiomyopathy – BC43.0 Dilated cardiomyopathy – BC43.1 Hypertrophic cardiomyopathy – BC43.2 Restrictive cardiomyopathy – BC43.3 Endocardial fibroelastosis – BC43.4 Cardiomyopathy due to drugs or other external agents – BC43.5 Stress-induced cardiomyopathy – BC43.6 Arrhythmogenic ventricular cardiomyopathy – BC43.7 Diabetic cardiomyopathy – BC43.Y Other specified cardiomyopathy – BC43.Z Cardiomyopathy, unspecified –– BC43.00 Familial-genetic dilated cardiomyopathy –– BC43.01 Nonfamilial dilated cardiomyopathy –– BC43.0Z Dilated cardiomyopathy, unspecified –– BC43.10 Familial-genetic hypertrophic cardiomyopathy –– BC43.11 Non-obstructive hypertrophic cardiomyopathy –– BC43.12 Obstructive hypertrophic cardiomyopathy –– BC43.1Y Other specified hypertrophic cardiomyopathy –– BC43.1Z Hypertrophic cardiomyopathy, unspecified –– BC43.20 Nonfamilial restrictive cardiomyopathy –– BC43.2Y Other specified restrictive cardiomyopathy –– BC43.2Z Restrictive cardiomyopathy, unspecified BC44 Noncompaction cardiomyopathy BC45 Cardiomegaly BC46 Intracardiac thrombosis BC4Y Other specified diseases of the myocardium or cardiac chambers BC4Z Diseases of the myocardium or cardiac chambers, unspecified BC60 Atrial premature depolarization BC61 Junctional premature depolarization BC62 Accessory pathway BC63 Conduction disorders – BC63.0 Atrioventricular block, first degree – BC63.1 Atrioventricular block, second degree – BC63.2 Complete atrioventricular block – BC63.3 Right bundle branch block – BC63.4 Left bundle branch block – BC63.5 Nonspecific intraventricular conduction delay – BC63.Y Other specified conduction disorders – BC63.Z Conduction disorders, unspecified –– BC63.10 High-grade second degree atrioventricular block –– BC63.1Y Other specified atrioventricular block, second degree –– BC63.1Z Atrioventricular block, second degree, unspecified –– BC63.20 Congenital complete atrioventricular block –– BC63.21 Acquired complete atrioventricular block –– BC63.2Z Complete atrioventricular block, unspecified –– BC63.40 Left anterior fascicular block –– BC63.41 Left posterior fascicular block –– BC63.4Z Left bundle branch block, fascicle unspecified BC64 Sudden arrhythmic death syndrome BC65 Cardiac arrhythmia associated with genetic disorder – BC65.0 Long QT syndrome – BC65.1 Brugada syndrome – BC65.2 Short QT syndrome – BC65.3 Early repolarisation syndrome – BC65.4 Idiopathic ventricular fibrillation – BC65.5 Catecholaminergic polymorphic ventricular tachycardia – BC65.Y Other specified cardiac arrhythmia associated with genetic disorder – BC65.Z Cardiac arrhythmia associated with genetic disorder, unspecified – BC70 Ventricular premature depolarization – BC71 Ventricular tachyarrhythmia –– BC71.0 Ventricular tachycardia –– BC71.1 Ventricular fibrillation –– BC71.2 Re-entry ventricular arrhythmia –– BC71.Y Other specified ventricular tachyarrhythmia –– BC71.Z Ventricular tachyarrhythmia, unspecified ––– BC71.00 Right outflow tract ventricular tachycardia ––– BC71.01 Polymorphic ventricular tachycardia ––– BC71.02 Sustained ventricular tachycardia ––– BC71.03 Non-sustained ventricular tachycardia ––– BC71.0Y Other specified ventricular tachycardia ––– BC71.0Z Ventricular tachycardia, unspecified – BC7Y Other specified ventricular rhythm disturbance – BC7Z Ventricular rhythm disturbance, unspecified – BC80 Supraventricular bradyarrhythmia –– BC80.0 Sinus pause –– BC80.1 Sinus bradycardia –– BC80.2 Sinus node dysfunction –– BC80.Y Other specified supraventricular bradyarrhythmia –– BC80.Z Supraventricular bradyarrhythmia, unspecified ––– BC80.20 Sick sinus syndrome ––– BC80.21 Sinoatrial block ––– BC80.2Y Other specified sinus node dysfunction ––– BC80.2Z Sinus node dysfunction, unspecified – BC81 Supraventricular tachyarrhythmia –– BC81.0 Ectopic atrial tachycardia –– BC81.1 Junctional ectopic tachycardia –– BC81.2 Macro reentrant atrial tachycardia –– BC81.3 Atrial fibrillation –– BC81.4 Wolff-Parkinson-White syndrome –– BC81.5 Sinus node reentrant tachycardia –– BC81.6 Inappropriate sinus tachycardia –– BC81.7 Atrioventricular reciprocating tachycardia –– BC81.8 Atrioventricular nodal reentry tachycardia –– BC81.Y Other specified supraventricular tachyarrhythmia –– BC81.Z Supraventricular tachyarrhythmia, unspecified ––– BC81.20 Cavotricuspid isthmus dependent macroreentry tachycardia ––– BC81.21 Non-scar, non-isthmus dependent macro reentrant atrial tachycardia ––– BC81.22 Scar mediated macro reentrant atrial tachycardia ––– BC81.2Y Other specified macro reentrant atrial tachycardia ––– BC81.2Z Macro reentrant atrial tachycardia, unspecified ––– BC81.30 Paroxysmal atrial fibrillation ––– BC81.31 Persistent atrial fibrillation ––– BC81.32 Permanent atrial fibrillation ––– BC81.33 Preexcited atrial fibrillation ––– BC81.3Y Other specified atrial fibrillation ––– BC81.3Z Atrial fibrillation, unspecified ––– BC81.70 Atrioventricular reciprocating tachycardia, orthodromic ––– BC81.71 Atrioventricular reciprocating tachycardia, antidromic ––– BC81.7Y Other specified atrioventricular reciprocating tachycardia ––– BC81.7Z Atrioventricular reciprocating tachycardia, unspecified – BC8Y Other specified supraventricular rhythm disturbance – BC8Z Supraventricular rhythm disturbance, unspecified BC90 Rhythm disturbance at level of atrioventricular junction BC91 Pacemaker or implantable cardioverter defibrillator battery at end of battery life BC9Y Other specified cardiac arrhythmia BC9Z Cardiac arrhythmia, unspecified BD10 Congestive heart failure BD11 Left ventricular failure – BD11.0 Left ventricular failure with preserved ejection fraction – BD11.1 Left ventricular failure with mid range ejection fraction – BD11.2 Left ventricular failure with reduced ejection fraction – BD11.Z Left ventricular failure, unspecified BD12 High output syndromes BD13 Right ventricular failure BD14 Biventricular failure BD1Y Other specified heart failure BD1Z Heart failure, unspecified BD30 Acute arterial occlusion – BD30.0 Acute upper limb arterial occlusion – BD30.1 Acute aortoiliac occlusion – BD30.2 Acute lower limb arterial occlusion – BD30.Y Other specified acute arterial occlusion – BD30.Z Acute arterial occlusion, unspecified –– BD30.00 Acute thromboembolic upper limb arterial occlusion –– BD30.01 Acute thrombotic upper limb arterial occlusion –– BD30.0Y Other specified acute upper limb arterial occlusion –– BD30.0Z Acute upper limb arterial occlusion, unspecified –– BD30.10 Acute thromboembolic aortoiliac occlusion –– BD30.11 Acute thrombotic aortoiliac occlusion –– BD30.1Y Other specified acute aortoiliac occlusion –– BD30.1Z Acute aortoiliac occlusion, unspecified –– BD30.20 Acute thromboembolic lower limb arterial occlusion –– BD30.21 Acute thrombotic lower limb arterial occlusion –– BD30.2Y Other specified acute lower limb arterial occlusion –– BD30.2Z Acute lower limb arterial occlusion, unspecified – BD40 Atherosclerotic chronic arterial occlusive disease –– BD40.0 Lower limb atherosclerosis –– BD40.1 Atherosclerosis of aorta –– BD40.2 Atherosclerosis of renal artery –– BD40.3 Aortic bifurcation syndrome –– BD40.Y Other specified atherosclerotic chronic arterial occlusive disease –– BD40.Z Atherosclerotic chronic arterial occlusive disease, unspecified – BD41 Non-atherosclerotic chronic arterial occlusive disease –– BD41.0 Arterial fibromuscular dysplasia –– BD41.Y Other specified non-atherosclerotic chronic arterial occlusive disease –– BD41.Z Non-atherosclerotic chronic arterial occlusive disease, unspecified – BD42 Raynaud phenomenon –– BD42.0 Primary Raynaud disease –– BD42.1 Secondary Raynaud phenomenon –– BD42.Z Raynaud phenomenon, unspecified – BD4Y Other specified chronic arterial occlusive disease – BD4Z Chronic arterial occlusive disease, unspecified BD50 Aortic aneurysm or dissection – BD50.0 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch – BD50.1 Ascending aorta dissection not beyond arch – BD50.2 Descending aorta dissection and distal propagation – BD50.3 Thoracic aortic aneurysm – BD50.4 Abdominal aortic aneurysm – BD50.5 Thoracoabdominal aortic aneurysm – BD50.Z Aortic aneurysm or dissection, unspecified –– BD50.00 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch with perforation –– BD50.01 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch with rupture –– BD50.02 Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch without mention of perforation or rupture –– BD50.0Y Other specified thoracic aortic dissection, ascending aorta dissection and propagation beyond arch –– BD50.0Z Thoracic aortic dissection, ascending aorta dissection and propagation beyond arch, unspecified –– BD50.10 Ascending aorta dissection not beyond arch with perforation –– BD50.11 Ascending aorta dissection not beyond arch with rupture –– BD50.12 Ascending aorta dissection not beyond arch without mention of perforation or rupture –– BD50.1Y Other specified ascending aorta dissection not beyond arch –– BD50.1Z Ascending aorta dissection not beyond arch, unspecified –– BD50.20 Descending aorta dissection and distal propagation with perforation –– BD50.21 Descending aorta dissection and distal propagation with rupture –– BD50.22 Descending aorta dissection and distal propagation without mention of perforation or rupture –– BD50.2Y Other specified descending aorta dissection and distal propagation –– BD50.2Z Descending aorta dissection and distal propagation, unspecified –– BD50.30 Thoracic aortic aneurysm with perforation –– BD50.31 Thoracic aortic aneurysm with rupture –– BD50.32 Thoracic aortic aneurysm without mention of perforation or rupture –– BD50.3Y Other specified thoracic aortic aneurysm –– BD50.3Z Thoracic aortic aneurysm, unspecified –– BD50.40 Abdominal aortic aneurysm with perforation –– BD50.41 Abdominal aortic aneurysm with rupture –– BD50.4Y Other specified abdominal aortic aneurysm –– BD50.4Z Abdominal aortic aneurysm, unspecified –– BD50.50 Thoracoabdominal aortic aneurysm with perforation –– BD50.51 Thoracoabdominal aortic aneurysm with rupture –– BD50.52 Thoracoabdominal aortic aneurysm without mention of perforation or rupture –– BD50.5Y Other specified thoracoabdominal aortic aneurysm –– BD50.5Z Thoracoabdominal aortic aneurysm, unspecified BD51 Arterial aneurysm or dissection, excluding aorta – BD51.0 Aneurysm or dissection of carotid artery – BD51.1 Aneurysm or dissection of vertebral artery – BD51.2 Aneurysm or dissection of other precerebral arteries – BD51.3 Aneurysm or dissection of artery of upper extremity – BD51.4 Aneurysm or dissection of renal artery – BD51.5 Aneurysm or dissection of iliac artery – BD51.6 Aneurysm or dissection of artery of lower extremity – BD51.Y Aneurysm and dissection of other artery, excluding aorta – BD51.Z Aneurysm and dissection of unspecified artery BD52 Certain specified disorders of arteries or arterioles – BD52.0 Segmental arterial mediolysis – BD52.1 Arteriovenous fistula, acquired – BD52.2 Stricture of artery – BD52.3 Rupture of artery – BD52.4 Necrosis of artery – BD52.5 Coeliac artery compression syndrome – BD52.6 Congenital great vessel related acquired abnormality – BD52.7 Certain acquired abnormalities of aorta –– BD52.70 Acquired abnormality of aortic arch branch –– BD52.71 Acquired ascending aorta or root dilation –– BD52.7Y Other specified certain acquired abnormalities of aorta –– BD52.7Z Certain acquired abnormalities of aorta, unspecified BD53 Secondary disorders of arteries and arterioles – BD53.0 Arterial cystic medial diseases – BD53.1 Hypothenar hammer syndrome – BD53.2 Iliac artery arteriopathy – BD53.3 Popliteal entrapment syndrome – BD53.4 Cholesterol atheroembolism – BD53.Y Other specified secondary disorders of arteries and arterioles – BD53.Z Secondary disorders of arteries and arterioles, unspecified –– BD53.40 Cholesterol atheroembolism to kidneys –– BD53.4Y Cholesterol atheroembolism to other specified sites –– BD53.4Z Cholesterol atheroembolism to unspecified site BD54 Diabetic foot ulcer BD55 Asymptomatic stenosis of intracranial or extracranial artery BD56 Asymptomatic occlusion of intracranial or extracranial artery BD5Y Other specified diseases of arteries or arterioles BD5Z Diseases of arteries or arterioles, unspecified BD70 Superficial thrombophlebitis – BD70.0 Superficial thrombophlebitis of lower limbs – BD70.1 Superficial thrombophlebitis of upper limbs – BD70.2 Thrombophlebitis migrans – BD70.3 Mondor disease – BD70.Y Other specified superficial thrombophlebitis – BD70.Z Superficial thrombophlebitis, unspecified BD71 Deep vein thrombosis – BD71.0 Upper limb deep vein thrombosis – BD71.1 Vena caval thrombosis – BD71.2 Renal vein thrombosis – BD71.3 Iliac vein thrombosis – BD71.4 Lower limb deep vein thrombosis – BD71.Y Other specified deep vein thrombosis BD72 Venous thromboembolism BD73 Acquired systemic vein abnormality – BD73.0 Acquired inferior caval vein abnormality – BD73.1 Acquired superior caval vein abnormality – BD73.2 Systemic vein obstruction – BD73.3 Acquired coronary sinus abnormality – BD73.Y Other specified acquired systemic vein abnormality – BD73.Z Acquired systemic vein abnormality, unspecified –– BD73.20 Obstruction of peripheral vein –– BD73.21 Obstruction of visceral vein –– BD73.2Y Other specified systemic vein obstruction –– BD73.2Z Systemic vein obstruction, unspecified BD74 Chronic peripheral venous insufficiency of lower extremities – BD74.0 Uncomplicated lower limb venous hypertension – BD74.1 Lower limb varicose veins – BD74.2 Lipodermatosclerosis – BD74.3 Venous leg ulcer – BD74.Z Chronic peripheral venous insufficiency of lower extremities, unspecified –– BD74.10 Varicose veins with great saphenous reflux –– BD74.11 Varicose veins with small saphenous reflux –– BD74.12 Varicose veins with non-truncal reflux –– BD74.1Z Lower limb varicose veins, not further specified –– BD74.30 Primary venous leg ulcer –– BD74.31 Recurrent venous leg ulcer –– BD74.32 Healed venous leg ulcer –– BD74.3Z Venous leg ulcer, unspecified BD75 Venous varicosities of sites other than lower extremity – BD75.0 Sublingual varices – BD75.1 Scrotal varices – BD75.2 Vulval varices – BD75.3 Pelvic varices – BD75.Y Venous varicosities of other specified sites – BD75.Z Venous varicosities of unspecified site BD7Y Other specified diseases of veins BD7Z Diseases of veins, unspecified BD90 Lymphadenitis – BD90.0 Acute lymphadenitis – BD90.1 Nonspecific mesenteric lymphadenitis – BD90.2 Chronic lymphadenitis – BD90.Y Other specified lymphadenitis – BD90.Z Lymphadenitis, unspecified –– BD90.20 Chronic cervical lymphadenitis –– BD90.21 Chronic axillary lymphadenitis –– BD90.22 Chronic inguinal lymphadenitis –– BD90.2Y Other specified chronic lymphadenitis –– BD90.2Z Chronic lymphadenitis, unspecified BD91 Lymphangitis BD92 Lymphangiectasia – BD92.0 Intestinal lymphangiectasia – BD92.1 Cutaneous lymphangiectasia – BD92.Z Lymphangiectasia, unspecified BD93 Lymphoedema – BD93.0 Primary lymphoedema – BD93.1 Secondary lymphoedema – BD93.Y Other specified forms of lymphoedema – BD93.Z Lymphoedema, unspecified –– BD93.10 Lymphoedema due to venous insufficiency –– BD93.11 Lymphoedema due to dependency and immobility –– BD93.12 Lymphoedema due to obesity –– BD93.13 Lymphoedema due to lymphatic filariasis –– BD93.14 Lymphoedema due to podoconiosis –– BD93.15 Lymphoedema due to malignant infiltration –– BD93.1Y Lymphoedema secondary to other specified cause –– BD93.1Z Secondary lymphoedema, unspecified BD9Y Other specified disorders of lymphatic vessels or lymph nodes BD9Z Disorders of lymphatic vessels or lymph nodes, unspecified BE10 Postcardiotomy syndrome BE11 Other functional disturbances following cardiac surgery BE12 Postprocedural valve disorders – BE12.0 Postprocedural mitral valve stenosis – BE12.1 Postprocedural mitral valve insufficiency – BE12.2 Postprocedural aortic valve stenosis – BE12.3 Postprocedural aortic valve insufficiency – BE12.4 Postprocedural tricuspid valve stenosis – BE12.5 Postprocedural tricuspid valve insufficiency – BE12.6 Postprocedural pulmonary valve stenosis – BE12.7 Postprocedural pulmonary valve insufficiency BE13 Postprocedural true or false aortic aneurysm BE14 Postprocedural disorder of circulatory system following repair of congenital heart or great vessel anomaly – BE14.4 Acquired abnormality of the neopulmonary valve – BE14.5 Postprocedural right-sided atrioventricular valvar abnormality in double-inlet ventricle – BE14.6 Postprocedural left-sided atrioventricular valvar abnormality in double-inlet ventricle – BE14.7 Postprocedural common atrioventricular valvar abnormality in double-inlet ventricle – BE14.8 Postprocedural ventricular septal defect disorder – BE14.9 Postprocedural aortic disorder related to congenital heart anomaly – BE14.A Postprocedural arterial duct disorder – BE14.B Postprocedural disorder following cardiovascular conduit or shunt procedure –– BE14.40 Neopulmonary valve stenosis –– BE14.41 Neopulmonary valve regurgitation BE15 Postprocedural pulmonary arterial tree disorder – BE15.0 Postprocedural pulmonary trunk stenosis – BE15.1 Postprocedural right pulmonary artery stenosis BE16 Postprocedural pulmonary venous disorder BE17 Postprocedural residual or recurrent interatrial communication BE19 Postprocedural ventricular abnormality BE1A Cardiac transplant associated coronary allograft vasculopathy BE1B Lymphoedema due to surgery or radiotherapy – BE1B.0 Postmastectomy lymphoedema syndrome – BE1B.1 Lymphoedema due to other medical or surgical procedures BE1C Inferior caval vein obstruction due to foreign body BE1D Superior caval vein obstruction due to foreign body BE1E Postprocedural right atrial complication – BE1E.0 Postprocedural right atrial perforation – BE1E.1 Right atrial erosion due to implanted device BE1F Postprocedural left atrial complication – BE1F.0 Postprocedural left atrial perforation – BE1F.1 Left atrial erosion due to implanted device BE2Y Other specified diseases of the circulatory system BE2Z Diseases of the circulatory system, unspecified DA00 Disorders of lips – DA00.0 Cheilitis – DA00.1 Self-induced lip trauma – DA00.2 Pigmentary abnormalities of lips – DA00.3 Lip fissure – DA00.Y Other specified disorders of lips – DA00.Z Disorder of lips, unspecified DA01 Disorders of oral mucosa – DA01.0 Disturbances of oral epithelium – DA01.1 Noninfectious erosive or ulcerative disorders of oral mucosa – DA01.2 Granuloma or granuloma-like lesions of oral mucosa – DA01.3 Infections of lips or oral mucosa – DA01.4 Irritative hyperplasia of oral mucosa – DA01.Y Other specified disorders of oral mucosa – DA01.Z Disorder of oral mucosa, unspecified –– DA01.00 Oral leukoplakia –– DA01.01 Hairy leukoplakia –– DA01.02 Wandering rash of the mouth –– DA01.0Y Other specified disturbances of oral epithelium –– DA01.10 Oral aphthae or aphtha-like ulceration –– DA01.11 Oral mucositis –– DA01.12 Chronic ulcerative stomatitis –– DA01.13 Erythema multiforme with oral ulceration –– DA01.14 Drug-induced oral ulcer –– DA01.15 Mouth ulcers –– DA01.1Y Other specified noninfectious erosive or ulcerative disorders of oral mucosa –– DA01.20 Giant cell granuloma, central –– DA01.21 Orofacial granulomatosis –– DA01.2Y Other specified granuloma or granuloma-like lesions of oral mucosa –– DA01.30 Cellulitis or abscess of soft tissues of the mouth –– DA01.3Y Other specified infections of lips or oral mucosa –– DA01.40 Papillary hyperplasia of oral mucosa –– DA01.41 Denture hyperplasia –– DA01.42 Oral fibroepithelial polyp –– DA01.4Z Irritative hyperplasia of oral mucosa, unspecified DA02 Miscellaneous specified disorders of lips or oral mucosa – DA02.0 Genetic or developmental disorders involving lips or oral mucosa – DA02.1 Xerostomia – DA02.2 Oral submucous fibrosis – DA02.3 Contact gingivostomatitis –– DA02.30 Allergic contact gingivostomatitis –– DA02.31 Irritant contact gingivostomatitis DA03 Diseases of tongue – DA03.0 Glossitis – DA03.1 Geographic tongue – DA03.2 Atrophy of tongue papillae – DA03.3 Median rhomboid glossitis – DA03.4 Hypertrophy of tongue papillae – DA03.5 Macroglossia – DA03.Y Other specified diseases of tongue – DA03.Z Diseases of tongue, unspecified DA04 Diseases of salivary glands – DA04.0 Atrophy of salivary gland – DA04.1 Hypertrophy of salivary gland – DA04.2 Sialoadenitis – DA04.3 Abscess of salivary gland – DA04.4 Sialolithiasis – DA04.5 Mucocele of salivary gland – DA04.6 Disturbances of salivary secretion – DA04.7 Sialophagia – DA04.8 Sialoschesis – DA04.Y Other specified diseases of salivary glands – DA04.Z Diseases of salivary glands, unspecified DA05 Cysts of oral or facial-neck region – DA05.0 Developmental odontogenic cysts – DA05.1 Developmental nonodontogenic cysts of oral region – DA05.Y Other specified cysts of oral or facial-neck region – DA05.Z Cysts of oral or facial-neck region, unspecified DA06 Certain specified diseases of jaws – DA06.0 Inflammatory conditions of jaws – DA06.1 Alveolitis of jaw – DA06.2 Exostosis of jaw – DA06.3 Stafne mandibular bone cavity DA07 Disorders of tooth development or eruption – DA07.0 Fluoride related opacities or lesions – DA07.1 Nonfluoride enamel opacities – DA07.3 Disturbances in tooth formation – DA07.4 Root anomaly – DA07.5 Cementum dysplasia – DA07.6 Disturbances in tooth eruption – DA07.7 Embedded teeth – DA07.8 Impacted teeth – DA07.Y Other specified disorders of tooth development or eruption – DA07.Z Disorders of tooth development or eruption, unspecified –– DA07.60 Teething syndrome –– DA07.61 Ankylosis of teeth –– DA07.6Y Other specified disturbances in tooth eruption –– DA07.6Z Disturbances in tooth eruption, unspecified DA08 Diseases of hard tissues of teeth – DA08.0 Dental caries – DA08.1 Certain specified diseases of hard tissues of teeth – DA08.2 Chronic dental injuries – DA08.3 Nontraumatic fracture of tooth – DA08.4 Deposits on teeth – DA08.Y Other specified diseases of hard tissues of teeth – DA08.Z Diseases of hard tissues of teeth, unspecified –– DA08.10 Excessive attrition of teeth –– DA08.11 Abrasion of teeth –– DA08.12 Erosion of teeth –– DA08.13 Abfraction –– DA08.14 Pathological resorption of teeth –– DA08.15 Posteruptive colour changes of dental hard tissues DA09 Diseases of pulp or periapical tissues – DA09.0 Pulpitis – DA09.1 Necrosis of pulp – DA09.2 Pulp abscess – DA09.3 Phoenix abscess – DA09.4 Pulp degeneration – DA09.5 Abnormal hard tissue formation in pulp – DA09.6 Periapical abscess – DA09.7 Periapical periodontitis – DA09.8 Radicular cyst – DA09.Y Other specified diseases of pulp or periapical tissues – DA09.Z Diseases of pulp or periapical tissues, unspecified –– DA09.60 Periapical abscess with facial involvement –– DA09.61 Periapical abscess with sinus –– DA09.62 Periapical abscess without sinus –– DA09.6Y Other specified periapical abscess –– DA09.6Z Periapical abscess, unspecified –– DA09.70 Acute apical periodontitis of pulpal origin –– DA09.71 Chronic apical periodontitis –– DA09.7Y Other specified periapical periodontitis –– DA09.7Z Periapical periodontitis, unspecified DA0A Certain specified disorders of teeth or supporting structures – DA0A.0 Exfoliation of teeth due to systemic causes – DA0A.1 Loss of teeth due to accident, extraction or local periodontal disease – DA0A.2 Atrophy of edentulous alveolar ridge – DA0A.3 Retained dental root – DA0A.Y Other specified disorders of teeth and supporting structures – DA0A.Z Unspecified disorders of teeth and supporting structures DA0B Gingival diseases – DA0B.0 Allergic gingivitis – DA0B.1 Catarrhal gingivitis – DA0B.2 Eruptive gingivitis – DA0B.3 Atrophic senile gingivitis – DA0B.4 Acute multiple gingival abscesses – DA0B.5 Developmental or acquired deformities or conditions of gingiva – DA0B.6 Pericoronitis – DA0B.Y Other specified gingival diseases – DA0B.Z Gingival diseases, unspecified DA0C Periodontal disease – DA0C.0 Acute periodontitis – DA0C.1 Aggressive periodontitis – DA0C.2 Periodontosis – DA0C.3 Necrotising periodontal diseases – DA0C.4 Abscess of periodontium – DA0C.5 Linear gingival erythema – DA0C.Y Other specified periodontal disease – DA0C.Z Periodontal disease, unspecified –– DA0C.30 Necrotising ulcerative periodontitis –– DA0C.31 Noma –– DA0C.3Y Other specified necrotising periodontal diseases –– DA0C.3Z Necrotising periodontal diseases, unspecified DA0D Certain specified disorders of gingiva or edentulous alveolar ridge – DA0D.0 Gingival recession – DA0D.1 Gingival enlargement – DA0D.2 Gingival or edentulous alveolar ridge lesions associated with trauma – DA0D.3 Hypoplasminogenaemia – DA0D.4 Cotton-roll gingivitis – DA0D.5 Gingival ulceration – DA0D.Y Other specified disorders of gingival or edentulous alveolar ridge DA0E Dentofacial anomalies – DA0E.0 Major anomalies of jaw size – DA0E.1 Anomalies of jaw-cranial base relationship – DA0E.2 Anomalies of dental arch relationship – DA0E.3 Anomalies of tooth position – DA0E.4 Food impaction – DA0E.5 Malocclusion – DA0E.6 Dentofacial functional abnormalities – DA0E.7 Dentofacial parafunctional disorders – DA0E.8 Temporomandibular joint disorders – DA0E.Y Other specified dentofacial anomalies – DA0E.Z Dentofacial anomalies, unspecified –– DA0E.00 Micrognathia –– DA0E.0Y Other specified major anomalies of jaw size –– DA0E.0Z Major anomalies of jaw size, unspecified –– DA0E.50 Class II division 2 malocclusion –– DA0E.51 Angle class I malocclusion –– DA0E.5Y Other specified malocclusion –– DA0E.5Z Malocclusion, unspecified DA0F Sensory disturbances affecting orofacial complex – DA0F.0 Burning mouth syndrome – DA0F.Y Other specified sensory disturbances affecting orofacial complex – DA0F.Z Sensory disturbances affecting orofacial complex, unspecified DA0Y Other specified diseases or disorders of orofacial complex DA0Z Diseases or disorders of orofacial complex, unspecified DA20 Acquired anatomical alterations of the oesophagus – DA20.0 Oesophageal obstruction – DA20.1 Diverticulum of oesophagus, acquired – DA20.2 Oesophageal web – DA20.3 Perforation of oesophagus – DA20.Y Other specified acquired anatomical alterations of the oesophagus – DA20.Z Acquired anatomical alterations of the oesophagus, unspecified –– DA20.30 Spontaneous rupture of oesophagus –– DA20.3Y Other specified perforation of oesophagus –– DA20.3Z Perforation of oesophagus, unspecified DA21 Motility disorders of oesophagus – DA21.0 Achalasia – DA21.1 Motility disorder of cervical or upper oesophagus – DA21.2 Disorder of oesophageal peristalsis – DA21.3 Disorder of lower oesophageal sphincter function – DA21.Y Other specified motility disorders of oesophagus – DA21.Z Motility disorders of oesophagus, unspecified –– DA21.20 Hypertensive peristalsis –– DA21.21 Hypotensive peristalsis –– DA21.22 Spastic peristalsis –– DA21.2Y Other specified disorder of oesophageal peristalsis –– DA21.2Z Disorder of oesophageal peristalsis, unspecified DA22 Gastro-oesophageal reflux disease – DA22.0 Non-erosive gastro-oesophageal reflux disease – DA22.1 Erosive gastro-oesophageal reflux disease – DA22.Z Gastro-oesophageal reflux disease, unspecified DA23 Columnar metaplastic epithelium of the oesophagus – DA23.0 Barrett epithelium – DA23.1 Dysplasia of Barrett epithelium – DA23.2 Barrett ulcer – DA23.Y Other specified columnar metaplastic epithelium of the oesophagus – DA23.Z Columnar metaplastic epithelium of the oesophagus, unspecified DA24 Oesophagitis – DA24.0 Infectious oesophagitis – DA24.1 Eosinophilic oesophagitis – DA24.2 Oesophagitis due to external causes – DA24.Y Other specified oesophagitis – DA24.Z Oesophagitis, unspecified –– DA24.00 Oesophageal phlegmon –– DA24.0Y Other specified infectious oesophagitis –– DA24.0Z Infectious oesophagitis, unspecified –– DA24.20 Chemical oesophagitis –– DA24.21 Drug-induced oesophagitis –– DA24.22 Radiation oesophagitis –– DA24.2Z Oesophagitis due to external causes, unspecified DA25 Oesophageal ulcer – DA25.0 Oesophageal erosion – DA25.1 Infectious oesophageal ulcer – DA25.2 Oesophageal ulcer due to allergic or immunologic disorder – DA25.3 Oesophageal ulcer due to external causes – DA25.Y Other specified oesophageal ulcer – DA25.Z Oesophageal ulcer, unspecified –– DA25.10 Bacterial oesophageal ulcer –– DA25.11 Fungal oesophageal ulcer –– DA25.12 Parasitic oesophageal ulcer –– DA25.13 Viral oesophageal ulcer –– DA25.1Y Other specified infectious oesophageal ulcer –– DA25.1Z Infectious oesophageal ulcer, unspecified –– DA25.30 Chemical oesophageal ulcer –– DA25.31 Drug-induced oesophageal ulcer –– DA25.32 Radiation oesophageal ulcer –– DA25.3Y Oesophageal ulcer due to other specified external causes –– DA25.3Z Oesophageal ulcer due to external causes, unspecified DA26 Vascular disorders of the oesophagus – DA26.0 Oesophageal varices – DA26.1 Angiodysplasia or arteriovenous malformation of oesophagus – DA26.2 Intramural haemorrhage of oesophagus – DA26.3 Gastro-oesophageal laceration-haemorrhage syndrome – DA26.Y Other specified vascular disorders of the oesophagus – DA26.Z Vascular disorders of the oesophagus, unspecified –– DA26.00 Oesophageal varices with bleeding –– DA26.01 Oesophageal varices without bleeding –– DA26.0Z Oesophageal varices, unspecified DA2Y Other specified diseases of oesophagus DA2Z Diseases of oesophagus, unspecified – DA40 Acquired anatomical alterations of the stomach –– DA40.0 Gastric outlet obstruction –– DA40.1 Gastric fistula, acquired –– DA40.2 Gastric volvulus –– DA40.3 Gastric diverticulum –– DA40.4 Hourglass stricture and stenosis of stomach –– DA40.5 Gastroptosis –– DA40.Y Other specified acquired anatomical alterations of the stomach –– DA40.Z Acquired anatomical alterations of the stomach, unspecified – DA41 Gastroduodenal motor or secretory disorders –– DA41.0 Abnormal gastric motility –– DA41.1 Acute dilatation of stomach –– DA41.2 Acid hypersecretion –– DA41.3 Achlorhydria –– DA41.Y Other specified gastroduodenal motor or secretory disorders –– DA41.Z Gastroduodenal motor or secretory disorders, unspecified ––– DA41.00 Gastroparesis ––– DA41.0Y Other specified abnormal gastric motility ––– DA41.0Z Abnormal gastric motility, unspecified – DA42 Gastritis –– DA42.0 Autoimmune gastritis –– DA42.1 Helicobacter pylori induced gastritis –– DA42.2 Eosinophilic gastritis –– DA42.3 Lymphocytic gastritis –– DA42.4 Allergic gastritis –– DA42.5 Gastritis due to duodenogastric reflux –– DA42.6 Menetrier disease –– DA42.7 Gastritis of unknown aetiology with specific endoscopic or pathological features –– DA42.8 Gastritis due to external causes –– DA42.9 Gastric phlegmon –– DA42.Y Other specified gastritis –– DA42.Z Gastritis, unspecified ––– DA42.40 Allergic gastritis due to IgE-mediated hypersensitivity ––– DA42.41 Allergic gastritis due to non-IgE-mediated hypersensitivity ––– DA42.4Y Other specified allergic gastritis ––– DA42.4Z Allergic gastritis, unspecified ––– DA42.70 Acute superficial gastritis of unknown aetiology ––– DA42.71 Chronic superficial gastritis of unknown aetiology ––– DA42.72 Acute haemorrhagic gastritis of unknown aetiology ––– DA42.73 Chronic atrophic gastritis of unknown aetiology ––– DA42.74 Metaplastic gastritis of unknown aetiology ––– DA42.75 Granulomatous gastritis of unknown aetiology ––– DA42.76 Hypertrophic gastritis of unknown aetiology ––– DA42.7Y Other specified gastritis of unknown aetiology with specific endoscopic or pathological features ––– DA42.80 Alcoholic gastritis ––– DA42.81 Radiation gastritis ––– DA42.82 Chemical gastritis ––– DA42.83 Drug-induced gastritis ––– DA42.8Z Gastritis due to external causes, unspecified – DA43 Vascular disorders of the stomach –– DA43.0 Gastric varices –– DA43.1 Angiodysplasia of stomach –– DA43.2 Arteriovenous malformation of stomach –– DA43.3 Portal hypertensive gastropathy –– DA43.4 Diffuse vascular ectasia of stomach –– DA43.Y Other specified vascular disorders of the stomach –– DA43.Z Vascular disorders of the stomach, unspecified – DA44 Gastric polyp –– DA44.0 Hyperplastic polyp of stomach –– DA44.1 Fundic gland polyp of stomach –– DA44.2 Hamartomatous polyp of stomach –– DA44.Y Other specified gastric polyp –– DA44.Z Gastric polyp, unspecified – DA4Y Other specified diseases of stomach – DA4Z Diseases of stomach, unspecified – DA50 Acquired anatomical alterations of the duodenum –– DA50.0 Obstruction of duodenum –– DA50.1 Diverticulum of duodenum –– DA50.2 Fistula of duodenum –– DA50.3 Deformity of duodenum, acquired –– DA50.Y Other specified acquired anatomical alterations of the duodenum –– DA50.Z Acquired anatomical alterations of the duodenum, unspecified – DA51 Duodenitis –– DA51.0 Helicobacter-pylori associated duodenitis –– DA51.1 Eosinophilic duodenitis –– DA51.2 Lymphocytic duodenitis –– DA51.3 Allergic duodenitis –– DA51.4 Duodenitis of unknown aetiology with specific endoscopic or pathologic features –– DA51.5 Duodenitis due to external causes –– DA51.6 Infectious duodenitis –– DA51.Y Other specified duodenitis –– DA51.Z Duodenitis, unspecified ––– DA51.40 Acute haemorrhagic duodenitis of unknown aetiology ––– DA51.41 Granulomatous duodenitis of unknown aetiology ––– DA51.4Z Duodenitis of unknown aetiology with specific endoscopic or pathologic features, unspecified ––– DA51.50 Alcoholic duodenitis ––– DA51.51 Drug-induced duodenitis ––– DA51.52 Chemical duodenitis ––– DA51.53 Radiation duodenitis ––– DA51.5Y Duodenitis due to other specified external causes ––– DA51.5Z Duodenitis due to external causes, unspecified ––– DA51.60 Duodenal phlegmon ––– DA51.6Y Other specified infectious duodenitis ––– DA51.6Z Infectious duodenitis, unspecified – DA52 Vascular disorders of the duodenum –– DA52.0 Duodenal varices –– DA52.1 Angiodysplasia of duodenum –– DA52.2 Arteriovenous malformation of duodenum –– DA52.Y Other specified vascular disorders of the duodenum –– DA52.Z Vascular disorders of the duodenum, unspecified – DA53 Duodenal polyp –– DA53.0 Hyperplastic duodenal polyp –– DA53.Y Other specified duodenal polyp –– DA53.Z Duodenal polyp, unspecified – DA5Y Other specified diseases of duodenum – DA5Z Diseases of duodenum, unspecified – DA60 Gastric ulcer –– DA60.0 Gastric erosion –– DA60.1 Helicobacter pylori associated gastric ulcer –– DA60.2 Helicobacter pylori associated and drug-induced gastric ulcer –– DA60.3 Stress ulcer of stomach –– DA60.4 Eosinophilic gastric ulcer –– DA60.5 Lymphocytic gastric ulcer –– DA60.6 Gastric ulcer due to external causes –– DA60.7 Infectious secondary gastric ulcer –– DA60.Y Other specified gastric ulcer –– DA60.Z Gastric ulcer, unspecified ––– DA60.60 Alcohol-induced gastric ulcer ––– DA60.61 Chemical gastric ulcer ––– DA60.62 Drug-induced gastric ulcer ––– DA60.63 Radiation gastric ulcer ––– DA60.6Y Other specified gastric ulcer due to external causes ––– DA60.6Z Gastric ulcer due to external causes, unspecified – DA61 Peptic ulcer, site unspecified – DA62 Anastomotic ulcer –– DA62.0 Anastomotic erosion –– DA62.1 Helicobacter pylori associated anastomotic ulcer –– DA62.2 Drug-induced anastomotic ulcer –– DA62.3 Peptic anastomotic ulcer –– DA62.Y Other specified anastomotic ulcer –– DA62.Z Anastomotic ulcer, unspecified – DA63 Duodenal ulcer –– DA63.0 Duodenal erosion –– DA63.1 Helicobacter-pylori associated duodenal ulcer –– DA63.2 Helicobacter-pylori associated and drug-induced duodenal ulcer –– DA63.3 Stress ulcer of duodenum –– DA63.4 Eosinophilic duodenal ulcer –– DA63.5 Duodenal ulcer due to external causes –– DA63.6 Infectious duodenal ulcer –– DA63.Y Other specified duodenal ulcer –– DA63.Z Duodenal ulcer, unspecified ––– DA63.50 Drug-induced duodenal ulcer ––– DA63.51 Radiation duodenal ulcer ––– DA63.52 Chemical duodenal ulcer ––– DA63.5Y Duodenal ulcer due to other specified external causes ––– DA63.5Z Duodenal ulcer due to external causes, unspecified ––– DA63.60 Bacterial duodenal ulcer ––– DA63.61 Viral duodenal ulcer ––– DA63.62 Fungal duodenal ulcer ––– DA63.6Z Infectious duodenal ulcer, unspecified DA7Z Diseases of the stomach or the duodenum, unspecified DA90 Nonstructural developmental anomalies of small intestine – DA90.0 Syndromic diarrhoea – DA90.1 Congenital intestinal transport defect – DA90.2 Congenital intestinal motility disorders – DA90.Y Other specified nonstructural developmental anomalies of small intestine – DA90.Z Nonstructural developmental anomalies of small intestine, unspecified DA91 Obstruction of small intestine – DA91.0 Intussusception of small intestine – DA91.1 Volvulus of small intestine – DA91.2 Intestinal adhesions or bands of small intestine with obstruction – DA91.3 Obstructive ileus of small intestine due to impaction – DA91.Y Other specified obstruction of small intestine – DA91.Z Obstruction of small intestine, unspecified –– DA91.30 Gallstone ileus of small intestine –– DA91.31 Enterolith of small intestine –– DA91.3Y Other specified obstructive ileus of small intestine due to impaction –– DA91.3Z Obstructive ileus of small intestine due to impaction, unspecified DA92 Other acquired anatomical alterations of small intestine – DA92.0 Fistula of small intestine – DA92.1 Pneumatosis intestinalis of small intestine – DA92.Y Other specified other acquired anatomical alterations of small intestine – DA92.Z Other acquired anatomical alterations of small intestine, unspecified DA93 Motility disorders of small intestine – DA93.0 Paralytic ileus – DA93.Y Other specified motility disorders of small intestine – DA93.Z Motility disorders of small intestine, unspecified DA94 Noninfectious enteritis or ulcer of small intestine – DA94.0 Primary ulcer of small intestine – DA94.1 Drug-induced or toxic enteritis of small intestine – DA94.2 Allergic or dietetic enteritis of small intestine – DA94.3 Enteritis or ulcer of small intestine due to other external causes – DA94.Y Other specified noninfectious enteritis or ulcer of small intestine – DA94.Z Noninfectious enteritis or ulcer of small intestine, unspecified –– DA94.00 Primary nonspecific ulceration of small intestine –– DA94.01 Chronic non-specific multiple ulcers of small intestine –– DA94.02 Cryptogenic multifocal ulcerous stenosing enteritis –– DA94.0Y Other specified primary ulcer of small intestine –– DA94.0Z Primary ulcer of small intestine, unspecified –– DA94.20 IgE mediated allergic enteritis of small intestine –– DA94.21 Eosinophilic enteritis –– DA94.22 Food protein-induced enterocolitis syndrome –– DA94.2Y Other specified allergic or dietetic enteritis of small intestine –– DA94.2Z Allergic or dietetic enteritis of small intestine, unspecified –– DA94.30 Enteritis or ulcer of small intestine due to foreign body –– DA94.31 Enteritis or ulcer of small intestine due to radiation –– DA94.32 Enteritis or ulcer of small intestine due to trauma –– DA94.3Z Enteritis or ulcer of small intestine due to other external causes, unspecified DA95 Coeliac disease DA96 Intestinal malabsorption or protein-losing enteropathy – DA96.0 Intestinal malabsorption – DA96.1 Protein-losing enteropathy – DA96.Y Other specified intestinal malabsorption or protein-losing enteropathy – DA96.Z Intestinal malabsorption or protein-losing enteropathy, unspecified –– DA96.00 Bacterial overgrowth syndrome –– DA96.01 Tropical sprue –– DA96.02 Malabsorption or intolerance of specific nutrients –– DA96.04 Short bowel syndrome –– DA96.05 Intestinal failure –– DA96.0Y Other specified intestinal malabsorption –– DA96.0Z Intestinal malabsorption, unspecified DA97 Certain vascular disorders of small intestine – DA97.0 Angiodysplasia of small intestine – DA97.1 Arteriovenous malformation of small intestine – DA97.2 Vasculitis of mesenteric arteries – DA97.3 Varices of small intestine – DA97.Z Certain vascular disorders of small intestine, unspecified DA98 Polyps of small intestine – DA98.0 Hamartoma of small intestine – DA98.1 Hyperplastic polyp of small intestine – DA98.2 Inflammatory fibroid polyp of small intestine – DA98.3 Lymphoid hyperplasia of small intestine – DA98.Y Other specified polyps of small intestine – DA98.Z Polyps of small intestine, unspecified DA9Y Other specified diseases of small intestine DA9Z Diseases of small intestine, unspecified DB10 Appendicitis – DB10.0 Acute appendicitis – DB10.1 Chronic appendicitis – DB10.Y Other specified appendicitis – DB10.Z Appendicitis, unspecified –– DB10.00 Acute appendicitis with generalised peritonitis –– DB10.01 Acute appendicitis with localised peritonitis –– DB10.02 Acute appendicitis without localised or generalised peritonitis DB11 Certain specified diseases of appendix – DB11.0 Megaloappendix – DB11.1 Hyperplasia of appendix – DB11.2 Appendicular concretions – DB11.3 Diverticulum of appendix, acquired – DB11.4 Fistula of appendix – DB11.5 Intussusception of appendix – DB11.6 Mucocele of appendix DB1Y Other specified diseases of appendix DB1Z Diseases of appendix, unspecified DB30 Obstruction of large intestine – DB30.0 Intussusception of the large intestine – DB30.1 Volvulus of large intestine – DB30.2 Adhesions of large intestine with obstruction – DB30.3 Impaction of large intestine – DB30.4 Stenosis of the rectum – DB30.Y Other specified obstruction of large intestine – DB30.Z Obstruction of large intestine, unspecified DB31 Other acquired anatomical alterations of large intestine – DB31.0 Fistula of large intestine – DB31.1 Pneumatosis intestinalis of large intestine – DB31.2 Rectal prolapse – DB31.Y Other specified other acquired anatomical alterations of large intestine – DB31.Z Other acquired anatomical alterations of large intestine, unspecified DB32 Motility disorders of large intestine – DB32.0 Pseudo-obstruction of colon – DB32.1 Slow transit constipation – DB32.2 Megacolon – DB32.3 Acquired hypoganglionosis of large intestine – DB32.Y Other specified motility disorders of large intestine – DB32.Z Motility disorders of large intestine, unspecified –– DB32.20 Toxic megacolon –– DB32.2Y Other specified megacolon –– DB32.2Z Megacolon, unspecified DB33 Certain noninfectious colitis or proctitis – DB33.0 Primary ulcer of colon – DB33.1 Microscopic colitis – DB33.2 Allergic or dietetic colitis – DB33.3 Diversion colitis – DB33.4 Colitis or proctitis due to external causes – DB33.Y Other specified noninfectious colitis or proctitis – DB33.Z Certain noninfectious colitis or proctitis, unspecified –– DB33.10 Collagenous colitis –– DB33.11 Lymphocytic colitis –– DB33.1Y Other specified microscopic colitis –– DB33.1Z Microscopic colitis, unspecified –– DB33.20 Food protein-induced proctitis or colitis of infants –– DB33.2Y Other specified allergic or dietetic colitis –– DB33.2Z Allergic or dietetic colitis, unspecified –– DB33.40 Chemical colitis or proctitis –– DB33.41 Radiation-induced colitis –– DB33.42 Radiation proctitis –– DB33.43 Drug-induced colitis –– DB33.4Y Other specified colitis or proctitis due to external causes –– DB33.4Z Colitis or proctitis due to external causes, unspecified DB34 Certain vascular disorders of large intestine – DB34.0 Angiodysplasia of colon – DB34.1 Arteriovenous malformation of large intestine – DB34.2 Vasculitis of large intestine – DB34.3 Varices of large intestine – DB34.4 Acute haemorrhagic rectal ulcer – DB34.Y Other specified vascular disorders of large intestine – DB34.Z Vascular disorders of large intestine, unspecified DB35 Polyp of large intestine – DB35.0 Hyperplastic polyp of large intestine – DB35.1 Inflammatory polyp of large intestine – DB35.2 Benign lymphoid polyp of large intestine – DB35.3 Hamartomatous polyp – DB35.4 Inflammatory fibroid polyp of large intestine – DB35.Y Other specified polyp of large intestine – DB35.Z Polyp of large intestine, unspecified DB36 Certain infections of the large intestine – DB36.0 Colonic abscess – DB36.1 Rectal abscess – DB36.Y Other specified infections of the large intestine – DB36.Z Certain infections of the large intestine, unspecified –– DB36.10 Perirectal abscess –– DB36.11 Ischiorectal abscess –– DB36.12 Rectal cellulitis DB3Y Other specified diseases of large intestine DB3Z Diseases of large intestine, unspecified – DB50 Fissure or fistula of anal regions –– DB50.0 Anal fissure –– DB50.1 Anal fistula –– DB50.2 Anorectal fistula –– DB50.Y Other specified fissure or fistula of anal regions –– DB50.Z Fissure or fistula of anal regions, unspecified – DB51 Stenosis of anal canal – DB52 Ulcer of anus – DB53 Anal prolapse – DB5Y Other specified acquired anatomical alterations of the anal canal – DB5Z Acquired anatomical alterations of the anal canal, unspecified – DB60 Haemorrhoids –– DB60.0 First degree haemorrhoids –– DB60.1 Second degree haemorrhoids –– DB60.2 Third degree haemorrhoids –– DB60.3 Fourth degree haemorrhoids –– DB60.Z Haemorrhoids, unspecified – DB61 Perianal venous thrombosis – DB62 Residual haemorrhoidal skin tags – DB6Y Other specified haemorrhoids or perianal venous conditions – DB6Z Haemorrhoids or perianal venous conditions, unspecified DB70 Infections of the anal region – DB70.0 Abscess of anal regions – DB70.Y Other specified infections of the anal region – DB70.Z Infections of the anal region, unspecified –– DB70.00 Anal abscess –– DB70.01 Anorectal abscess –– DB70.02 Intrasphincteric abscess –– DB70.0Y Other specified abscess of anal regions –– DB70.0Z Abscess of anal regions, unspecified DB71 Anal polyp – DB71.0 Inflammatory anal polyp – DB71.1 Lymphoid polyp – DB71.2 Hypertrophied anal papillae – DB71.Y Other specified anal polyp – DB71.Z Anal polyp, unspecified DB72 Certain specified diseases of anal canal – DB72.0 Anal spasm – DB72.Z Certain specified diseases of anal canal, unspecified DB7Y Other specified diseases of anal canal DB7Z Diseases of anal canal, unspecified DB90 Infectious liver disease – DB90.0 Abscess of liver – DB90.Y Other specified infectious liver disease – DB90.Z Infectious liver disease, unspecified DB91 Acute or subacute hepatic failure – DB91.0 Acute or subacute hepatic failure due to hepatitis virus – DB91.1 Other acute or subacute hepatic failure – DB91.Z Acute or subacute hepatic failure, unspecified DB92 Non-alcoholic fatty liver disease – DB92.0 Non-alcoholic fatty liver disease without non-alcoholic steatohepatitis – DB92.1 Non-alcoholic steatohepatitis – DB92.Y Other specified non-alcoholic fatty liver disease – DB92.Z Non-alcoholic fatty liver disease, unspecified DB93 Hepatic fibrosis or cirrhosis – DB93.0 Hepatic fibrosis – DB93.1 Hepatic cirrhosis – DB93.2 Certain specified fibrosis or cirrhosis of liver – DB93.Y Other specified hepatic fibrosis or cirrhosis –– DB93.20 Hereditary North American Indian childhood cirrhosis –– DB93.21 Idiopathic copper-associated cirrhosis DB94 Alcoholic liver disease – DB94.0 Alcoholic fatty liver – DB94.1 Alcoholic hepatitis – DB94.2 Alcoholic liver fibrosis – DB94.3 Alcoholic cirrhosis of liver without hepatitis – DB94.Y Other specified alcoholic liver disease – DB94.Z Alcoholic liver disease, unspecified –– DB94.10 Alcoholic hepatitis with cirrhosis –– DB94.1Y Other specified alcoholic hepatitis –– DB94.1Z Alcoholic hepatitis, unspecified DB95 Drug-induced or toxic liver disease – DB95.0 Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis – DB95.1 Drug-induced or toxic liver disease with chronic hepatitis – DB95.2 Drug-induced or toxic liver disease with cholestasis – DB95.3 Drug-induced or toxic liver disease with fatty liver – DB95.4 Drug-induced or toxic liver disease with granulomatous hepatitis – DB95.5 Drug-induced or toxic liver disease with fibrosis or cirrhosis of liver – DB95.6 Drug-induced or toxic liver disease with vascular disorders of the liver – DB95.7 Drug-induced or toxic liver disease with liver tumours – DB95.Y Other specified drug-induced or toxic liver disease – DB95.Z Drug-induced or toxic liver disease, unspecified –– DB95.10 Drug-induced or toxic liver disease with chronic hepatitis with cirrhosis –– DB95.11 Drug-induced or toxic liver disease with chronic hepatitis without cirrhosis –– DB95.1Y Other specified drug-induced or toxic liver disease with chronic hepatitis –– DB95.1Z Drug-induced or toxic liver disease with chronic hepatitis, unspecified –– DB95.20 Chronic drug-induced or toxic liver disease with cholestasis –– DB95.2Y Other specified drug-induced or toxic liver disease with cholestasis –– DB95.2Z Drug-induced or toxic liver disease with cholestasis, unspecified –– DB95.30 Drug-induced or toxic liver disease with chronic fatty liver disease –– DB95.3Y Other specified drug-induced or toxic liver disease with fatty liver –– DB95.3Z Drug-induced or toxic liver disease with fatty liver, unspecified DB96 Autoimmune liver disease – DB96.0 Autoimmune hepatitis – DB96.1 Primary biliary cholangitis – DB96.2 Primary sclerosing cholangitis – DB96.Y Other specified autoimmune liver disease – DB96.Z Autoimmune liver disease, unspecified –– DB96.10 Primary biliary cholangitis with overlap syndrome –– DB96.1Y Other specified primary biliary cholangitis –– DB96.1Z Primary biliary cholangitis, unspecified –– DB96.20 Primary sclerosing cholangitis with cirrhosis –– DB96.2Y Other specified primary sclerosing cholangitis –– DB96.2Z Primary sclerosing cholangitis, unspecified DB97 Certain specified inflammatory liver diseases – DB97.0 Idiopathic granulomatous hepatitis – DB97.1 Hepatic berylliosis – DB97.2 Chronic hepatitis, not elsewhere classified – DB97.Y Other specified inflammatory liver disease – DB97.Z Inflammatory liver disease, unspecified DB98 Vascular disorders of the liver – DB98.0 Infarction of liver – DB98.1 Peliosis hepatis – DB98.2 Nodular regenerative hyperplasia of liver – DB98.3 Portal vein thrombosis – DB98.4 Splenic vein thrombosis – DB98.5 Budd-Chiari syndrome – DB98.6 Hepatic veno-occlusive disease – DB98.7 Portal hypertension – DB98.8 Passive congestion of liver – DB98.9 Hepatic artery aneurysm – DB98.A Hepatic haemorrhage – DB98.B Ischaemia reperfusion injury of liver – DB98.Y Other specified vascular disorders of the liver – DB98.Z Vascular disorders of the liver, unspecified –– DB98.70 Idiopathic portal hypertension –– DB98.71 Non-cirrhotic portal fibrosis –– DB98.72 Partial nodular transformation of liver –– DB98.73 Splanchnic arteriovenous fistula –– DB98.74 Secondary portal hypertension –– DB98.7Y Other specified portal hypertension –– DB98.7Z Portal hypertension, unspecified DB99 Certain specified diseases of liver – DB99.0 Chronic liver disease – DB99.1 Hepatic cyst – DB99.2 Hepatorenal syndrome – DB99.3 Portopulmonary hypertension – DB99.4 Hepatopulmonary syndrome – DB99.5 Hepatic encephalopathy – DB99.6 Intrahepatic cholestasis, not elsewhere classified – DB99.7 Hepatic failure without mention whether acute or chronic – DB99.8 Chronic hepatic failure – DB99.Y Other diseases of liver –– DB99.10 Polycystic liver disease –– DB99.1Y Other specified hepatic cyst –– DB99.1Z Hepatic cyst, unspecified –– DB99.60 Cholestasis of parenteral nutrition –– DB99.6Y Other specified intrahepatic cholestasis, not elsewhere classified –– DB99.6Z Intrahepatic cholestasis, not elsewhere classified, unspecified DB9Z Diseases of liver, unspecified DC10 Acquired anatomical alterations of gallbladder or bile ducts – DC10.0 Obstruction of gallbladder or bile ducts – DC10.1 Hydrops of gallbladder – DC10.2 Fistula of gallbladder or bile duct – DC10.3 Polyp of gallbladder – DC10.4 Cholesterolosis of gallbladder – DC10.Y Other specified acquired anatomical alterations of gallbladder or bile ducts – DC10.Z Acquired anatomical alterations of gallbladder or bile ducts, unspecified –– DC10.00 Obstruction of cystic duct –– DC10.01 Obstruction of gall bladder –– DC10.02 Obstruction of bile duct –– DC10.0Y Other specified obstruction of gallbladder or bile ducts –– DC10.0Z Obstruction of gallbladder or bile ducts, unspecified DC11 Cholelithiasis – DC11.0 Calculus of gallbladder or cystic duct with acute cholecystitis – DC11.1 Calculus of gallbladder or cystic duct with other cholecystitis – DC11.2 Calculus of gallbladder or cystic duct with cholangitis – DC11.3 Calculus of gallbladder or cystic duct without cholecystitis or cholangitis – DC11.4 Calculus of bile duct with cholangitis – DC11.5 Calculus of bile duct with cholecystitis – DC11.6 Calculus of bile duct without cholangitis or cholecystitis – DC11.7 Intrahepatic cholelithiasis – DC11.Y Other specified cholelithiasis – DC11.Z Cholelithiasis, unspecified DC12 Cholecystitis – DC12.0 Acute cholecystitis – DC12.1 Chronic cholecystitis – DC12.Y Other specified cholecystitis – DC12.Z Cholecystitis, unspecified –– DC12.00 Acute on chronic cholecystitis –– DC12.0Y Other specified acute cholecystitis –– DC12.0Z Acute cholecystitis, unspecified DC13 Cholangitis DC14 Certain specified biliary diseases – DC14.0 Haemorrhage of bile duct – DC14.1 Postcholecystectomy syndrome – DC14.2 Dyskinesia of sphincter of Oddi – DC14.3 Adenomyomatosis of gallbladder – DC14.Y Other biliary diseases – DC14.Z Biliary disease, unspecified DC1Y Other specified diseases of gallbladder or biliary tract DC1Z Diseases of gallbladder or biliary tract, unspecified DC30 Cystic diseases of the pancreas – DC30.0 Cyst of pancreas – DC30.1 Pseudocyst of pancreas – DC30.Y Other specified cystic diseases of the pancreas – DC30.Z Cystic diseases of the pancreas, unspecified DC31 Acute pancreatitis – DC31.0 Acute idiopathic pancreatitis – DC31.1 Acute alcohol-induced pancreatitis – DC31.2 Acute biliary pancreatitis – DC31.3 Acute drug-induced pancreatitis – DC31.4 Hereditary acute pancreatitis – DC31.5 Acute exacerbation of chronic pancreatitis – DC31.Y Other specified acute pancreatitis – DC31.Z Acute pancreatitis, unspecified DC32 Chronic pancreatitis – DC32.0 Calcific pancreatitis – DC32.1 Groove pancreatitis – DC32.2 Hereditary chronic pancreatitis – DC32.3 Chronic alcohol-induced pancreatitis – DC32.4 Chronic idiopathic pancreatitis – DC32.5 Tropical pancreatitis – DC32.Y Other specified chronic pancreatitis – DC32.Z Chronic pancreatitis, unspecified DC33 Autoimmune pancreatitis DC34 Obstructive pancreatitis DC35 Certain specified diseases of pancreas – DC35.0 Atrophy of pancreas – DC35.1 Secondary pancreatic insufficiency – DC35.2 Pancreatic steatorrhoea – DC35.Z Certain specified diseases of pancreas, unspecified DC3Y Other specified diseases of pancreas DC3Z Diseases of pancreas, unspecified DC50 Peritonitis – DC50.0 Primary peritonitis – DC50.1 Secondary peritonitis – DC50.2 Peritoneal abscess – DC50.Z Peritonitis, unspecified –– DC50.00 Spontaneous bacterial peritonitis –– DC50.01 Other specified primary peritonitis –– DC50.10 Eosinophilic peritonitis –– DC50.11 Mesenteric peritonitis –– DC50.12 Chronic proliferative peritonitis –– DC50.13 Peritonitis due to Streptococcus pneumoniae –– DC50.1Y Other specified secondary peritonitis –– DC50.1Z Secondary peritonitis, unspecified DC51 Certain specified disorders of peritoneum or retroperitoneum – DC51.0 Chylous ascites – DC51.1 Peritoneal adhesions – DC51.2 Haemoperitoneum – DC51.Y Other specified disorders of peritoneum or retroperitoneum DC5Z Diseases of peritoneum, unspecified – DC70 Diverticulitis of small intestine –– DC70.0 Diverticulitis of small intestine with complication –– DC70.1 Diverticulitis of small intestine without complication –– DC70.Z Diverticulitis of small intestine without specification of presence of complications ––– DC70.00 Diverticulitis of small intestine with perforation or abscess ––– DC70.0Y Diverticulitis of small intestine with other specified complication ––– DC70.0Z Diverticulitis of small intestine with unspecified complication – DC71 Diverticulosis of small intestine –– DC71.0 Diverticulosis of small intestine with haemorrhage –– DC71.1 Diverticulosis of small intestine without haemorrhage –– DC71.Z Diverticulosis of small intestine, unspecified – DC72 Diverticulum of small intestine –– DC72.0 Diverticulum of small intestine with haemorrhage –– DC72.1 Diverticulum of small intestine without haemorrhage –– DC72.Z Diverticulum of small intestine, no specification about presence or absence of haemorrhage – DC80 Diverticulitis of large intestine –– DC80.0 Diverticulitis of large intestine with complication –– DC80.1 Diverticulitis of large intestine without complication –– DC80.Z Diverticulitis of large intestine without specification of presence of complications ––– DC80.00 Diverticulitis of large intestine with perforation or abscess ––– DC80.0Z Diverticulitis of large intestine with complication, unspecified – DC81 Diverticulosis of large intestine –– DC81.0 Diverticulosis of large intestine with haemorrhage –– DC81.1 Diverticulosis of large intestine without haemorrhage –– DC81.Z Diverticulosis of large intestine, unspecified – DC82 Diverticulum of large intestine –– DC82.0 Diverticulum of large intestine with haemorrhage –– DC82.1 Diverticulum of large intestine without haemorrhage –– DC82.Z Diverticulum of large intestine, unspecified – DC90 Diverticular disease of small and large intestine – DD00 Diverticulitis of unspecified part of intestine –– DD00.0 Diverticulitis of unspecified part of intestine with complication –– DD00.1 Diverticulitis of unspecified part of intestine without complication –– DD00.Z Diverticulitis of unspecified part of intestine without specification of presence or absence of complications ––– DD00.00 Diverticulitis of unspecified part of intestine with perforation or abscess ––– DD00.0Y Other specified diverticulitis of unspecified part of intestine with complication ––– DD00.0Z Diverticulitis of unspecified part of intestine with complication, unspecified – DD01 Diverticulosis of unspecified part of intestine –– DD01.0 Diverticulosis of unspecified part of intestine with haemorrhage –– DD01.1 Diverticulosis of unspecified part of intestine without haemorrhage –– DD01.Z Diverticulosis of unspecified part of intestine, unspecified – DD02 Diverticulum of unspecified part of intestine –– DD02.0 Diverticular disease of unspecified part of intestine with haemorrhage –– DD02.1 Diverticulum of unspecified part of intestine without complication –– DD02.Z Diverticulum of unspecified part of intestine, unspecified DD1Z Diverticular disease of intestine, unspecified DD30 Acute vascular disorders of intestine – DD30.0 Acute mesenteric arterial infarction – DD30.1 Acute mesenteric arterial ischaemia – DD30.2 Acute mesenteric venous occlusion – DD30.Y Other specified acute vascular disorders of intestine – DD30.Z Acute vascular disorders of intestine, unspecified DD31 Chronic vascular disorders of intestine – DD31.0 Non-occlusive mesenteric ischaemia – DD31.Y Other specified chronic vascular disorders of intestine – DD31.Z Chronic vascular disorders of intestine, unspecified –– DD31.00 Ischaemic colitis –– DD31.0Y Other specified non-occlusive mesenteric ischaemia –– DD31.0Z Non-occlusive mesenteric ischaemia, unspecified DD3Y Other specified ischaemic vascular disorders of intestine DD3Z Ischaemic vascular disorders of intestine, unspecified DD50 Non-abdominal wall hernia – DD50.0 Diaphragmatic hernia – DD50.1 Pelvic hernia – DD50.2 Intra-abdominal hernia – DD50.Y Other specified non-abdominal wall hernia – DD50.Z Non-abdominal wall hernia, unspecified –– DD50.20 Primary intra-abdominal hernia –– DD50.21 Secondary intra-abdominal hernia –– DD50.2Y Other specified intra-abdominal hernia –– DD50.2Z Intra-abdominal hernia, unspecified DD51 Inguinal hernia DD52 Femoral hernia DD53 Umbilical hernia DD54 Paraumbilical hernia DD55 Epigastric hernia DD56 Incisional hernia DD57 Parastomal hernia DD5Y Other specified hernias DD5Z Hernias, unspecified DD70 Crohn disease – DD70.0 Crohn disease of upper gastrointestinal tract – DD70.1 Crohn disease of small intestine – DD70.2 Crohn disease of appendix – DD70.3 Crohn disease of large intestine – DD70.4 Crohn disease of anal region – DD70.5 Crohn disease of both small and large intestine – DD70.6 Crohn disease of anastomotic sites – DD70.Y Crohn disease of other specified site – DD70.Z Crohn disease, unspecified site DD71 Ulcerative colitis – DD71.0 Ulcerative pancolitis – DD71.1 Left sided ulcerative colitis – DD71.2 Ulcerative rectosigmoiditis – DD71.3 Ulcerative proctitis – DD71.Y Other specified ulcerative colitis – DD71.Z Ulcerative colitis, unspecified DD72 Indeterminate colitis DD7Y Other specified inflammatory bowel diseases DD7Z Inflammatory bowel diseases, unspecified DD90 Functional oesophageal or gastroduodenal disorders – DD90.0 Globus – DD90.1 Functional swallowing disorder – DD90.2 Functional heartburn – DD90.3 Functional dyspepsia – DD90.4 Functional nausea or vomiting – DD90.5 Functional belching disorders – DD90.6 Adult rumination syndrome – DD90.Y Other specified functional oesophageal or gastroduodenal disorders – DD90.Z Functional oesophageal or gastroduodenal disorders, unspecified DD91 Irritable bowel syndrome or certain specified functional bowel disorders – DD91.0 Irritable bowel syndrome – DD91.1 Functional constipation – DD91.2 Functional diarrhoea – DD91.3 Functional bloating – DD91.4 Functional abdominal pain syndrome – DD91.Y Other specified irritable bowel syndrome or functional bowel disorders – DD91.Z Irritable bowel syndrome or functional bowel disorders, unspecified –– DD91.00 Irritable bowel syndrome, constipation predominant –– DD91.01 Irritable bowel syndrome, diarrhoea predominant –– DD91.02 Irritable bowel syndrome, mixed type –– DD91.03 Irritable bowel syndrome, unsubtyped –– DD91.0Z Irritable bowel syndrome, type unspecified DD92 Functional anorectal disorders – DD92.0 Functional faecal incontinence – DD92.1 Functional anorectal pain – DD92.2 Functional defaecation disorders – DD92.Y Other specified functional anorectal disorders – DD92.Z Functional anorectal disorders, unspecified DD93 Functional digestive disorders of infants, toddlers or children – DD93.0 Infant regurgitation – DD93.1 Infantile colic – DD93.2 Infant dyschezia – DD93.Y Other functional digestive disorders of infants, neonates or toddlers – DD93.Z Functional digestive disorders of infants, toddlers or children, unspecified DD94 Functional gallbladder disorder DD95 Functional sphincter of Oddi disorder DD9Y Other specified functional gastrointestinal disorders DD9Z Functional gastrointestinal disorders, unspecified DE10 Vomiting following gastrointestinal surgery DE11 Dumping syndrome DE12 Malfunction or complication of external stoma of digestive organs – DE12.0 Colostomy or enterostomy malfunction or complication – DE12.1 Gastrostomy malfunction DE13 Postsurgical malabsorption, not elsewhere classified DE2Y Other specified diseases of the digestive system DE2Z Diseases of the digestive system, unspecified –– EA00 Viral exanthem due to unknown or unspecified agent –– EA0Y Viral exanthem due to other specified virus –– EA10 Pityriasis rosea –– EA11 Papular purpuric gloves and socks syndrome –– EA12 Infantile papular acrodermatitis –– EA20 Necrolytic acral erythema – EA3Z Unspecified skin disorder attributable to viral infection –– EA40 Tropical phagedaenic ulcer – EA50 Toxin-mediated cutaneous reactions to distant or systemic bacterial infection –– EA50.0 Erythema marginatum rheumaticum –– EA50.1 Streptococcal toxin-mediated perineal erythema –– EA50.2 Staphylococcal scalded skin syndrome –– EA50.3 Staphylococcal scarlatina –– EA50.Y Other specified toxin-mediated cutaneous reactions to distant or systemic bacterial infection –– EA50.Z Toxin-mediated cutaneous reactions to distant or systemic bacterial infection, unspecified – EA51 Skin complications of BCG immunisation – EA5Y Cutaneous involvement by other specified bacterial infection – EA5Z Cutaneous involvement by unspecified bacterial infection EA60 Certain skin disorders attributable to fungal infection – EA60.0 Subcutaneous mycoses – EA60.1 Systemic mycoses affecting skin – EA60.Y Skin involvement in other specified fungal infection – EA60.Z Fungal infection of the skin, unspecified EA6Y Cutaneous involvement by other specified infection or infestation – EA80 Atopic eczema –– EA80.0 Infantile atopic eczema –– EA80.1 Childhood atopic eczema –– EA80.2 Adult atopic eczema –– EA80.Y Other specified forms of atopic eczema –– EA80.Z Atopic eczema, unspecified – EA81 Seborrhoeic dermatitis and related conditions –– EA81.0 Seborrhoeic dermatitis of face –– EA81.1 Seborrhoeic dermatitis of the scalp –– EA81.Y Seborrhoeic dermatosis of other specified type or distribution –– EA81.Z Seborrhoeic dermatitis, unspecified – EA82 Nummular dermatitis – EA83 Lichen simplex or lichenification –– EA83.0 Lichen simplex –– EA83.1 Secondary lichenification ––– EA83.00 Lichen simplex of vulva ––– EA83.01 Lichen simplex of male genitalia ––– EA83.02 Perianal lichen simplex ––– EA83.0Y Lichen simplex of other specified site ––– EA83.0Z Lichen simplex of unspecified site – EA84 Asteatotic eczema – EA85 Dermatitis or eczema of hands and feet –– EA85.0 Vesicular dermatitis of hands and feet –– EA85.1 Hyperkeratotic dermatitis of hands and feet –– EA85.2 Dermatitis of hands –– EA85.3 Dermatitis of feet ––– EA85.20 Atopic eczema of hands ––– EA85.2Y Other specified dermatitis of hands ––– EA85.2Z Dermatitis of hands, unspecified – EA86 Dermatitis and eczema of lower legs –– EA86.0 Stasis dermatitis of the lower legs – EA87 Dermatitis or eczema of anogenital region –– EA87.0 Dermatitis or eczema of male genitalia –– EA87.1 Dermatitis or eczema of female genitalia –– EA87.2 Dermatitis or eczema of perianal area –– EA87.Z Dermatitis or eczema of anogenital region, unspecified – EA88 Miscellaneous specified eczematous dermatoses –– EA88.0 Infectious dermatitis –– EA88.1 Post traumatic eczema –– EA88.2 Disseminated secondary eczema –– EA88.3 Secondary eczema –– EA88.4 Pityriasis alba ––– EA88.00 Human T-cell lymphotropic virus type 1 associated infective dermatitis of childhood ––– EA88.0Y Other specified infectious dermatitis ––– EA88.0Z Infectious dermatitis, unspecified – EA89 Generalised eczematous dermatitis of unspecified type – EA8Y Other specified eczematous dermatosis – EA8Z Dermatitis or eczema, unspecified – EA90 Psoriasis –– EA90.0 Plaque psoriasis –– EA90.1 Guttate psoriasis –– EA90.2 Unstable psoriasis –– EA90.3 Erythrodermic psoriasis –– EA90.4 Pustular psoriasis –– EA90.5 Psoriasis of specified site or distribution –– EA90.Y Other specified forms of psoriasis –– EA90.Z Psoriasis of unspecified type ––– EA90.40 Generalised pustular psoriasis ––– EA90.41 Acropustulosis of Hallopeau ––– EA90.42 Palmoplantar pustulosis ––– EA90.4Y Other specified pustular psoriasis ––– EA90.4Z Pustular psoriasis, unspecified ––– EA90.50 Scalp psoriasis ––– EA90.51 Nail psoriasis ––– EA90.52 Flexural and intertriginous psoriasis ––– EA90.53 Anogenital psoriasis ––– EA90.5Y Psoriasis of other specified site or distribution – EA91 Lichen planus –– EA91.0 Acute eruptive lichen planus –– EA91.1 Hypertrophic lichen planus –– EA91.2 Follicular lichen planus –– EA91.3 Lichen planus of genital skin and mucous membranes –– EA91.4 Lichen planus and lichenoid reactions of oral mucosa –– EA91.5 Lichen planus of the nails –– EA91.6 Subacute lichen planus –– EA91.Y Other specified lichen planus –– EA91.Z Lichen planus of unspecified type ––– EA91.40 Non-erosive lichen planus of oral mucosa ––– EA91.41 Erosive oral lichen planus ––– EA91.42 Oral lichen planus, unspecified ––– EA91.43 Lichenoid mucositis ––– EA91.4Y Other specified lichenoid reactions of oral mucosa – EA92 Lichenoid dermatoses – EA93 Pityriasis lichenoides – EA94 Pityriasis rubra pilaris – EA95 Small plaque parapsoriasis – EB00 Spontaneous urticaria –– EB00.0 Acute urticaria –– EB00.1 Chronic urticaria –– EB00.Z Spontaneous urticaria, unspecified – EB01 Inducible urticaria and angioedema –– EB01.0 Dermographism –– EB01.1 Cold urticaria –– EB01.2 Delayed pressure urticaria –– EB01.3 Contact urticaria –– EB01.Y Other specified forms of inducible urticaria and angioedema –– EB01.Z Inducible urticaria and angioedema, unspecified – EB02 Cholinergic urticaria and related conditions –– EB02.0 Cholinergic urticaria –– EB02.Y Other conditions mediated by cholinergic activation – EB03 Syndromes with urticarial reactions or angioedema – EB04 Idiopathic angioedema – EB05 Urticaria of unspecified type – EB0Y Other specified urticarial disorders – EB10 Diffuse inflammatory erythemas – EB11 Annular erythema – EB12 Erythema multiforme –– EB12.0 Cutaneous erythema multiforme –– EB12.1 Mucocutaneous erythema multiforme –– EB12.Y Other specified erythema multiforme –– EB12.Z Erythema multiforme, unspecified – EB13 Stevens-Johnson syndrome or toxic epidermal necrolysis –– EB13.0 Stevens-Johnson syndrome –– EB13.1 Toxic epidermal necrolysis –– EB13.2 Stevens-Johnson and toxic epidermal necrolysis overlap syndrome –– EB20 Acute febrile neutrophilic dermatosis –– EB21 Pyoderma gangrenosum –– EB2Y Other specified neutrophilic dermatoses – EB30 Eosinophilic cellulitis – EB31 Erythema nodosum – EB40 Pemphigus –– EB40.0 Pemphigus vulgaris –– EB40.1 Pemphigus foliaceus –– EB40.2 Paraneoplastic pemphigus –– EB40.Y Other specified pemphigus –– EB40.Z Pemphigus, unspecified ––– EB40.00 Oral pemphigus ––– EB40.0Y Other specified pemphigus vulgaris ––– EB40.0Z Pemphigus vulgaris, unspecified – EB41 Pemphigoid –– EB41.0 Bullous pemphigoid –– EB41.1 Mucous membrane pemphigoid –– EB41.Y Other specified pemphigoid –– EB41.Z Pemphigoid, unspecified – EB42 Linear IgA bullous dermatosis – EB43 Epidermolysis bullosa acquisita – EB44 Dermatitis herpetiformis – EB4Y Other specified immunobullous disorder – EB50 Subacute cutaneous lupus erythematosus – EB51 Chronic cutaneous lupus erythematosus –– EB51.0 Discoid lupus erythematosus –– EB51.Y Other specified chronic cutaneous lupus erythematosus –– EB51.Z Chronic cutaneous lupus erythematosus, unspecified – EB5Z Cutaneous lupus erythematosus of unspecified type – EB60 Lichen sclerosus –– EB60.0 Lichen sclerosus of vulva –– EB60.1 Lichen sclerosus of penis –– EB60.Y Lichen sclerosus of other specified sites –– EB60.Z Lichen sclerosus, unspecified – EB61 Morphoea –– EB61.0 Plaque morphoea –– EB61.1 Linear morphoea –– EB61.Y Other specified forms of morphoea –– EB61.Z Morphoea, unspecified EB7Y Other specified inflammatory dermatoses EB90 Dermatoses resulting from disturbed metabolic processes – EB90.0 Diabetic skin lesions – EB90.1 Cutaneous mucinosis – EB90.2 Cutaneous and subcutaneous xanthomata – EB90.3 Porphyria or pseudoporphyria affecting the skin – EB90.4 Calcification of skin or subcutaneous tissue –– EB90.10 Pretibial myxoedema –– EB90.11 Lichen myxoedematosus –– EB90.12 Reticular erythematous mucinosis –– EB90.1Y Other specified forms of cutaneous mucinosis –– EB90.20 Plane xanthoma –– EB90.21 Tuberous xanthoma –– EB90.22 Eruptive xanthoma –– EB90.23 Tendinous xanthoma –– EB90.24 Xanthoma due to specified disorder of lipid metabolism –– EB90.2Z Cutaneous and subcutaneous xanthomata of unspecified type –– EB90.30 Pseudoporphyria –– EB90.3Y Other specified porphyria or pseudoporphyria affecting the skin –– EB90.40 Dystrophic calcification of the skin of uncertain or unspecified aetiology –– EB90.41 Calcific panniculitis –– EB90.42 Calcific arteriolopathy –– EB90.4Y Other specified calcification of skin or subcutaneous tissue EB9Y Other specified metabolic and nutritional disorders affecting the skin – EC10 Genetic syndromes with poikiloderma – EC1Y Other specified genetic syndromes affecting the skin EC20 Genetic disorders of keratinisation – EC20.0 Non-syndromic ichthyosis – EC20.1 Hereditary skin peeling – EC20.2 Hereditary acantholytic dermatoses – EC20.3 Hereditary palmoplantar keratodermas – EC20.Y Other specified genetic disorders of keratinisation –– EC20.00 Ichthyosis vulgaris –– EC20.01 X-linked ichthyosis –– EC20.02 Autosomal recessive congenital ichthyosis –– EC20.03 Keratinopathic ichthyoses –– EC20.0Y Other specified or unclassifiable non-syndromic ichthyosis –– EC20.30 Diffuse palmoplantar keratodermas –– EC20.31 Focal palmoplantar keratodermas –– EC20.32 Papular palmoplantar keratodermas –– EC20.3Z Hereditary palmoplantar keratoderma of unspecified type EC21 Genetic defects of hair or hair growth – EC21.0 Genetic defects of the hair shaft – EC21.1 Genetic syndromes with abnormalities of the hair shaft – EC21.2 Hereditary alopecia or hypotrichosis – EC21.3 Genetic syndromes with alopecia or hypotrichosis – EC21.4 Genetically-determined hypertrichosis – EC21.Y Other specified genetic defects of hair or hair growth – EC21.Z Genetic defects of hair or hair growth, unspecified EC22 Genetic defects of nails or nail growth – EC22.0 Inherited deformities of nails EC23 Genetic disorders of skin pigmentation – EC23.0 Non-syndromic genetically-determined hypermelanosis or lentiginosis – EC23.1 Syndromic genetically-determined hypermelanosis or lentiginosis – EC23.2 Albinism or other specified genetically-determined hypomelanotic disorders – EC23.Y Other specified genetic disorders of skin pigmentation – EC23.Z Genetic disorders of skin pigmentation, unspecified –– EC23.20 Oculocutaneous albinism –– EC23.2Y Other specified genetically-determined hypomelanotic disorders – EC30 Epidermolysis bullosa simplex – EC31 Junctional epidermolysis bullosa – EC32 Dystrophic epidermolysis bullosa – EC33 Syndromic epidermolysis bullosa – EC3Z Epidermolysis bullosa – EC40 Pseudoxanthoma elasticum – EC4Y Other specified genetic disorders affecting dermal matrix proteins – EC50 Developmental anomalies of the umbilicus – EC5Y Other specified developmental anomalies affecting the skin EC7Y Other specified genetic and developmental disorders affecting the skin – EC90 Pruritus –– EC90.0 Pruritus due to skin disorder –– EC90.1 Pruritus due to systemic disorder –– EC90.2 Drug-induced pruritus –– EC90.3 Pruritus due to neurological disorder –– EC90.4 Psychogenic pruritus –– EC90.5 Anogenital pruritus –– EC90.6 Pruritus of unknown cause –– EC90.Y Pruritus of other specified type or aetiology –– EC90.Z Pruritus, unspecified ––– EC90.10 Uraemic pruritus ––– EC90.11 Cholestatic pruritus ––– EC90.12 Haemodialysis-associated pruritus ––– EC90.1Y Pruritus due to other specified systemic disorder – EC91 Prurigo –– EC91.0 Nodular prurigo –– EC91.1 Atopic prurigo –– EC91.Z Prurigo, unspecified – EC92 Mucocutaneous or cutaneous pain syndromes –– EC92.0 Penoscrotodynia –– EC92.1 Scalp dysaesthesia – EC9Y Other specified disturbances of cutaneous sensation –– ED00 Artefactual skin disorder –– ED01 Simulated skin disease –– ED02 Painful bruising syndrome –– ED0Y Other specified self-inflicted skin disorders – ED2Y Other specified mental conditions affecting the skin – ED30 Neuropathic skin damage –– ED30.0 Neuropathic skin ulceration –– ED30.Y Other specified neuropathic skin damage – ED31 Burning feet syndrome – ED3Y Cutaneous involvement in other specified neurological condition –– ED50 Ichthyoses ––– ED50.0 Acquired ichthyosis ––– ED50.Z Ichthyosis of unspecified type –– ED51 Diffuse epidermal hyperkeratosis and acanthosis ––– ED51.0 Acanthosis nigricans ––– ED51.Y Other specified hyperkeratotic and acanthotic dermatoses –––– ED51.00 Benign acanthosis nigricans –––– ED51.0Y Other specified acanthosis nigricans –––– ED51.0Z Acanthosis nigricans, unspecified –– ED52 Porokeratoses –– ED53 Skin peeling –– ED54 Xerosis cutis or asteatosis –– ED55 Palmoplantar keratodermas ––– ED55.0 Acquired palmoplantar keratodermas ––– ED55.Z Palmoplantar keratoderma, unspecified –– ED56 Keratosis pilaris –– ED5Y Other specified disorders of epidermal keratinisation –– ED60 Acquired hypermelanosis ––– ED60.0 Physiological hypermelanosis ––– ED60.1 Melasma ––– ED60.2 Postinflammatory hypermelanosis ––– ED60.Y Hypermelanosis of other specified aetiology ––– ED60.Z Hypermelanosis of unspecified aetiology –––– ED60.00 Suntan –––– ED60.01 Tanning due to exposure to artificial sources of ultraviolet radiation –– ED61 Acquired melanotic macules or lentigines ––– ED61.0 Freckles ––– ED61.1 Mucosal melanosis ––– ED61.Y Other specified acquired melanotic macules or lentigines –––– ED61.10 Penile melanotic macule –––– ED61.11 Vulval melanotic macule –––– ED61.1Y Other specified mucosal melanosis –– ED62 Endogenous non-melanin pigmentation ––– ED62.0 Haemosiderin pigmentation of skin ––– ED62.Y Other specified endogenous non-melanin pigmentation –– ED63 Acquired hypomelanotic disorders ––– ED63.0 Vitiligo ––– ED63.1 Hypomelanosis due to exposure to chemicals ––– ED63.2 Postinflammatory hypomelanosis ––– ED63.3 Vogt-Koyanagi-Harada syndrome ––– ED63.Y Acquired hypomelanosis due to other specified disorder ––– ED63.Z Acquired hypomelanosis of unknown or unspecified aetiology –– ED64 Abnormal skin pigmentation –– ED6Y Other specified disorders of skin pigmentation –– ED70 Alopecia or hair loss ––– ED70.0 Male pattern hair loss ––– ED70.1 Female pattern hair loss ––– ED70.2 Alopecia areata ––– ED70.3 Telogen effluvium ––– ED70.4 Anagen effluvium ––– ED70.5 Scarring alopecia ––– ED70.Y Other specified alopecia or hair loss ––– ED70.Z Alopecia, unspecified –––– ED70.20 Patchy alopecia areata of scalp –––– ED70.21 Alopecia totalis –––– ED70.2Y Other specified forms of alopecia areata –––– ED70.2Z Alopecia areata, unspecified –––– ED70.30 Acute telogen effluvium –––– ED70.31 Postpartum telogen effluvium –––– ED70.3Y Telogen hair shedding due to other specified cause –––– ED70.3Z Telogen effluvium unspecified –––– ED70.50 Folliculitis decalvans –––– ED70.51 Dissecting cellulitis –––– ED70.5Y Scarring alopecia due to other specified cause –––– ED70.5Z Scarring alopecia of unknown or unspecified aetiology –– ED71 Hypertrichosis –– ED72 Hirsutism and syndromes with hirsutism ––– ED72.0 Constitutional hirsutism ––– ED72.1 Hirsutism associated with hyperandrogenaemia ––– ED72.Z Hirsutism, unspecified –– ED73 Acquired disorders of the hair shaft ––– ED73.0 Weathered hair ––– ED73.1 Acquired changes in hair colour ––– ED73.Y Other specified acquired disorders of the hair shaft –––– ED73.10 Premature canities –––– ED73.11 Acquired poliosis –– ED7Y Other specified disorders of hair ––– ED80 Acne –––– ED80.0 Comedonal acne –––– ED80.1 Superficial mixed comedonal and papulopustular acne –––– ED80.2 Papulopustular acne –––– ED80.3 Nodular acne –––– ED80.4 Severe inflammatory acne –––– ED80.5 Acne scarring –––– ED80.6 Infantile acne –––– ED80.Y Other specified acne –––– ED80.Z Acne, unspecified ––––– ED80.40 Acne fulminans ––––– ED80.41 Acne conglobata ––––– ED80.4Y Other specified severe inflammatory acne ––––– ED80.4Z Severe inflammatory acne, unspecified ––– ED81 Acneform inflammatory disorders –––– ED81.0 Folliculitis cruris pustulosa atrophicans –––– ED81.1 Acneform reactions to halogenated aromatic hydrocarbons –––– ED81.Y Other specified acneform inflammatory disorders –– ED90 Rosacea and related disorders ––– ED90.0 Rosacea ––– ED90.1 Periorificial dermatitis ––– ED90.Y Other specified rosacea-like disorders ––– ED90.Z Rosacea-like disorders unspecified –––– ED90.00 Erythematotelangiectatic rosacea –––– ED90.01 Papulopustular rosacea –––– ED90.02 Phymatous rosacea –––– ED90.0Y Other specified rosacea –––– ED90.0Z Rosacea, unspecified –– ED91 Disorders of the sebaceous gland ––– ED91.0 Heterotopic sebaceous glands ––– ED91.1 Sebaceous gland hyperplasia ––– ED91.2 Seborrhoea ––– ED91.Y Other specified disorders of the sebaceous gland ––– ED91.Z Disorders of the sebaceous gland, unspecified –– ED92 Disorders involving the apocrine follicular unit ––– ED92.0 Hidradenitis suppurativa ––– ED92.1 Apocrine sweat disorders ––– ED92.Y Other specified disorders involving the apocrine follicular unit ––– ED92.Z Disorders involving the apocrine follicular unit, unspecified –– ED9Y Other specified disorders involving the hair follicle –– EE00 Hyperhidrosis ––– EE00.0 Localised hyperhidrosis ––– EE00.1 Primary generalised hyperhidrosis ––– EE00.Z Hyperhidrosis, unspecified –––– EE00.00 Palmoplantar hyperhidrosis –––– EE00.01 Axillary hyperhidrosis –––– EE00.02 Craniofacial hyperhidrosis –––– EE00.0Y Other specified localised hyperhidrosis –––– EE00.0Z Localised hyperhidrosis, unspecified –– EE01 Hypohidrosis ––– EE01.0 Hypohidrosis attributable to defective sudomotor innervation or function ––– EE01.1 Hypohidrosis due to genetic abnormalities of eccrine gland structure or function ––– EE01.2 Hypohidrosis of undetermined aetiology ––– EE01.Y Other specified forms of hypohidrosis ––– EE01.Z Hypohidrosis, unspecified –– EE02 Miliaria ––– EE02.0 Neonatal miliaria ––– EE02.Y Other specified forms of miliaria ––– EE02.Z Miliaria, unspecified –– EE0Y Other specified disorders of eccrine sweat glands or sweating –– EE10 Acquired deformities of the nail plate ––– EE10.0 Abnormality of nail shape ––– EE10.1 Abnormality of nail surface ––– EE10.2 Onycholysis ––– EE10.3 Nail hypertrophy ––– EE10.4 Nail atrophy ––– EE10.5 Nail dystrophy, not otherwise specified ––– EE10.Y Other specified acquired deformities of the nail plate ––– EE10.Z Acquired deformities of the nail plate, unspecified –––– EE10.10 Nail pitting –––– EE10.1Y Other specified abnormality of nail surface –––– EE10.1Z Abnormality of nail surface, unspecified –– EE11 Acquired abnormalities of nail colour ––– EE11.0 Melanonychia ––– EE11.1 Yellow nail syndrome ––– EE11.Y Other abnormalities of nail colour ––– EE11.Z Acquired abnormalities of nail colour, unspecified –– EE12 Infections of the nail or perionychium ––– EE12.0 Acute bacterial paronychia ––– EE12.1 Onychomycosis ––– EE12.Y Other specified infections of the nail or perionychium ––– EE12.Z Infections of the nail or perionychium, unspecified –– EE13 Certain disorders affecting the nails or perionychium ––– EE13.0 Nail fragility ––– EE13.1 Ingrowing nail ––– EE13.2 Chronic paronychia ––– EE13.3 Nail disorder associated with specified dermatosis ––– EE13.4 Nail disorder associated with specified systemic disease ––– EE13.5 Eczematous nail dystrophy ––– EE13.Y Other specified nail disorder –––– EE13.10 Ingrowing toenail –––– EE13.11 Infected ingrowing toenail –––– EE13.1Y Other specified ingrowing nail –––– EE13.1Z Ingrowing nail, unspecified –– EE1Y Other specified disorders of the nail or perionychium –– EE1Z Disorders of the nail or perionychium, unspecified –– EE20 Acute cutaneous distension syndrome –– EE21 Epidermal fragility –– EE40 Atrophy or degeneration of dermal or subcutaneous connective tissue ––– EE40.0 Corticosteroid-induced skin atrophy ––– EE40.1 Stretch marks ––– EE40.2 Atrophic scarring of the skin ––– EE40.3 Skin fragility ––– EE40.Y Other specified atrophy or degeneration of dermal or subcutaneous connective tissue ––– EE40.Z Atrophy or degeneration of dermal or subcutaneous connective tissue, unspecified type –––– EE40.10 Stretch marks of pregnancy –––– EE40.1Y Stretch marks of other specified aetiology –––– EE40.1Z Stretch marks, unspecified –––– EE40.30 Genetically-determined skin fragility –––– EE40.31 Age-related skin fragility –––– EE40.32 Purpura or bruising due to vascular fragility –– EE41 Abnormalities of dermal elastin ––– EE41.0 Cutis laxa ––– EE41.1 Anetoderma ––– EE41.Y Other specified dermatoses characterised by abnormal dermal elastin ––– EE41.Z Abnormalities of dermal elastin, unspecified ––– EE50 Acquired poikiloderma ––– EE60 Keloid or hypertrophic scars –––– EE60.0 Keloid –––– EE60.1 Hypertrophic scar –––– EE60.Y Other specified keloidal disorders ––––– EE60.00 Ear-lobe keloid ––––– EE60.0Y Other specified keloid ––––– EE60.0Z Keloid, unspecified ––– EE61 Superficial fibromatoses ––– EE6Y Other specified fibromatous disorders of skin and soft tissue –– EE70 Perforating dermatoses ––– EE70.0 Acquired perforating dermatosis ––– EE70.Y Other specified perforating dermatoses ––– EE70.Z Perforating dermatoses, unspecified –– EE7Y Other specified disorders of cutaneous connective tissue –– EE80 Necrobiotic granulomatous skin disorders ––– EE80.0 Granuloma annulare ––– EE80.1 Necrobiosis lipoidica ––– EE80.Z Necrobiotic granulomatous skin disorders, unspecified –– EE81 Dermal dendrocyte, Class IIa histiocytoses –– EE8Y Other specified histiocytic and granulomatous disorders of the skin –– EE90 Benign lymphocytic infiltration of the skin –– EE91 Lymphocytoma cutis –– EF00 Panniculitis ––– EF00.0 Pancreatic enzyme panniculitis ––– EF00.Y Panniculitis of other specified aetiology ––– EF00.Z Panniculitis of undetermined or unspecified etiology –– EF01 Lipoatrophy or lipodystrophy ––– EF01.0 Acquired partial lipodystrophy ––– EF01.1 Localised lipoatrophy and lipodystrophy ––– EF01.Y Other specified forms of lipodystrophy and lipoatrophy ––– EF01.Z Lipodystrophy of unspecified type –– EF02 Certain noninflammatory disorders of subcutaneous fat ––– EF02.0 Fat hypertrophy ––– EF02.1 Subcutaneous lipomatosis ––– EF02.2 Lipoedema ––– EF02.3 Cellulite ––– EF02.Y Other specified noninflammatory disorders of subcutaneous fat ––– EF02.Z Noninflammatory disorders of subcutaneous fat, unspecified –– EF0Y Other specified disorders of subcutaneous fat –– EF20 Acquired malformations of cutaneous blood vessels ––– EF20.0 Venous lake ––– EF20.1 Angiokeratoma ––– EF20.2 Lower limb venous telangiectases ––– EF20.3 Spider telangiectasis ––– EF20.4 Generalised essential telangiectasia ––– EF20.Y Other specified acquired malformations of cutaneous blood vessels ––– EF20.Z Acquired malformations of cutaneous blood vessels, unspecified –– EF2Z Cutaneous vascular malformation, unspecified –– EF30 Purpura or bruising due to disorders of coagulation –– EF31 Traumatic purpura –– EF3Y Other specified purpura –– EF3Z Purpura of unspecified aetiology – EF40 Vasculitis or capillaritis involving the skin –– EF40.0 Capillaritis –– EF40.1 Vasculitis affecting small cutaneous blood vessels –– EF40.2 Localised cutaneous vasculitis –– EF40.Z Cutaneous vasculitis unspecified ––– EF40.10 Urticarial vasculitis ––– EF40.1Y Other specified vasculitis affecting small cutaneous blood vessels ––– EF40.20 Granuloma faciale ––– EF40.2Y Other specified localised cutaneous vasculitis –– EF50 Livedoid vasculopathy –– EF5Y Other specified dermatoses attributable to hyperviscosity or microvascular occlusion –– EF60 Ischaemic ulceration of skin ––– EF70 Lower limb venous eczema ––– EF7Y Other specified dermatoses due to venous disease ––– EF7Z Dermatoses due to venous disease, unspecified –– EF9Y Other specified dermatoses resulting from vascular insufficiency –– EG00 Vasodilatation of extremities –– EG01 Vasoconstriction of extremities –– EG02 Flushing disorders – EG30 Skin disorders localised to the scalp –– EG30.0 Scalp folliculitis –– EG30.1 Erosive pustular dermatosis of scalp –– EG30.2 Pityriasis amiantacea –– EG30.Y Other specified scalp disorders not elsewhere classifiable –– EG30.Z Skin disorders localised to the scalp, unspecified ––– EG40 Contact dermatitis of external ear –––– EG40.0 Allergic contact dermatitis of external ear ––– EG4Y Other specified inflammatory disorder of external ear ––– EG4Z Inflammatory disorder of external ear, unspecified –– EG60 Anal pruritus –– EG61 Infections of the anus or perianal skin –– EG62 Inflammatory dermatoses of the perianal area –– EG63 Sacrococcygeal pilonidal disease ––– EG63.0 Sacrococcygeal pilonidal sinus ––– EG63.1 Sacrococcygeal pilonidal cyst ––– EG63.2 Sacrococcygeal pilonidal abscess ––– EG63.Z Sacrococcygeal pilonidal disease, unspecified – EG7Y Other specified skin disorders involving the genital and perianal regions EG9Y Skin disorders involving other specific body regions EG9Z Skin disorders involving certain specific body regions, unspecified –– EH10 Neonatal viral infections involving the skin –– EH11 Neonatal pyogenic skin infections –– EH12 Neonatal fungal infections involving the skin –– EH1Z Neonatal skin infection, unspecified – EH3Y Other specified skin disorders specific to the perinatal or neonatal period EH40 Dermatoses of infancy – EH40.0 Infantile seborrhoeic dermatitis – EH40.1 Infantile napkin dermatoses – EH40.2 Erythrodermas of infancy – EH40.3 Acute haemorrhagic oedema of infancy – EH40.Y Other specified dermatoses of infancy – EH40.Z Dermatoses of infancy, unspecified –– EH40.00 Cradle cap –– EH40.01 Disseminated infantile seborrhoeic dermatitis –– EH40.02 Psoriasiform napkin dermatitis –– EH40.0Z Infantile seborrhoeic dermatitis, unspecified –– EH40.10 Primary irritant napkin dermatitis –– EH40.1Y Other specified infantile napkin dermatoses –– EH40.1Z Infantile napkin dermatoses, unspecified – EH60 Exanthematic drug eruption – EH61 Drug-induced urticaria, angioedema and anaphylaxis –– EH61.0 Drug-induced urticaria –– EH61.1 Drug-induced angioedema – EH62 Lichenoid drug eruption – EH63 Stevens-Johnson syndrome and toxic epidermal necrolysis due to drug –– EH63.0 Drug-induced Stevens-Johnson syndrome –– EH63.1 Drug-induced toxic epidermal necrolysis –– EH63.2 Drug-induced Stevens-Johnson and toxic epidermal necrolysis overlap syndrome – EH64 Drug-induced erythroderma – EH65 DRESS syndrome – EH66 Fixed drug eruption – EH67 Acne or acneform reactions attributable to drugs –– EH67.0 Drug-induced acute generalised exanthematous pustulosis –– EH67.Y Other specified acne or acneform reactions attributable to drugs –– EH67.Z Acne or acneform reactions attributable to drugs, unspecified – EH6Y Drug eruption of other specified type – EH6Z Drug eruption of unspecified type EH70 Pigmentary abnormalities of skin due to drug EH71 Dermatoses precipitated by drug therapy EH72 Drug-induced hair abnormalities – EH72.0 Drug-induced alopecia – EH72.Y Other specified drug-induced hair abnormalities – EH72.Z Drug-induced hair abnormalities, unspecified –– EH72.00 Drug-induced telogen hair loss –– EH72.01 Drug-induced anagen effluvium EH73 Drug-induced nail abnormalities EH74 Drug-induced oral conditions EH75 Photosensitivity due to drug EH76 Dermatoses associated with specific classes of medication – EH76.0 Dermatoses resulting from cytotoxic or cancer chemotherapy – EH76.1 Dermatoses resulting from immunosuppressive therapy – EH76.2 Dermatoses attributable to corticosteroid therapy – EH76.3 Dermatoses resulting from anticoagulant therapy – EH76.Y Other dermatoses associated with specific classes of medication EH77 Localised adverse cutaneous reactions to administration of drug EH78 Adverse cutaneous reactions to herbal, homoeopathic or other alternative therapies EH7Y Other specified adverse cutaneous reactions to medication EH7Z Unspecified adverse cutaneous reactions to medication EH90 Pressure ulceration – EH90.0 Pressure ulceration grade 1 – EH90.1 Pressure ulceration grade 2 – EH90.2 Pressure ulceration grade 3 – EH90.3 Pressure ulceration grade 4 – EH90.4 Suspected deep pressure-induced tissue damage, depth unknown – EH90.5 Pressure ulceration, ungradable – EH90.Z Pressure ulcer of unspecified grade EH92 Dermatoses provoked by friction or mechanical stress – EH92.0 Corns or callosities – EH92.1 Friction blister – EH92.Y Other specified skin damage due to repetitive friction and mechanical trauma –– EH92.00 Hard corn –– EH92.01 Soft corn –– EH92.0Z Callosity, unspecified EH93 Dermatoses due to foreign bodies – EH93.0 Tattoos or tattoo reactions – EH93.1 Foreign body reaction to inorganic matter in the skin – EH93.2 Foreign body reaction to organic matter in the skin – EH93.3 Foreign body granuloma of skin – EH93.Y Other specified reaction to foreign body in the skin – EH93.Z Dermatoses due to foreign bodies, unspecified EH94 Scar of skin, not elsewhere classified – EJ0Y Other specified dermatoses provoked or exacerbated by exposure to cold – EJ10 Erythema ab igne – EJ1Y Other specified dermatoses provoked by heat or electricity –– EJ20 Photoaging of the skin ––– EJ20.0 Actinic elastosis ––– EJ20.1 Actinic lentigo ––– EJ20.2 Actinic lentiginosis ––– EJ20.3 Actinic telangiectasia ––– EJ20.Z Photoaging of the skin, unspecified –– EJ2Y Other specified chronic effects of ultraviolet radiation on the skin – EJ30 Autoimmune or other photodermatoses –– EJ30.0 Polymorphic light eruption –– EJ30.1 Chronic actinic dermatitis –– EJ30.Y Other specified photodermatoses –– EJ30.Z Photodermatoses, unspecified –– EJ40 Sunburn ––– EJ40.0 Sunburn erythema ––– EJ40.1 Sunburn with blisters or exudation ––– EJ40.Z Sunburn, unspecified –– EJ41 Burn from exposure to artificial source of ultraviolet radiation ––– EJ41.0 Burn from exposure to therapeutic ultraviolet radiation ––– EJ41.Y Other specified burn from exposure to artificial source of ultraviolet radiation ––– EJ41.Z Burn from exposure to artificial source of ultraviolet radiation, unspecified –– EJ4Z Acute effects of ultraviolet radiation on normal skin, unspecified – EJ6Y Other specified dermatoses provoked by light or UV radiation – EJ71 Chronic effects of ionizing radiation on the skin – EJ7Z Dermatoses due to ionizing radiation, unspecified EK00 Allergic contact dermatitis – EK00.0 Allergic contact dermatitis due to clothing or footwear – EK00.1 Allergic contact dermatitis due to cosmetics or fragrances – EK00.2 Allergic contact dermatitis due to dental materials – EK00.3 Allergic contact dermatitis due to food flavours or additives – EK00.4 Allergic contact dermatitis due to hairdressing products – EK00.5 Allergic contact dermatitis due to industrial biocides, cutting oils or disinfectants – EK00.6 Allergic contact dermatitis due to metals or metal salts – EK00.7 Allergic contact dermatitis due to allergenic haptens derived from plants or organic matter – EK00.8 Allergic contact dermatitis due to plastics, glues or resin systems – EK00.9 Allergic contact dermatitis due to preservatives or biocides – EK00.A Allergic contact dermatitis due to rubber chemicals – EK00.B Allergic contact dermatitis due to systemic medicaments – EK00.C Allergic contact dermatitis due to topical medicaments – EK00.Y Other specified allergic contact dermatitis – EK00.Z Allergic contact dermatitis, unspecified EK01 Photo-allergic contact dermatitis EK02 Irritant contact dermatitis – EK02.0 Irritant contact dermatitis from specified external agents – EK02.1 Irritant contact dermatitis of specified site – EK02.2 Irritant contact dermatitis due to friction, sweating or contact with body fluids – EK02.Y Irritant contact dermatitis due to other specified cause – EK02.Z Irritant contact dermatitis, unspecified –– EK02.00 Irritant contact dermatitis due to wet work –– EK02.01 Irritant contact dermatitis due to solvents –– EK02.02 Irritant contact dermatitis due to exposure to acids, alkalis or other specified chemical irritants –– EK02.03 Irritant contact dermatitis due to cosmetics or emollients –– EK02.04 Irritant contact dermatitis due to topical medicaments or antimicrobials –– EK02.05 Irritant contact dermatitis due to plants or other vegetable matter –– EK02.06 Irritant contact dermatitis due to foods –– EK02.10 Irritant contact dermatitis of external ear –– EK02.11 Irritant contact blepharoconjunctivitis –– EK02.12 Irritant contact dermatitis of hands –– EK02.13 Irritant contact dermatitis of vulva –– EK02.1Y Irritant contact dermatitis of other specified site –– EK02.20 Intertriginous dermatitis due to friction, sweating or contact with body fluids –– EK02.21 Irritant contact dermatitis due to saliva –– EK02.22 Irritant contact dermatitis due to incontinence –– EK02.23 Irritant contact dermatitis related to stoma or fistula –– EK02.24 Irritant contact dermatitis related to skin contact with prostheses or surgical appliances EK10 Allergic contact urticaria – EK10.0 Oral allergy syndrome – EK10.1 Contact urticaria due to food allergen – EK10.Y Other specified allergic contact urticaria – EK10.Z Allergic contact urticaria, unspecified EK11 Protein contact dermatitis EK12 Allergic contact sensitisation – EK20 Phototoxic reaction to fragrance or cosmetics – EK2Y Phototoxic reaction to skin contact with other specified photoactive agent – EK2Z Phototoxic dermatitis, unspecified EK50 Cutaneous reactions to venomous or noxious animals – EK50.0 Cutaneous insect bite reactions –– EK50.00 Papular urticaria –– EK50.01 Bullous insect bite reaction –– EK50.02 Persistent insect bite reaction –– EK50.0Y Other specified cutaneous insect bite reactions –– EK50.0Z Cutaneous insect bite reactions, unspecified EK5Y Other specified skin disorders provoked by external factors EK70 Cutaneous cysts – EK70.0 Epidermoid cyst – EK70.1 Trichilemmal cyst – EK70.2 Digital myxoid pseudocyst – EK70.3 Hidrocystoma – EK70.Y Other specified cutaneous cysts – EK70.Z Cutaneous cysts, unspecified –– EK70.00 Infected epidermoid cyst –– EK70.0Z Epidermoid cyst, unspecified EK71 Skin tags or polyps – EK71.0 Fibroepithelial polyp of skin – EK71.1 Multiple skin tags – EK71.Z Polyp of skin not elsewhere classified EK90 Actinic keratosis and other discrete epidermal dysplasias – EK90.0 Actinic keratosis – EK90.1 Diffuse actinic keratinocyte dysplasia – EK90.Y Other discrete epidermal dysplasias EK91 Dermatoses which may presage cutaneous lymphoma – EK91.0 Large plaque parapsoriasis – EK91.1 Poikiloderma vasculare atrophicans – EK91.2 Primary cutaneous plasmacytosis EK92 Histiocytoses of uncertain malignant potential – EL10 Paraneoplastic syndromes involving skin – EL1Y Other specified cutaneous markers of internal malignancy EL3Y Other specified cutaneous markers of internal disorders EL50 Unsatisfactory surgical scar of skin – EL50.0 Keloidal surgical scar – EL50.1 Hypertrophic surgical scar – EL50.2 Atrophic surgical scar – EL50.3 Expanded surgical scar – EL50.Z Unsatisfactory surgical scar of skin, unspecified EL51 Cutaneous flap necrosis EL52 Myocutaneous flap necrosis EL53 Skin graft failure EL54 Composite graft failure – EL60 Acute radiodermatitis following radiotherapy – EL61 Chronic radiodermatitis following radiotherapy – EL63 Radionecrosis of skin due to therapeutic ionizing irradiation – EL73 Unsatisfactory outcome from cutaneous cosmetic surgical procedure –– EL73.0 Adverse reaction to dermal or deep fillers –– EL73.1 Adverse reaction to chemical peel –– EL73.2 Adverse reaction to injection of neurotoxin –– EL73.3 Unsatisfactory outcome from cosmetic laser surgery –– EL73.4 Hypomelanosis resulting from cosmetic procedure –– EL73.5 Dyspigmentation resulting from cosmetic procedure –– EL73.6 Fibrosis or scarring following cosmetic procedure EL80 Adverse cutaneous effects of diagnostic procedures EM0Y Other specified diseases of the skin EM0Z Skin disease of unspecified nature – FA10 Direct infections of joint –– FA10.0 Bacterial infection of joint –– FA10.1 Viral infection of joint –– FA10.2 Fungal infection of joint –– FA10.Z Direct infections of joint, unspecified – FA11 Reactive arthropathies –– FA11.0 Arthropathy following intestinal bypass –– FA11.1 Arthropathy following vaccination –– FA11.2 Arthropathy following genitourinary infection –– FA11.Y Other specified reactive arthropathies –– FA11.Z Reactive arthropathies, unspecified – FA12 Postinfectious arthropathies –– FA12.0 Bacterial postinfectious arthropathy –– FA12.1 Viral postinfectious arthropathies –– FA12.2 Fungal postinfectious arthropathies –– FA12.3 Parasitic postinfectious arthropathies –– FA12.Y Other specified postinfectious arthropathies –– FA12.Z Postinfectious arthropathies, unspecified – FA13 Infectious spondyloarthritis – FA1Y Other specified infection related arthropathies – FA1Z Infection related arthropathies, unspecified – FA20 Rheumatoid arthritis –– FA20.0 Seropositive rheumatoid arthritis –– FA20.1 Seronegative rheumatoid arthritis –– FA20.Z Rheumatoid arthritis, serology unspecified – FA21 Psoriatic arthritis –– FA21.0 Psoriatic spondyloarthritis –– FA21.Y Other specified psoriatic arthritis –– FA21.Z Psoriatic arthritis, unspecified – FA22 Polymyalgia rheumatica – FA23 Adult-onset Still disease – FA24 Juvenile idiopathic arthritis –– FA24.0 Juvenile idiopathic oligoarthritis –– FA24.1 Juvenile idiopathic polyarthritis –– FA24.2 Juvenile psoriatic arthritis –– FA24.3 Juvenile enthesitis related arthritis –– FA24.4 Juvenile systemic arthritis –– FA24.Y Other specified juvenile idiopathic arthritis –– FA24.Z Juvenile idiopathic arthritis, unspecified ––– FA24.00 Juvenile idiopathic oligoarthritis, onset persistent ––– FA24.01 Juvenile idiopathic oligoarthritis, onset extended ––– FA24.0Z Juvenile idiopathic oligoarthritis, onset unspecified – FA25 Gout –– FA25.0 Primary gout –– FA25.1 Secondary gout –– FA25.2 Gout without specification whether primary or secondary ––– FA25.10 Lead-induced gout ––– FA25.11 Drug-induced gout ––– FA25.12 Gouty arthropathy due to enzyme defects or other inherited disorders ––– FA25.1Y Other specified secondary gout ––– FA25.1Z Secondary gout, unspecified ––– FA25.20 Tophaceous gout ––– FA25.2Y Other specified gout without specification whether primary or secondary ––– FA25.2Z Gout, unspecified – FA26 Certain specified crystal arthropathies –– FA26.0 Calcium pyrophosphate dehydrate deposition disease –– FA26.1 Hydroxyapatite deposition disease –– FA26.2 Chondrocalcinosis –– FA26.Y Other specified crystal arthropathies –– FA26.Z Crystal arthropathies, unspecified – FA27 Certain specified inflammatory arthropathies –– FA27.0 Kashin-Beck disease –– FA27.1 Pigmented villonodular synovitis –– FA27.2 Palindromic rheumatism –– FA27.3 Transient synovitis –– FA27.4 Intermittent hydrarthrosis –– FA27.Y Other specified inflammatory arthropathies – FA2Z Inflammatory arthropathies, unspecified – FA30 Acquired deformities of fingers or toes –– FA30.0 Acquired hallux valgus –– FA30.1 Hallux rigidus –– FA30.2 Acquired hammer toe –– FA30.Y Other specified acquired deformities of fingers or toes –– FA30.Z Acquired deformities of fingers or toes, unspecified – FA31 Other acquired deformities of limbs –– FA31.0 Valgus deformity, not elsewhere classified –– FA31.1 Varus deformity, not elsewhere classified –– FA31.2 Flexion deformity –– FA31.3 Acquired wrist drop –– FA31.4 Acquired foot drop –– FA31.5 Acquired pes planus –– FA31.6 Acquired clawhand or clubhand –– FA31.7 Acquired clawfoot or clubfoot –– FA31.8 Acquired unequal limb length –– FA31.Y Other specified acquired deformities of limbs –– FA31.Z Acquired deformities of limbs, unspecified – FA32 Disorders of patella –– FA32.0 Recurrent instability of patella –– FA32.1 Patellofemoral disorders –– FA32.Y Other specified disorders of patella –– FA32.Z Disorders of patella, unspecified – FA33 Internal derangement of knee –– FA33.0 Cystic meniscus –– FA33.1 Discoid meniscus –– FA33.2 Derangement of meniscus due to old tear or injury –– FA33.3 Loose body in knee –– FA33.4 Chronic instability of knee –– FA33.Y Other specified internal derangement of knee –– FA33.Z Internal derangement of knee, unspecified ––– FA33.40 Chronic instability of knee, medial collateral ligament or other or unspecified part of medial meniscus ––– FA33.4Y Other specified chronic instability of knee ––– FA33.4Z Chronic instability of knee, unspecified – FA34 Certain specified joint derangements –– FA34.0 Loose body in joint –– FA34.1 Disorder of ligament –– FA34.2 Recurrent instability of joint –– FA34.3 Contracture of joint –– FA34.4 Ankylosis of joint –– FA34.5 Impingement syndrome of hip –– FA34.Y Other joint derangements – FA35 Wear of articular bearing surface of joint prosthesis –– FA35.0 Wear of articular bearing surface of joint prosthesis of hip –– FA35.1 Wear of articular bearing surface of joint prosthesis of knee –– FA35.2 Wear of articular bearing surface of joint prosthesis of other joint –– FA35.Z Wear of articular bearing surface of joint prosthesis of unspecified joint – FA36 Effusion of joint –– FA36.0 Effusion of joint containing blood –– FA36.Y Other specified effusion of joint –– FA36.Z Effusion of joint, unspecified – FA37 Certain joint disorders, not elsewhere classified –– FA37.0 Osteophyte –– FA37.Y Other specified certain joint disorders, not elsewhere classified –– FA37.Z Certain joint disorders, not elsewhere classified, unspecified – FA38 Arthropathy in diseases classified elsewhere –– FA38.0 Diabetic arthropathy –– FA38.1 Neuropathic arthropathy –– FA38.2 Arthropathy in hypersensitivity reactions classified elsewhere –– FA38.3 Haemophilic arthropathy –– FA38.Y Other specified arthropathy in diseases classified elsewhere –– FA38.Z Unspecified arthropathy in diseases classified elsewhere ––– FA38.10 Diabetic Charcot arthropathy ––– FA38.1Y Other specified neuropathic arthropathy ––– FA38.1Z Neuropathic arthropathy, unspecified – FA3Z Unspecified joint disorders and deformities of limbs – FA70 Spinal deformities –– FA70.0 Kyphosis –– FA70.1 Scoliosis –– FA70.2 Lordosis –– FA70.Z Spinal deformities, unspecified – FA71 Torticollis – FA72 Disorders of vertebra –– FA72.0 Ankylosing hyperostosis –– FA72.1 Kissing spine –– FA72.2 Traumatic spondylopathy –– FA72.3 Fatigue fracture of vertebra –– FA72.4 Collapsed vertebra, not elsewhere classified –– FA72.Y Other specified disorders of vertebra –– FA72.Z Disorders of vertebra, unspecified – FA7Y Other specified structural disorders of spine – FA7Z Structural disorders of spine, unspecified – FA80 Intervertebral disc degeneration –– FA80.0 Intervertebral disc degeneration of cervical spine without prolapsed disc –– FA80.1 Intervertebral disc degeneration of cervical spine with prolapsed disc –– FA80.2 Intervertebral disc degeneration of cervical spine with bony spur at the vertebra –– FA80.3 Intervertebral disc degeneration of cervical spine with nervous system involvement –– FA80.4 Intervertebral disc degeneration of thoracic spine without prolapsed disc –– FA80.5 Intervertebral disc degeneration of thoracic spine with prolapsed disc –– FA80.6 Intervertebral disc degeneration of thoracic spine with bony spur at the vertebra –– FA80.7 Intervertebral disc degeneration of thoracic spine with nervous system involvement –– FA80.8 Intervertebral disc degeneration of lumbar spine without prolapsed disc –– FA80.9 Intervertebral disc degeneration of lumbar spine with prolapsed disc –– FA80.A Intervertebral disc degeneration of lumbar spine with bony spur at the vertebra –– FA80.B Intervertebral disc degeneration of lumbar spine with nervous system involvement –– FA80.Y Other specified intervertebral disc degeneration –– FA80.Z Intervertebral disc degeneration, unspecified – FA81 Spondylolysis –– FA81.0 Spondylolysis with slippage –– FA81.1 Spondylolysis without slippage –– FA81.Z Spondylolysis, unspecified – FA82 Spinal stenosis – FA83 Ossification of spinal ligaments – FA84 Spondylolisthesis –– FA84.0 Spondylolisthesis with pars defect –– FA84.1 Spondylolisthesis without pars defect –– FA84.Z Spondylolisthesis, unspecified – FA85 Spinal endplate defects –– FA85.0 Spinal epiphysiopathy with no determinant –– FA85.1 Spinal epiphysiopathy with determinants –– FA85.Y Other specified spinal endplate defects –– FA85.Z Spinal endplate defects, unspecified ––– FA85.10 Localised central endplate defect ––– FA85.11 Multiple anterior endplate defect ––– FA85.12 Separation of ring apophysis ––– FA85.1Y Other specified spinal epiphysiopathy with determinants ––– FA85.1Z Spinal epiphysiopathy with determinants, unspecified – FA8Y Other specified degenerative condition of spine – FA8Z Degenerative condition of spine, unspecified – FA90 Infection of vertebra –– FA90.0 Infection of vertebra with no determinant –– FA90.1 Infection of vertebra with determinants –– FA90.Y Other specified infection of vertebra –– FA90.Z Infection of vertebra, unspecified – FA91 Infection of intervertebral disc – FA92 Inflammatory spondyloarthritis –– FA92.0 Axial spondyloarthritis –– FA92.1 Peripheral spondyloarthritis –– FA92.Y Other specified inflammatory spondyloarthritis –– FA92.Z Inflammatory spondyloarthritis, unspecified ––– FA92.00 Spinal enthesitis ––– FA92.01 Sacroiliitis, not elsewhere classified ––– FA92.0Y Other specified axial spondyloarthritis ––– FA92.0Z Axial spondyloarthritis, unspecified – FA9Y Other specified inflammation of spine – FA9Z Inflammation of spine, unspecified – FB00 Ankylosis of spinal joint – FB0Y Other specified spondylopathies – FB0Z Spondylopathies, unspecified FB10 Spinal instabilities FB1Y Other specified conditions associated with the spine FB1Z Conditions associated with the spine, unspecified – FB30 Infectious myositis – FB31 Calcification or ossification of muscle –– FB31.0 Progressive osseous heteroplasia –– FB31.1 Fibrodysplasia ossificans progressiva –– FB31.Y Other specified calcification or ossification of muscle –– FB31.Z Calcification or ossification of muscle, unspecified – FB32 Certain specified disorders of muscle –– FB32.0 Diastasis of muscle –– FB32.1 Spontaneous rupture of muscle –– FB32.2 Ischaemic infarction of muscle –– FB32.3 Immobility syndrome –– FB32.4 Contracture of muscle –– FB32.5 Muscle strain or sprain –– FB32.Y Other specified disorders of muscles ––– FB32.20 Idiopathic rhabdomyolysis ––– FB32.2Y Other specified ischaemic infarction of muscle ––– FB32.2Z Ischaemic infarction of muscle, unspecified – FB33 Secondary disorders of muscle – FB3Z Disorders of muscles, unspecified – FB40 Tenosynovitis –– FB40.0 Infectious tenosynovitis –– FB40.1 Plantar fasciitis –– FB40.2 Posterior tibial tendonitis –– FB40.3 Calcific tendinitis –– FB40.4 Trigger finger –– FB40.5 Radial styloid tenosynovitis –– FB40.Y Other specified tenosynovitis –– FB40.Z Tenosynovitis, unspecified – FB41 Spontaneous rupture of synovium or tendon –– FB41.0 Spontaneous rupture of popliteal cyst –– FB41.1 Spontaneous rupture of synovium –– FB41.2 Spontaneous rupture of tendon –– FB41.Y Other specified spontaneous rupture of synovium or tendon –– FB41.Z Spontaneous rupture of synovium or tendon, unspecified – FB42 Certain specified disorders of synovium or tendon –– FB42.0 Acquired short Achilles tendon –– FB42.1 Contracture of tendon sheath –– FB42.2 Ganglion –– FB42.3 Synovial hypertrophy, not elsewhere classified – FB43 Secondary disorders of synovium or tendon – FB4Y Other specified disorders of synovium or tendon – FB4Z Disorders of synovium or tendon, unspecified – FB50 Bursitis –– FB50.0 Infectious bursitis –– FB50.1 Bursitis related to use, overuse or pressure –– FB50.2 Synovial cyst of popliteal space –– FB50.3 Calcium deposit in bursa –– FB50.Y Other specified bursitis –– FB50.Z Bursitis, unspecified – FB51 Fibroblastic disorders –– FB51.0 Palmar fascial fibromatosis –– FB51.1 Knuckle pads –– FB51.2 Fasciitis and fibromatosis –– FB51.3 Fibroblastic rheumatism –– FB51.4 Retroperitoneal fibrosis –– FB51.Y Other specified fibroblastic disorders –– FB51.Z Fibroblastic disorders, unspecified ––– FB51.40 Primary retroperitoneal fibrosis ––– FB51.4Y Other specified retroperitoneal fibrosis ––– FB51.4Z Retroperitoneal fibrosis, unspecified – FB52 Soft tissue disorders in diseases classified elsewhere – FB53 Shoulder lesions –– FB53.0 Adhesive capsulitis of shoulder –– FB53.1 Rotator cuff syndrome –– FB53.2 Impingement syndrome of shoulder –– FB53.Y Other specified shoulder lesions –– FB53.Z Shoulder lesions, unspecified – FB54 Enthesopathies of lower limb –– FB54.0 Iliac crest spur –– FB54.1 Iliotibial band syndrome –– FB54.2 Tibial collateral bursitis –– FB54.3 Calcaneal spur –– FB54.4 Metatarsalgia –– FB54.Y Other specified enthesopathies of lower limb –– FB54.Z Enthesopathies of lower limb, unspecified – FB55 Certain specified enthesopathies –– FB55.0 Medial epicondylitis of elbow –– FB55.1 Lateral epicondylitis of elbow –– FB55.2 Periarthritis of wrist –– FB55.Z Enthesopathies, unspecified – FB56 Specified soft tissue disorders, not elsewhere classified –– FB56.0 Foreign body granuloma of soft tissue, not elsewhere classified –– FB56.1 Residual foreign body in soft tissue –– FB56.2 Myalgia –– FB56.3 Hypertrophy of infrapatellar fat pad –– FB56.4 Pain in limb –– FB56.6 Other specified soft tissue disorders FB6Z Soft tissue disorders, unspecified FB80 Certain specified disorders of bone density or structure – FB80.0 Fibrous dysplasia of bone – FB80.1 Skeletal fluorosis – FB80.2 Osteitis condensans – FB80.3 Hyperostosis of skull – FB80.4 Osteosclerosis – FB80.5 Solitary bone cyst – FB80.6 Aneurysmal bone cyst – FB80.7 Malunion of fracture – FB80.8 Nonunion of fracture – FB80.9 Delayed union of fracture – FB80.A Stress fracture, not elsewhere classified – FB80.B Pathological fracture – FB80.Y Other specified disorders of bone density and structure – FB80.Z Disorder of bone density and structure, unspecified FB81 Osteonecrosis – FB81.0 Idiopathic aseptic osteonecrosis – FB81.1 Osteonecrosis due to dialysis – FB81.2 Drug-induced osteonecrosis – FB81.3 Osteonecrosis due to trauma – FB81.4 Osteonecrosis due to haemoglobinopathy – FB81.5 Osteonecrosis due to ionizing radiation – FB81.6 Alcohol induced osteonecrosis – FB81.Y Other specified osteonecrosis – FB81.Z Osteonecrosis, unspecified FB82 Chondropathies – FB82.0 Chondromalacia – FB82.1 Osteochondrosis or osteochondritis dissecans – FB82.2 Slipped upper femoral epiphysis – FB82.3 Relapsing polychondritis – FB82.Y Other specified chondropathies – FB82.Z Chondropathies, unspecified –– FB82.00 Chondromalacia patellae –– FB82.0Y Other specified chondromalacia –– FB82.0Z Chondromalacia, unspecified FB83 Low bone mass disorders – FB83.0 Osteopenia – FB83.1 Osteoporosis – FB83.2 Adult osteomalacia –– FB83.00 Premenopausal idiopathic osteopenia –– FB83.01 Postmenopausal osteopenia –– FB83.02 Senile osteopenia –– FB83.03 Osteopenia of disuse –– FB83.04 Drug-induced osteopenia –– FB83.0Y Other specified osteopenia –– FB83.0Z Osteopenia, unspecified –– FB83.10 Premenopausal idiopathic osteoporosis –– FB83.11 Postmenopausal osteoporosis –– FB83.12 Osteoporosis of disuse –– FB83.13 Drug-induced osteoporosis –– FB83.14 Osteoporosis due to malabsorption –– FB83.1Y Other specified osteoporosis –– FB83.1Z Osteoporosis, unspecified –– FB83.20 Aluminium bone disease –– FB83.21 Adult osteomalacia due to malnutrition –– FB83.22 Drug-induced adult osteomalacia –– FB83.2Y Other specified adult osteomalacia –– FB83.2Z Adult osteomalacia, unspecified FB84 Osteomyelitis or osteitis – FB84.0 Acute haematogenous osteomyelitis – FB84.1 Other acute osteomyelitis – FB84.2 Subacute osteomyelitis – FB84.3 Chronic multifocal osteomyelitis – FB84.4 Chronic osteomyelitis with draining sinus – FB84.5 Other chronic haematogenous osteomyelitis – FB84.Y Other specified osteomyelitis or osteitis – FB84.Z Osteomyelitis or osteitis, unspecified FB85 Paget disease of bone – FB85.0 Juvenile Paget disease – FB85.1 Paget disease of bone in neoplastic disease – FB85.Y Other specified Paget disease of bone – FB85.Z Paget disease of bone, unspecified FB86 Disorders associated with bone growth – FB86.0 Epiphyseal arrest – FB86.1 Bone hyperplasias – FB86.2 Osteolysis – FB86.Y Other specified disorders associated with bone growth – FB86.Z Disorders associated with bone growth, unspecified –– FB86.10 Hypertrophic osteoarthropathy –– FB86.11 Hypertrophy of bone –– FB86.1Y Other specified bone hyperplasias –– FB86.1Z Bone hyperplasias, unspecified FB8Y Other specified osteopathies or chondropathies FB8Z Osteopathies or chondropathies, unspecified FC00 Certain specified acquired deformities of musculoskeletal system or connective tissue, not elsewhere classified FC00.0 Acquired deformity of nose FC00.1 Acquired deformity of neck FC00.2 Acquired deformity of chest or rib FC00.3 Acquired deformity of pelvis FC00.4 Acquired deformity of trunk FC00.Y Acquired deformities of musculoskeletal system and connective tissue, not classified elsewhere, other specified sites FC01 Postprocedural disorders of the musculoskeletal system FC01.0 Pseudarthrosis after fusion or arthrodesis FC01.1 Postlaminectomy syndrome, not elsewhere classified FC01.2 Post radiation kyphosis FC01.3 Postlaminectomy kyphosis FC01.4 Postsurgical lordosis FC01.5 Post radiation scoliosis FC01.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate FC01.7 Nonunion after arthrodesis FC01.8 Postsurgical osteolysis FC01.9 Postoophorectomy osteoporosis FC01.A Postsurgical malabsorption osteoporosis – FC01.70 Nonunion after spinal arthrodesis – FC01.7Y Nonunion after arthrodesis of other sites – GA00 Vulvitis –– GA00.0 Acute vulvitis –– GA00.1 Subacute, chronic or recurrent vulvitis –– GA00.2 Abscess of vulva –– GA00.3 Genital ulcer of vulva –– GA00.4 Vulvovaginal ulceration and inflammation ––– GA00.40 Vulvovaginal ulceration ––– GA00.4Y Other specified vulvovaginal ulceration and inflammation ––– GA00.4Z Vulvovaginal ulceration and inflammation, unspecified – GA01 Inflammatory disorders of the uterus, except cervix –– GA01.0 Acute inflammatory disease of uterus –– GA01.1 Chronic inflammatory disease of uterus –– GA01.Y Other specified inflammatory disorders of the uterus, except cervix –– GA01.Z Inflammatory disorders of the uterus, except cervix, unspecified ––– GA01.00 Acute endometritis ––– GA01.01 Acute inflammatory disease of uterus with pyometra ––– GA01.0Z Acute inflammatory disease of uterus, unspecified ––– GA01.10 Chronic endometritis ––– GA01.11 Chronic inflammatory disease of uterus with pyometra ––– GA01.1Z Chronic inflammatory disease of uterus, unspecified – GA02 Vaginitis –– GA02.0 Acute vaginitis –– GA02.1 Inflammatory vaginitis –– GA02.2 Subacute or chronic vaginitis –– GA02.3 Genital ulcer disease of vagina –– GA02.Z Vaginitis, unspecified – GA03 Diseases of Bartholin gland –– GA03.0 Abscess of Bartholin gland –– GA03.1 Cyst of Bartholin gland –– GA03.Y Other specified diseases of Bartholin gland –– GA03.Z Diseases of Bartholin gland, unspecified – GA04 Cervicitis – GA05 Female pelvic inflammatory diseases –– GA05.0 Acute female pelvic inflammatory disease –– GA05.1 Chronic pelvic inflammatory disease –– GA05.2 Female pelvic peritonitis, unspecified –– GA05.3 Tuboovarian abscess –– GA05.Y Other specified female pelvic inflammatory diseases –– GA05.Z Female pelvic inflammatory diseases, unspecified – GA06 Pelvic peritoneal adhesions of unknown or combined origin – GA07 Salpingitis and oophoritis –– GA07.0 Acute salpingitis and oophoritis –– GA07.1 Chronic salpingitis and oophoritis –– GA07.Z Salpingitis and oophoritis, unspecified – GA0Z Inflammatory disorders of the female genital tract, unspecified GA10 Endometriosis – GA10.B Endometriosis of the reproductive system – GA10.C Endometriosis of the digestive system – GA10.D Endometriosis of urinary system – GA10.E Endometriosis of the circulatory system – GA10.F Endometriosis of the nervous system – GA10.G Thoracic endometriosis – GA10.H Endometriosis in cutaneous scar – GA10.J Endometriosis-related adhesions – GA10.Y Endometriosis of other specified sites – GA10.Z Endometriosis of unspecified site –– GA10.B0 Endometriosis of the uterosacral ligaments –– GA10.B1 Endometriosis of the pelvic side wall –– GA10.B2 Endometriosis of rectovaginal septum or vagina –– GA10.B3 Endometriosis of fallopian tube –– GA10.B4 Superficial ovarian endometriosis –– GA10.B5 Deep ovarian endometriosis –– GA10.BY Endometriosis of other sites of the reproductive system –– GA10.BZ Endometriosis of unspecified site of reproductive system –– GA10.C0 Endometriosis of the gallbladder –– GA10.C1 Endometriosis of intestine –– GA10.C2 Endometriosis of pelvic peritoneum –– GA10.C3 Peritoneal pockets due to endometriosis –– GA10.CY Endometriosis of other sites within the digestive system –– GA10.CZ Endometriosis of unspecified site within the digestive system –– GA10.D0 Endometriosis of the bladder –– GA10.DY Endometriosis of other sites in the urinary system –– GA10.DZ Endometriosis of unspecified site in the urinary system GA11 Adenomyosis – GA12 Dyspareunia – GA13 Acquired abnormalities of vulva or perineum –– GA13.0 Polyp of vulva –– GA13.1 Low grade squamous intraepithelial lesion of vulva –– GA13.2 Hypertrophy of vulva –– GA13.3 Vulvar cyst –– GA13.4 Labial agglutination –– GA13.5 Skene duct cyst –– GA13.6 Vulvar laceration –– GA13.7 Vulvar haematoma –– GA13.Y Other specified acquired abnormalities of vulva or perineum –– GA13.Z Acquired abnormalities of vulva or perineum, unspecified – GA14 Acquired abnormalities of vagina –– GA14.0 Polyp of vagina –– GA14.1 Haematocolpos –– GA14.2 Vaginal foreign body –– GA14.3 Vaginal haematoma –– GA14.5 Leukoplakia of vagina –– GA14.6 Low grade squamous intraepithelial lesion of vagina –– GA14.Y Other specified acquired abnormalities of vagina –– GA14.Z Acquired abnormalities of vagina, unspecified – GA15 Acquired abnormalities of cervix uteri –– GA15.0 Polyp of cervix uteri –– GA15.1 Erosion or ectropion of cervix uteri –– GA15.2 Nabothian cyst –– GA15.3 Old laceration of cervix uteri –– GA15.4 Stricture or stenosis of cervix uteri –– GA15.5 Hypertrophic elongation of cervix uteri –– GA15.6 Incompetence of cervix uteri –– GA15.7 Low grade squamous intraepithelial lesion of cervix uteri –– GA15.Y Other specified acquired abnormalities of cervix uteri –– GA15.Z Acquired abnormalities of cervix uteri, unspecified – GA16 Acquired abnormalities of uterus, except cervix –– GA16.0 Endometrial glandular hyperplasia –– GA16.1 Malposition of uterus –– GA16.2 Intrauterine synechiae –– GA16.3 Haematometra –– GA16.Y Other specified acquired abnormalities of uterus, except cervix –– GA16.Z Acquired abnormalities of uterus, except cervix, unspecified – GA17 Acquired abnormalities of fallopian tube –– GA17.0 Acquired parafimbrial cyst of the fallopian tube –– GA17.1 Fimbrial agglutination –– GA17.2 Hydrosalpinx –– GA17.3 Haematosalpinx –– GA17.4 Salpingitis isthmica nodosa –– GA17.Y Other specified acquired abnormalities of fallopian tube –– GA17.Z Acquired abnormalities of fallopian tube, unspecified – GA18 Acquired abnormalities of ovary –– GA18.0 Follicular cyst of ovary –– GA18.1 Corpus luteum cyst –– GA18.2 Theca lutein cyst –– GA18.4 Para ovarian cyst –– GA18.5 Torsion of ovary, ovarian pedicle or fallopian tube –– GA18.6 Other or unspecified ovarian cysts –– GA18.7 Acquired atrophy of ovary or fallopian tube –– GA18.Y Other specified acquired abnormalities of ovary –– GA18.Z Acquired abnormalities of ovary, unspecified – GA19 Acquired abnormalities of broad ligament –– GA19.0 Haematoma of broad ligament –– GA19.Y Other specified acquired abnormalities of broad ligament –– GA19.Z Acquired abnormalities of broad ligament, unspecified – GA1Y Other specified noninflammatory disorders of female genital tract – GA1Z Noninflammatory disorders of female genital tract, unspecified – GA20 Menstrual cycle bleeding disorders –– GA20.0 Amenorrhoea –– GA20.1 Abnormal frequency of uterine bleeding –– GA20.2 Ovulation bleeding –– GA20.3 Abnormal regularity of uterine bleeding –– GA20.4 Abnormal duration of uterine bleeding –– GA20.5 Abnormal volume of uterine bleeding –– GA20.Y Other specified menstrual cycle bleeding disorders –– GA20.Z Menstrual cycle bleeding disorders, unspecified ––– GA20.00 Primary amenorrhoea ––– GA20.01 Secondary amenorrhoea ––– GA20.02 Lactational amenorrhoea ––– GA20.0Y Other specified amenorrhoea ––– GA20.0Z Amenorrhoea, unspecified ––– GA20.10 Frequent menstrual bleeding ––– GA20.11 Infrequent menstrual bleeding ––– GA20.1Z Abnormal frequency of uterine bleeding, unspecified ––– GA20.20 Intermenstrual bleeding ––– GA20.2Y Other specified ovulation bleeding ––– GA20.2Z Ovulation bleeding, unspecified ––– GA20.50 Heavy menstrual bleeding ––– GA20.51 Light menstrual bleeding ––– GA20.5Z Abnormal volume of uterine bleeding, unspecified – GA21 Nonmenstrual bleeding disorders –– GA21.0 Postcoital or contact bleeding –– GA21.Y Other specified nonmenstrual bleeding disorders –– GA21.Z Nonmenstrual bleeding disorders, unspecified – GA22 Excessive menstruation with irregular cycle – GA23 Anovulatory bleeding – GA2Y Other specified abnormal uterine or vaginal bleeding – GA2Z Abnormal uterine or vaginal bleeding, unspecified GA30 Menopausal or certain specified perimenopausal disorders – GA30.0 Menopause – GA30.1 Postmenopausal uterine bleeding – GA30.2 Postmenopausal atrophic vaginitis – GA30.3 States associated with artificial menopause – GA30.4 Menopausal hot flush – GA30.5 Menopausal osteoporosis – GA30.6 Premature ovarian failure – GA30.Y Other specified menopausal and perimenopausal disorders – GA30.Z Menopausal and perimenopausal disorders, unspecified –– GA30.00 Menopausal or female climacteric states –– GA30.01 Menopausal transition –– GA30.02 Excessive bleeding in the premenopausal period –– GA30.0Y Other specified menopause –– GA30.0Z Menopause, unspecified GA31 Female infertility – GA31.0 Primary female infertility – GA31.1 Secondary female infertility – GA31.Z Female infertility without specification whether primary or secondary –– GA31.00 Primary female infertility of uterine origin –– GA31.01 Primary female infertility of tubal origin –– GA31.0Y Primary female infertility of other specified origin –– GA31.0Z Primary female infertility of unspecified origin –– GA31.10 Secondary female infertility of uterine origin –– GA31.11 Secondary female infertility of tubal origin –– GA31.1Y Secondary female infertility of other specified origin –– GA31.1Z Secondary female infertility of unspecified origin GA32 Complications associated with medically assisted reproduction – GA32.0 Ovarian hyperstimulation syndrome – GA32.1 Bleeding after egg retrieval – GA32.2 Infection associated with medically assisted reproduction – GA32.3 Complications of attempted embryo transfer or medically assisted insemination – GA32.Y Other specified complications associated with medically assisted reproduction – GA32.Z Complications associated with medically assisted reproduction, unspecified GA33 Recurrent pregnancy loss GA34 Female pelvic pain associated with genital organs or menstrual cycle – GA34.0 Pain related to vulva, vagina or pelvic floor – GA34.1 Vaginal laxity – GA34.2 Female pelvic pain – GA34.3 Dysmenorrhoea – GA34.4 Premenstrual disturbances – GA34.5 Ovarian remnant syndrome – GA34.6 Female genital pain – GA34.Y Other specified female pelvic pain associated with genital organs or menstrual cycle – GA34.Z Female pelvic pain associated with genital organs or menstrual cycle, unspecified –– GA34.00 Vulval pain –– GA34.01 Perineal pain –– GA34.02 Vulvodynia –– GA34.0Y Other specified pain related to vulva, vagina or pelvic floor –– GA34.0Z Pain related to vulva, vagina or pelvic floor, unspecified –– GA34.20 Cyclic pelvic pain –– GA34.21 Noncyclic pelvic pain –– GA34.2Z Female pelvic pain, unspecified –– GA34.40 Premenstrual tension syndrome –– GA34.41 Premenstrual dysphoric disorder –– GA34.4Y Other specified premenstrual disturbances –– GA34.4Z Premenstrual disturbances, unspecified – GA40 Inflammatory dermatoses of the vulva – GA41 Ulcerative or erosive disorders of the vulva –– GA41.0 Vulval aphthosis –– GA41.Y Other specified ulcerative or erosive disorders of the vulva – GA42 Sensory disturbance of the vulva –– GA42.0 Vulval pruritus – GA4Y Other specified dermatoses of female genitalia GA6Y Other specified diseases of the female genital system GA6Z Diseases of the female genital system, unspecified – GA80 Ulcerative disorders of the penis or scrotum –– GA80.0 Aphthosis of penis or scrotum –– GA80.1 Ulcer of penis of uncertain nature –– GA80.Y Other specified ulcerative disorders of penis and scrotum – GA81 Miscellaneous dermatoses of male genitalia –– GA81.0 Penoscrotal pruritus –– GA81.Y Other specified dermatoses of male genitalia – GA90 Hyperplasia of prostate – GA91 Inflammatory and other diseases of prostate –– GA91.0 Chronic prostatitis –– GA91.1 Abscess of prostate –– GA91.2 Prostatocystitis –– GA91.3 Calculus of prostate –– GA91.4 Haemorrhage of the prostate –– GA91.5 Atrophy of prostate –– GA91.6 Low grade intraepithelial lesion of prostate –– GA91.Y Other specified inflammatory and other diseases of prostate –– GA91.Z Inflammatory and other diseases of prostate, unspecified GB00 Hydrocele or spermatocele – GB00.0 Encysted hydrocele – GB00.1 Infected hydrocele – GB00.2 Spermatocele – GB00.Y Other specified hydrocele or spermatocele – GB00.Z Hydrocele or spermatocele, unspecified GB01 Torsion of testis, epididymis or appendices – GB01.0 Torsion of testis – GB01.1 Torsion of epididymis – GB01.2 Torsion of hydatids – GB01.Z Torsion of testis, epididymis or appendices, unspecified GB02 Orchitis or epididymitis – GB02.0 Orchitis, epididymitis or epididymo-orchitis with abscess – GB02.1 Orchitis, epididymitis or epididymo-orchitis without abscess – GB02.Y Other specified orchitis or epididymitis – GB02.Z Orchitis or epididymitis, unspecified GB03 Atrophy of testis GB04 Male infertility – GB04.0 Azoospermia – GB04.Y Other specified male infertility – GB04.Z Male infertility, unspecified GB05 Redundant prepuce, phimosis or paraphimosis – GB05.0 Redundant prepuce – GB05.1 Frenulum breve – GB05.2 Phimosis – GB05.3 Paraphimosis – GB05.4 Adherent prepuce – GB05.Z Redundant prepuce, phimosis or paraphimosis, unspecified GB06 Certain specified disorders of penis – GB06.0 Balanoposthitis – GB06.1 Priapism – GB06.2 Penile fibromatosis – GB06.3 Mondor disease of the penis – GB06.4 Chronic penile oedema – GB06.5 Sclerosing lymphangitis of penis – GB06.Y Other specified disorders of penis – GB06.Z Disorders of penis, unspecified –– GB06.01 Irritant balanoposthitis –– GB06.02 Balanoposthitis due to infection –– GB06.0Y Other specified forms of balanitis and balanoposthitis –– GB06.0Z Balanoposthitis, unspecified GB07 Inflammatory disorders of male genital organs, not elsewhere classified – GB07.0 Inflammatory disorders of seminal vesicle – GB07.1 Inflammatory disorders of spermatic cord, tunica vaginalis or vas deferens – GB07.2 Inflammatory disorders of scrotum – GB07.Y Other specified inflammatory disorders of male genital organs, not elsewhere classified GB08 Vascular disorders of male genital organs GB0Y Other specified diseases of the male genital system GB0Z Diseases of the male genital system, unspecified GB20 Benign breast disease – GB20.0 Fibrocystic change of breast – GB20.1 Fibroadenosis of breast – GB20.Y Other specified benign breast disease – GB20.Z Benign breast disease, unspecified GB21 Inflammatory disorders of breast – GB21.0 Breast abscess – GB21.Y Other specified inflammatory disorders of breast – GB21.Z Inflammatory disorders of breast, unspecified GB22 Hypertrophy of breast GB23 Certain specified disorders of breast – GB23.0 Mammary duct ectasia – GB23.1 Fissure or fistula of nipple – GB23.2 Fat necrosis of breast – GB23.3 Atrophy of breast – GB23.4 Galactorrhoea not associated with childbirth – GB23.5 Mastodynia GB2Z Disorders of breast, unspecified – GB40 Nephritic syndrome – GB41 Nephrotic syndrome – GB42 Persistent proteinuria or albuminuria –– GB42.0 Albuminuria, Grade A2 –– GB42.1 Albuminuria, Grade A3 –– GB42.Y Other specified persistent proteinuria or albuminuria –– GB42.Z Persistent proteinuria or albuminuria, unspecified – GB4Y Other specified glomerular diseases – GB4Z Glomerular diseases, unspecified – GB50 Acute tubulo-interstitial nephritis – GB51 Acute pyelonephritis – GB52 Acute tubular necrosis – GB53 Acute renal papillary necrosis – GB54 Tubulo-interstitial nephritis, not specified as acute or chronic – GB55 Chronic tubulo-interstitial nephritis –– GB55.0 Balkan nephropathy –– GB55.1 Nephropathy induced by heavy metals –– GB55.2 Chronic urate nephropathy –– GB55.Y Other specified chronic tubulo-interstitial nephritis –– GB55.Z Chronic tubulo-interstitial nephritis, unspecified – GB56 Obstructive or reflux nephropathy –– GB56.0 Hydronephrosis with ureteropelvic junction obstruction –– GB56.1 Hydronephrosis with ureteral obstruction –– GB56.2 Hydronephrosis with ureteral orifice obstruction –– GB56.3 Hydronephrosis due to bladder obstruction –– GB56.4 Other or unspecified hydronephrosis –– GB56.5 Hydronephrosis and reflux nephropathy with vesicoureteral or vesico-uretero-renal reflux –– GB56.Y Other specified obstructive or reflux nephropathy –– GB56.Z Obstructive or reflux nephropathy, unspecified – GB57 Nephrocalcinosis – GB58 Pyonephrosis – GB59 Renal or perinephric abscess – GB5Y Other specified renal tubulo-interstitial diseases – GB5Z Renal tubulo-interstitial diseases, unspecified – GB60 Acute kidney failure –– GB60.0 Acute kidney failure, stage 1 –– GB60.1 Acute kidney failure, stage 2 –– GB60.2 Acute kidney failure, stage 3 –– GB60.Y Other specified acute kidney failure –– GB60.Z Acute kidney failure, stage unspecified – GB61 Chronic kidney disease –– GB61.0 Chronic kidney disease, stage 1 –– GB61.1 Chronic kidney disease, stage 2 –– GB61.2 Chronic kidney disease, stage 3a –– GB61.3 Chronic kidney disease, stage 3b –– GB61.4 Chronic kidney disease, stage 4 –– GB61.5 Chronic kidney disease, stage 5 –– GB61.Z Chronic kidney disease, stage unspecified – GB6Z Kidney failure, unspecified – GB70 Calculus of upper urinary tract –– GB70.0 Calculus of kidney –– GB70.1 Calculus of ureter –– GB70.Z Calculus of upper urinary tract, unspecified ––– GB70.00 Staghorn calculus ––– GB70.0Y Other specified calculus of kidney ––– GB70.0Z Calculus of kidney, unspecified – GB71 Calculus of lower urinary tract –– GB71.0 Calculus in bladder –– GB71.1 Calculus in urethra –– GB71.2 Calculus of bowel segments for urinary diversion –– GB71.Z Calculus of lower urinary tract, unspecified – GB7Z Urolithiasis, unspecified – GB80 Nonfamilial nongenetic cystic kidney disease –– GB80.0 Simple renal cyst –– GB80.1 Complex renal cyst –– GB80.2 Subscapular or perirenal urinoma –– GB80.Y Other specified nonfamilial nongenetic cystic kidney disease –– GB80.Z Nonfamilial nongenetic cystic kidney disease, unspecified – GB81 Autosomal dominant polycystic kidney disease – GB82 Autosomal dominant tubulointerstitial disease – GB83 Nephronophthisis – GB8Y Other specified cystic or dysplastic kidney disease – GB8Z Cystic or dysplastic kidney disease, unspecified GB90 Certain specified disorders of kidney or ureter – GB90.0 Nephroptosis – GB90.1 Hydroureter – GB90.2 Ureteral kinking or deviation without obstruction – GB90.3 Ischaemia or infarction of kidney – GB90.4 Renal tubular function disorders – GB90.Y Other specified disorders of kidney or ureter –– GB90.40 Hypotonia-cystinuria type 1 –– GB90.41 Pseudohypoaldosteronism type 1 –– GB90.42 Fanconi syndrome –– GB90.43 Bartter syndrome –– GB90.44 Renal tubular acidosis –– GB90.45 Renal glycosuria –– GB90.46 Tubular disorders of sodium or potassium transport –– GB90.47 Aminoaciduria –– GB90.48 Disorders of calcium or phosphate excretion –– GB90.49 Renal hypocalciuria –– GB90.4A Nephrogenic diabetes insipidus –– GB90.4Y Other specified renal tubular function disorders –– GB90.4Z Renal tubular function disorders, unspecified – GC00 Cystitis –– GC00.0 Trigonitis –– GC00.1 Infectious cystitis –– GC00.2 Contracted urinary bladder –– GC00.3 Interstitial cystitis –– GC00.Y Other specified cystitis –– GC00.Z Cystitis, unspecified – GC01 Other disorders of bladder –– GC01.0 Bladder neck obstruction –– GC01.1 Vesical fistula, not elsewhere classified –– GC01.2 Diverticulum of bladder –– GC01.3 Rupture of bladder, nontraumatic –– GC01.4 Neuromuscular dysfunction of bladder, not elsewhere classified –– GC01.Y Other specified disorders of bladder –– GC01.Z Disorder of bladder, unspecified – GC02 Urethritis and urethral syndrome –– GC02.0 Urethral abscess –– GC02.1 Nonspecific urethritis –– GC02.Y Other specified urethritis and urethral syndrome –– GC02.Z Urethritis and urethral syndrome, unspecified – GC03 Urethral stricture – GC04 Fistula of the genitourinary tract –– GC04.0 Urethral fistula –– GC04.1 Fistulae involving female genital tract –– GC04.2 Ureteral fistula –– GC04.Y Other specified fistula of the genitourinary tract –– GC04.Z Fistula of the genitourinary tract, unspecified ––– GC04.10 Vesicovaginal fistula ––– GC04.11 Fistula of small intestine to vagina ––– GC04.12 Fistula of large intestine to vagina ––– GC04.13 Female genital tract-skin fistulae ––– GC04.14 Urethrovaginal fistula ––– GC04.15 Combined urethrovesicovaginal fistula ––– GC04.16 Rectovaginal fistula ––– GC04.17 Vesicouterine fistula with severe scar or extensive tissue loss ––– GC04.18 Other combined urinary fistula with severe scar or extensive tissue loss ––– GC04.19 Combined urinary and rectal fistula including cloaca with severe scar or extensive tissue loss ––– GC04.1A Vaginal stenosis or gynatresia related to obstetric fistula ––– GC04.1Y Other specified fistulae involving female genital tract ––– GC04.1Z Fistulae involving female genital tract, unspecified – GC05 Prolapsed urethral mucosa – GC06 Urethral diverticulum – GC07 Urethral caruncle – GC08 Urinary tract infection, site not specified –– GC08.0 Urinary tract infection, site not specified, due to Escherichia coli –– GC08.1 Urinary tract infection, site not specified, due to Klebsiella pneumoniae –– GC08.2 Urinary tract infection, site not specified, due to Proteus –– GC08.Y Urinary tract infection, site not specified due to other agent –– GC08.Z Urinary tract infection, site and agent not specified – GC0Y Other diseases of urinary system GC2Z Diseases of the urinary system, unspecified – GC40 Pelvic organ prolapse –– GC40.0 Prolapse of anterior vaginal wall –– GC40.1 Prolapse of posterior vaginal wall –– GC40.2 Prolapse of the vaginal apex –– GC40.3 Uterovaginal prolapse –– GC40.4 Pelvic floor muscle disruption –– GC40.5 Urinary incontinence associated with pelvic organ prolapse –– GC40.6 Functional bladder disorders associated with pelvic organ prolapse –– GC40.Z Pelvic organ prolapse, unspecified ––– GC40.00 Incomplete anterior vaginal wall prolapse ––– GC40.01 Complete anterior vaginal wall prolapse ––– GC40.0Z Prolapse of anterior vaginal wall, unspecified ––– GC40.10 Incomplete posterior vaginal wall prolapse ––– GC40.11 Complete posterior vaginal wall prolapse ––– GC40.1Z Prolapse of posterior vaginal wall, unspecified ––– GC40.20 Incomplete apical vaginal wall prolapse ––– GC40.21 Complete apical vaginal wall prolapse ––– GC40.2Z Prolapse of the vaginal apex, unspecified ––– GC40.30 Incomplete uterovaginal prolapse ––– GC40.31 Incomplete uterine prolapse with anterior vaginal wall prolapse ––– GC40.32 Incomplete uterine prolapse with posterior vaginal wall prolapse ––– GC40.33 Incomplete uterine prolapse with anterior and posterior vaginal wall prolapse ––– GC40.34 Complete uterovaginal prolapse ––– GC40.35 Complete uterine prolapse with anterior vaginal wall prolapse ––– GC40.36 Complete uterine prolapse with posterior vaginal wall prolapse ––– GC40.37 Complete uterine prolapse with anterior and posterior vaginal wall prolapse ––– GC40.3Z Uterovaginal prolapse, unspecified ––– GC40.40 Levator avulsion from symphysis pubis ––– GC40.4Y Other specified pelvic floor muscle disruption ––– GC40.4Z Pelvic floor muscle disruption, unspecified ––– GC40.50 Stress incontinence associated with pelvic organ prolapse ––– GC40.51 Urge incontinence associated with pelvic organ prolapse ––– GC40.52 Mixed urinary incontinence associated with pelvic organ prolapse ––– GC40.53 Overflow incontinence associated with pelvic organ prolapse ––– GC40.54 Urinary incontinence, not otherwise specified with pelvic organ prolapse ––– GC40.60 Overactive bladder associated with pelvic organ prolapse ––– GC40.6Y Other specified functional bladder disorders associated with pelvic organ prolapse ––– GC40.6Z Functional bladder disorders associated with pelvic organ prolapse, unspecified – GC41 Anorectal dysfunction associated with pelvic organ prolapse – GC42 Sexual dysfunction associated with pelvic organ prolapse –– GC42.0 Diminished sensation due to vaginal or introital laxity –– GC42.1 Obstructed intercourse – GC4Z Female pelvic floor dysfunction, unspecified GC50 Functional bladder disorders, not otherwise specified – GC50.0 Overactive bladder – GC50.1 Absent or diminished bladder sensation – GC50.Y Other specified functional bladder disorders, not otherwise specified – GC50.Z Functional bladder disorders, not otherwise specified, unspecified –– GC50.10 Absent or diminished bladder sensation associated with pelvic organ prolapse –– GC50.1Y Other specified absent or diminished bladder sensation –– GC50.1Z Absent or diminished bladder sensation, unspecified GC51 Female Genital Mutilation – GC51.0 Female Genital Mutilation Type 1 – GC51.1 Female Genital Mutilation Type 2 – GC51.2 Female Genital Mutilation Type 3 – GC51.3 Female Genital Mutilation Type 4 – GC51.Z Female Genital Mutilation, unspecified –– GC51.00 Female Genital Mutilation Type 1a –– GC51.01 Female Genital Mutilation Type 1b –– GC51.0Z Female Genital Mutilation Type 1, unspecified –– GC51.10 Female Genital Mutilation Type 2a –– GC51.11 Female Genital Mutilation Type 2b –– GC51.12 Female Genital Mutilation Type 2c –– GC51.1Z Female Genital Mutilation Type 2, unspecified –– GC51.20 Female Genital Mutilation Type 3a –– GC51.21 Female Genital Mutilation Type 3b –– GC51.2Z Female Genital Mutilation Type 3, unspecified GC70 Postoperative adhesions of vagina GC71 Prolapse of vaginal vault after hysterectomy GC72 Postprocedural urethral stricture GC73 Postprocedural pelvic peritoneal adhesions GC74 Malfunction or complication of external stoma of urinary tract GC75 Malfunction of the afferent segment of a continent urinary pouch GC76 Malfunction of the efferent segment of a continent urinary pouch GC77 Postprocedural nonmenstrual uterine bleeding GC78 Postprocedural acute female pelvic inflammatory disease GC79 Disorders of breast reduction GC7A Disorders of breast augmentation GC7B Postinterventional ischemia or infarction of kidney GC8Y Other specified diseases of the genitourinary system GC8Z Diseases of the genitourinary system, unspecified – LB70 Structural developmental anomalies of cranium –– LB70.0 Craniosynostosis –– LB70.1 Wormian bones –– LB70.2 J-shaped sella turcica –– LB70.3 Macrocephaly –– LB70.Y Other specified structural developmental anomalies of cranium –– LB70.Z Structural developmental anomalies of cranium, unspecified ––– LB70.00 Plagiocephaly ––– LB70.0Y Other specified craniosynostosis ––– LB70.0Z Craniosynostosis, unspecified – LB71 Structural developmental anomalies of facial bones –– LB71.0 Hypotelorism –– LB71.1 Hypertelorism –– LB71.Y Other specified structural developmental anomalies of facial bones –– LB71.Z Structural developmental anomalies of facial bones, unspecified – LB72 Structural developmental anomalies of shoulder girdle –– LB72.0 Cervical rib –– LB72.1 Sprengel deformity –– LB72.2 Deformation of scapula –– LB72.Y Other specified structural developmental anomalies of shoulder girdle –– LB72.Z Structural developmental anomalies of shoulder girdle, unspecified – LB73 Structural developmental anomalies of spine or bony thorax –– LB73.0 Occult spinal dysraphism –– LB73.1 Structural developmental anomalies of chest wall –– LB73.2 Structural developmental anomalies of spine –– LB73.Y Other specified structural developmental anomalies of spine or bony thorax –– LB73.Z Structural developmental anomalies of spine or bony thorax, unspecified ––– LB73.10 Poland syndrome ––– LB73.11 Bifid rib ––– LB73.12 Accessory rib ––– LB73.13 Structural developmental anomalies of sternum ––– LB73.1Y Other specified structural developmental anomalies of chest wall ––– LB73.1Z Structural developmental anomalies of chest wall, unspecified ––– LB73.20 Klippel-Feil anomaly ––– LB73.21 Occipitalisation of atlas ––– LB73.22 Atlanto-axial instability or subluxation ––– LB73.23 Aplasia or hypoplasia of the odontoid process of axis ––– LB73.24 Segmentation anomalies of vertebrae ––– LB73.25 Congenital scoliosis due to congenital bony malformation ––– LB73.26 Sacralisation of the last lumbar vertebra ––– LB73.27 Lumbarisation of the first sacral vertebra ––– LB73.28 Sacrum agenesis or hypoplasia ––– LB73.29 Caudal appendage ––– LB73.2A Congenital spondylolisthesis ––– LB73.2Y Other specified structural developmental anomalies of spine ––– LB73.2Z Structural developmental anomalies of spine, unspecified – LB74 Structural developmental anomalies of pelvic girdle –– LB74.0 Developmental dysplasia of hip –– LB74.1 Congenital subluxation of hip –– LB74.2 Unstable hip –– LB74.3 Congenital coxa vara –– LB74.4 Congenital coxa valga –– LB74.5 Wide symphysis pubis –– LB74.Y Other specified structural developmental anomalies of pelvic girdle –– LB74.Z Structural developmental anomalies of pelvic girdle, unspecified – LB75 Brachydactyly –– LB75.0 Brachydactyly of fingers –– LB75.1 Brachydactyly of toes –– LB75.2 Symbrachydactyly of hands or feet –– LB75.Y Other specified brachydactyly –– LB75.Z Brachydactyly, unspecified – LB76 Triphalangeal thumb – LB77 Hyperphalangy – LB78 Polydactyly –– LB78.0 Polydactyly of the thumb –– LB78.1 Polysyndactyly –– LB78.2 Postaxial polydactyly of fingers –– LB78.3 Polydactyly of toes –– LB78.Y Other specified polydactyly –– LB78.Z Polydactyly, unspecified – LB79 Syndactyly –– LB79.0 Fused fingers –– LB79.1 Webbed fingers –– LB79.2 Fused toes –– LB79.3 Webbed toes –– LB79.Y Other specified syndactyly –– LB79.Z Syndactyly, unspecified –– LB80 Congenital deformities of fingers ––– LB80.0 Clinodactyly of fingers ––– LB80.2 Radial deviation of fingers ––– LB80.Y Other specified congenital deformities of fingers ––– LB80.Z Congenital deformities of fingers, unspecified –– LB81 Congenital deformities of toes ––– LB81.0 Clinodactyly of toes ––– LB81.Y Other specified congenital deformities of toes ––– LB81.Z Congenital deformities of toes, unspecified – LB90 Joint formation defects –– LB90.0 Humero-radio-ulnar synostosis –– LB90.1 Humero-radial synostosis –– LB90.2 Humero-ulnar synostosis –– LB90.3 Radio-ulnar synostosis –– LB90.4 Madelung deformity –– LB90.5 Congenital digital clubbing –– LB90.6 Tibio-fibular synostosis –– LB90.7 Cubitus valgus –– LB90.8 Cubitus varus –– LB90.Y Other specified joint formation defects –– LB90.Z Joint formation defects, unspecified – LB91 Congenital shoulder dislocation – LB92 Congenital elbow dislocation – LB93 Congenital knee dislocation –– LB93.0 Congenital genu recurvatum –– LB93.1 Congenital genu flexum –– LB93.Y Other specified congenital knee dislocation –– LB93.Z Congenital knee dislocation, unspecified – LB94 Congenital patella dislocation – LB95 Patella aplasia or hypoplasia – LB96 Congenital bowing of long bones –– LB96.0 Congenital bowing of femur –– LB96.1 Congenital bowing of tibia –– LB96.Y Other specified congenital bowing of long bones –– LB96.Z Congenital bowing of long bones, unspecified – LB97 Limb overgrowth –– LB97.0 Macrodactyly of fingers –– LB97.1 Macrodactyly of toes –– LB97.2 Upper limb hypertrophy –– LB97.3 Lower limb hypertrophy –– LB97.Y Other specified limb overgrowth –– LB97.Z Limb overgrowth, unspecified – LB98 Congenital deformities of feet –– LB98.0 Congenital varus deformities of feet –– LB98.1 Congenital pes planus –– LB98.2 Congenital valgus deformities of feet –– LB98.3 Congenital pes cavus –– LB98.4 Congenital vertical talus –– LB98.5 Congenital hammer toe –– LB98.Y Other specified congenital deformities of feet –– LB98.Z Congenital deformities of feet, unspecified ––– LB98.00 Talipes equinovarus ––– LB98.01 Talipes calcaneovarus ––– LB98.02 Metatarsus varus ––– LB98.0Y Other specified congenital varus deformities of feet ––– LB98.0Z Congenital varus deformities of feet, unspecified ––– LB98.20 Congenital hallux valgus ––– LB98.21 Metatarsus valgus ––– LB98.22 Talipes calcaneovalgus ––– LB98.2Y Other specified congenital valgus deformities of feet ––– LB98.2Z Congenital valgus deformities of feet, unspecified – LB99 Reduction defects of upper limb –– LB99.0 Amelia of upper limb –– LB99.1 Humeral agenesis or hypoplasia –– LB99.2 Radial hemimelia –– LB99.3 Ulnar hemimelia –– LB99.4 Congenital absence of upper arm or forearm with hand present –– LB99.5 Congenital absence of both forearm and hand –– LB99.6 Acheiria –– LB99.7 Adactyly of hands –– LB99.8 Split hand –– LB99.Y Other specified reduction defects of upper limb –– LB99.Z Reduction defects of upper limb, unspecified – LB9A Reduction defects of lower limb –– LB9A.0 Amelia of lower limb –– LB9A.1 Tibial hemimelia –– LB9A.2 Fibular hemimelia –– LB9A.3 Congenital absence of thigh or lower leg with foot present –– LB9A.4 Apodia –– LB9A.5 Adactyly of feet –– LB9A.6 Split foot –– LB9A.7 Congenital absence of both lower leg and foot –– LB9A.8 Femoral agenesis or hypoplasia –– LB9A.Y Other specified reduction defects of lower limb –– LB9A.Z Reduction defects of lower limb, unspecified – LB9B Reduction defects of upper and lower limbs – LB9Y Other specified structural developmental anomalies of the skeleton – LB9Z Structural developmental anomalies of the skeleton, unspecified LD24 Syndromes with skeletal anomalies as a major feature – LD24.0 Syndromes with micromelia – LD24.1 Bone diseases with increased bone density – LD24.2 Bone diseases with disorganised development of skeletal components – LD24.3 Spondyloepiphyseal or spondyloepimetaphyseal dysplasias – LD24.4 Spondylometaphyseal dysplasias – LD24.5 Spondylodysplastic dysplasias – LD24.6 Multiple epiphyseal dysplasia or pseudoachondroplasia – LD24.7 Multiple metaphyseal dysplasias – LD24.8 Acromelic dysplasias – LD24.9 Acromesomelic dysplasias – LD24.A Mesomelic or rhizomesomelic dysplasias – LD24.B Short rib syndromes – LD24.C Bent bone dysplasias – LD24.D Slender bone dysplasias – LD24.E Bone dysplasias with multiple joint dislocations – LD24.F Progressive ossification of skin, skeletal muscle, fascia, tendons or ligaments – LD24.G Syndromic craniosynostoses – LD24.H Dysostoses with predominant vertebral and costal involvement – LD24.J Patellar dysostoses – LD24.K Genetic bone diseases with decreased bone density – LD24.Y Other specified syndromes with skeletal anomalies as a major feature – LD24.Z Syndromes with skeletal anomalies as a major feature, unspecified –– LD24.00 Achondroplasia –– LD24.01 Hypochondroplasia –– LD24.02 Thanatophoric dysplasia –– LD24.03 Diastrophic dysplasia –– LD24.04 Chondrodysplasia punctata –– LD24.0Y Other specified syndromes with micromelia –– LD24.0Z Syndromes with micromelia, unspecified –– LD24.10 Osteopetrosis –– LD24.11 Osteopoikilosis –– LD24.1Y Other specified bone diseases with increased bone density –– LD24.1Z Bone diseases with increased bone density, unspecified –– LD24.20 Multiple osteochondromas –– LD24.21 Exostoses with anetodermia and brachydactyly type E –– LD24.22 Cherubism –– LD24.23 Yunis-Varon disease –– LD24.2Y Other specified bone diseases with disorganised development of skeletal components –– LD24.2Z Bone diseases with disorganised development of skeletal components, unspecified –– LD24.50 Achondrogenesis –– LD24.51 Hypochondrogenesis –– LD24.5Y Other specified spondylodysplastic dysplasias –– LD24.5Z Spondylodysplastic dysplasias, unspecified –– LD24.60 Pseudoachondroplasia –– LD24.61 Multiple epiphyseal dysplasias –– LD24.6Y Other specified multiple epiphyseal dysplasia or pseudoachondroplasia –– LD24.6Z Multiple epiphyseal dysplasia or pseudoachondroplasia, unspecified –– LD24.80 Langer-Giedion syndrome –– LD24.8Y Other specified acromelic dysplasias –– LD24.8Z Acromelic dysplasias, unspecified –– LD24.B0 Short rib-polydactyly syndrome –– LD24.B1 Asphyxiating thoracic dystrophy –– LD24.BY Other specified short rib syndromes –– LD24.BZ Short rib syndromes, unspecified –– LD24.G0 Pfeiffer syndrome –– LD24.G1 Crouzon disease –– LD24.G2 Apert syndrome –– LD24.GY Other specified syndromic craniosynostoses –– LD24.GZ Syndromic craniosynostoses, unspecified –– LD24.J0 Nail-patella syndrome –– LD24.JY Other specified patellar dysostoses –– LD24.JZ Patellar dysostoses, unspecified –– LD24.K0 Osteogenesis imperfecta –– LD24.KY Other specified genetic bone diseases with decreased bone density –– LD24.KZ Genetic bone diseases with decreased bone density, unspecified LD28 Syndromes with connective tissue involvement as a major feature – LD28.0 Marfan syndrome or Marfan-related disorders – LD28.1 Ehlers-Danlos syndrome – LD28.2 Genetically-determined cutis laxa – LD28.Y Other specified syndromes with connective tissue involvement as a major feature – LD28.Z Syndromes with connective tissue involvement as a major feature, unspecified –– LD28.00 Congenital contractural arachnodactyly –– LD28.01 Marfan syndrome –– LD28.0Y Other specified Marfan syndrome or Marfan-related disorders –– LD28.0Z Marfan syndrome or Marfan-related disorders, unspecified –– LD28.10 Ehlers-Danlos syndrome, classical type –– LD28.1Y Other specified types of Ehlers-Danlos syndrome – ME80 Clicking hip – ME81 Musculoskeletal chest pain –– ME81.0 Intercostal pain –– ME81.Y Other specified musculoskeletal chest pain –– ME81.Z Musculoskeletal chest pain, unspecified – ME82 Pain in joint – ME83 Rheumatism, unspecified – ME84 Spinal pain –– ME84.0 Cervical spine pain –– ME84.1 Thoracic spine pain –– ME84.2 Low back pain –– ME84.3 Sciatica –– ME84.Z Spinal pain, unspecified ––– ME84.20 Lumbago with sciatica ––– ME84.2Y Other specified low back pain ––– ME84.2Z Low back pain, unspecified – ME85 Stiffness of joint – ME86 Symptom or complaint of a body part –– ME86.0 Symptom or complaint of the ankle –– ME86.1 Symptom or complaint of the arm –– ME86.2 Symptom or complaint of the back –– ME86.3 Symptom or complaint of the chest –– ME86.4 Symptom or complaint of the elbow –– ME86.5 Symptom or complaint of the flank or axilla –– ME86.6 Symptom or complaint of the foot or toe –– ME86.7 Symptom or complaint of the hand or finger –– ME86.8 Symptom or complaint of the hip –– ME86.9 Symptom or complaint of the jaw –– ME86.A Symptom or complaint of the knee –– ME86.B Symptom or complaint of the leg or thigh –– ME86.C Symptom or complaint of the neck –– ME86.D Symptom or complaint of the shoulder –– ME86.E Symptom or complaint of the wrist –– ME86.F Symptom or complaint of joint, not otherwise specified –– ME86.G Symptom or complaint of muscle, not otherwise specified –– ME86.Y Problem of other specified body part –– ME86.Z Problem of unspecified body part ––– ME86.20 Back syndrome without radiating pain ––– ME86.21 Back syndrome with radiating pain ––– ME86.22 Symptom or complaint of the low back ––– ME86.2Y Other specified symptom or complaint of the back ––– ME86.2Z Symptom or complaint of the back, unspecified ––– ME86.D0 Shoulder syndrome ––– ME86.DY Other specified symptom or complaint of the shoulder ––– ME86.DZ Symptom or complaint of the shoulder, unspecified – ME8Y Other specified symptoms or signs of the musculoskeletal system – ME90 Clinical findings on diagnostic imaging of skull and head – ME91 Clinical findings on diagnostic imaging of limbs – ME92 Clinical findings on diagnostic imaging of other parts of musculoskeletal system –– ME92.0 Wedging of vertebra –– ME92.1 Bony erosion –– ME92.Y Other specified clinical findings on diagnostic imaging of other parts of musculoskeletal system –– ME92.Z Clinical findings on diagnostic imaging of other parts of musculoskeletal system, unspecified – ME93 Biomechanical lesions, not elsewhere classified –– ME93.0 Segmental and somatic dysfunction –– ME93.1 Subluxation stenosis of neural canal –– ME93.2 Osseous stenosis of neural canal –– ME93.3 Connective tissue stenosis of neural canal –– ME93.4 Intervertebral disc stenosis of neural canal –– ME93.5 Osseous and subluxation stenosis of intervertebral foramina –– ME93.6 Connective tissue and disc stenosis of intervertebral foramina –– ME93.Y Other specified biomechanical lesions, not elsewhere classified –– ME93.Z Biomechanical lesions, unspecified ––– ME93.40 Intervertebral disc stenosis of neural canal, head region ––– ME93.41 Intervertebral disc stenosis of neural canal, cervical region ––– ME93.42 Intervertebral disc stenosis of neural canal, thoracic region ––– ME93.43 Intervertebral disc stenosis of neural canal, lumbar region ––– ME93.44 Intervertebral disc stenosis of neural canal, sacral region ––– ME93.45 Intervertebral disc stenosis of neural canal, pelvic region ––– ME93.46 Intervertebral disc stenosis of neural canal, lower extremity ––– ME93.47 Intervertebral disc stenosis of neural canal, upper extremity ––– ME93.48 Intervertebral disc stenosis of neural canal, rib cage ––– ME93.4Y Other specified intervertebral disc stenosis of neural canal ––– ME93.4Z Intervertebral disc stenosis of neural canal, unspecified – ME9Y Other specified clinical findings in the musculoskeletal system MF1Y Other specified symptoms, signs or clinical findings of the musculoskeletal system
synonyms Other secondary osteoarthritis of other specified joint
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com